Insights into the Structure and Hydrogen Bonding Interactions of Polyglutamine Peptides Using UV Resonance Raman Spectroscopy by Jakubek, Ryan
  
Title Page  
Insights into the Structure and Hydrogen Bonding Interactions of Polyglutamine Peptides 
Using UV Resonance Raman Spectroscopy 
 
 
 
 
 
 
 
 
by 
 
Ryan S. Jakubek 
 
B.S. in Chemistry, University of Pittsburgh at Greensburg, 2013 
 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
 
The Kenneth P. Dietrich School of Arts and Sciences in partial fulfillment 
    
of the requirements for the degree of 
 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
 
2019 
 
 ii 
 
UNIVERSITY OF PITTSBURGH 
DIETRICH SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Ryan S. Jakubek 
 
 
It was defended on 
 
July 9, 2019 
 
and approved by 
 
Dr. Sunil Saxena, Professor, Department of Chemistry 
 
Dr. Sean Garrett-Roe, Associate Professor, Department of Chemistry 
 
Dr. Patrick van der Wel, Associate Professor, Zernike Institute for Advanced Materials 
 
Dissertation Director: Dr. Sanford A. Asher, Distinguished Professor of Chemistry, Department 
of Chemistry 
  
 iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © by Ryan S. Jakubek 
 
2019 
 
 
 
  
 iv 
 
Abstract 
 
Insights into the Structure and Hydrogen Bonding Interactions of Polyglutamine Peptides 
Using UV Resonance Raman Spectroscopy 
 
Ryan S. Jakubek, PhD 
 
University of Pittsburgh, 2019 
 
 
 
 
Proteins containing expanded polyglutamine (polyQ) tracts are prone to aggregation and 
fibrillization. This fibrillization is associated with many different neurodegenerative diseases 
including Huntington’s disease. The pathology of these diseases is poorly understood. This is in 
part due to the difficulty of studying the structures and fibrillization mechanism of polyglutamine 
tracts. In this work, we utilize UV resonance Raman (UVRR) spectroscopy, as well as other 
techniques, to investigate the structures and hydrogen bonding interactions of solution-state, 
fibril-state, and insoluble forms of polyQ peptides. For example, we find that solution-state 
polyglutamine peptides can be prepared in an aggregation-prone β-strand-like conformation or 
an aggregation-resistant PPII-like conformation. We find that longer polyQ peptides have an 
increased population of aggregation-prone β-strand-like conformation that may contribute to 
faster aggregation kinetics and decreased age of onset for disease symptoms. We also developed 
a method to quantitatively correlate the frequency of the amide I (AmI) Raman band to the 
hydrogen bonding strength between the glutamine side chain C=O oxygen and a hydrogen bond 
donor. Using this technique, as well as other techniques, we investigated the oligomerization and 
hydrogen bonding interactions in the various structures of polyQ peptides to examine their role 
in polyQ aggregation.  
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1.0 Introduction 
1.1 Expanded Polyglutamine Tracts, Aggregation, and Neurodegeneration 
1.1.1  CAG Codon Repeat Diseases 
The expansion of CAG codon repeats in DNA encodes elongated polyglutamine (PolyQ) 
tracts in proteins. These elongated polyQ tracts induce protein aggregation that is linked to 
numerous neurodegenerative diseases, including Huntington’s disease (HD).1 A list of CAG 
repeat neurodegenerative diseases and their symptoms is provided in Table 1.1.    
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Table 1.1: CAG Repeat Expansion PolyQ Diseases 
Disease Affected Protein Q repeat Disease 
Critical Length 
Clinical Features 
HD Huntingtin Q ≥ 36 Chorea, dystonia, cognitive defects, 
psychiatric problems 
SCA1 Ataxin1 Q ≥ 39 Ataxia, Slurred speech, spasticity, 
cognitive impairments 
SCA2 Ataxin2 Q ≥ 32 Ataxia, polyneuropathy, decreased 
reflexes, infantile variant with 
retinopathy 
SCA3 Ataxin3 Q ≥ 61 Ataxia, parkinsonism, spasticity 
SCA6 CACNA1A Q ≥ 10 Ataxia dysarthria, nystagmus, tremors 
SCA7 Ataxin7 Q ≥ 37 Ataxia, blindness, cardiac failure in 
infants 
SCA12 PPP2R2B Q ≥ 55 Ataxia, head and hand tremor, akinesia 
SCA17 TBP Q ≥ 47 Ataxia, cognitive decline, seizures, 
psychiatric problems 
SBMA Androgen 
Receptor 
Q ≥ 38 Motor weakness, swallowing, 
gynecomastia, decreased fertility 
DRPLA Atrophin Q ≥ 49 Ataxia, seizures, choreoathetosis, 
dementia 
HD, Huntington’s disease; SCA, Spinocerebellar Ataxia; SBMA, Spinobulbar Muscular 
Atrophy; DRPLA, Dentatorubral-pallidoluysian dystrophy;   
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For CAG repeat diseases, longer polyQ tracts are correlated with an increase in 
neurodegenerative disease symptom severity and patient mortality.1–5 For each disease, 
symptoms only occur if the polyQ tract surpasses a critical length. For example, Huntington’s 
disease only occurs when the polyQ tract length in the huntingtin protein has ≥36 glutamine 
(Gln) residues.1 In addition, longer polyQ tracts are correlated to a younger age of onset for 
disease symptoms.5   
The presence of insoluble, polyQ-rich protein aggregates is observed in the neurons of 
patients suffering from CAG repeat diseases.6,7 These aggregates generally appear as round or 
rod-shaped and are located in cell nuclei. The number of intranuclear inclusions is correlated 
with neuronal cell death, the severity of disease symptoms, and the length of the protein’s polyQ 
tract.7 Thus, polyQ-rich protein aggregates are thought to play an important role in CAG repeat 
disease pathology. 
1.1.2  Toxicity of PolyQ in CAG Repeat Diseases 
Much evidence suggests that CAG repeat diseases result from the protein gaining a toxic 
function as a result of the expanded polyQ tract. For example, Ordway et al. showed that 
expanded polyQ tracts will cause neurodegeneration and the formation of intraneuclear 
inclusions when included in a protein that is not naturally associated with CAG repeat diseases.8 
This suggests that toxicity originates from a gain-of-function from the expanded polyQ tract 
rather than a loss-of-function for a specific protein. In addition, it has been observed that polyQ 
peptides alone, outside of the context of a specific protein, can cause neurodegeneration.9,10  
Though CAG repeat diseases are thought to result from protein gain-of-function, there is 
evidence to suggest that protein loss-of-function could also contribute to disease symptoms. 
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Studies have shown that wild-type huntingtin protects neuronal cells from various apoptotic 
stimuli.11,12 This suggests that neurodegenerative disease symptoms for HD may partially result 
from loss-of-function of the huntingtin protein. In addition, Dragatsis et al. have shown that 
when huntingtin expression is disrupted, mice show neurological alterations similar to those in 
Huntington’s disease.13 
The toxic species of CAG repeat diseases is currently debated. The correlation between 
the presence of intranuclear inclusions and neuronal death suggests that the aggregate species 
may play a role in toxicity.7 In addition, Yang et al. showed that synthetic, aggregated polyQ 
peptides are toxic to mammalian cells when introduced to the nuclei.14 However, evidence also 
suggests that aggregation of polyQ-rich proteins may protect against neurodegeneration. For 
example, Arrasate et al. found that neuronal death is inversely correlated to the formation of 
Huntingtin aggregates.15 
There is also evidence that monomeric proteins containing expanded polyQ tracts may be 
neurotoxic. For example, Nagai et al. found that a monomeric polyQ-rich protein species causes 
cytotoxicity when introduced to cultured cells.16  Also, Trottier et al.17 showed that monoclonal 
polyQ antibodies will recognize polyQ expansions in HD, Spinocerebellar Ataxia 1 (SCA1), and 
Spinocerebellar Ataxia 3 (SCA3), and that the binding affinity increases with polyQ length. 
From this they concluded that the antibody binds to a unique conformation of polyQ that is more 
prevalent for longer polyQ tracts. This study lead to the hypothesis that the toxic species might 
be a low concentration monomeric species that increases in concentration with polyQ tract 
length. However, the data by Trottier et al. could also result from the antibodies kinetically 
trapping polyQ conformations that are not otherwise populated. Also, the results of Trottier et al. 
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can be explained by the linear lattice effect, where increased binding of the antibody is due to an 
increase in epitopes for longer polyQ tracts.18,19  
1.2 Protein Structure 
The structure of a protein plays a large role in dictating its function. Thus, a detailed 
understanding of the pathology of CAG repeat diseases requires detailed knowledge of the 
structures of polyQ-rich proteins and peptides in their solution-state and aggregate forms. In this 
section we review the general motifs of protein structure.  
Proteins are described as having four levels of structure: primary, secondary, tertiary, and 
quaternary structure (Figure 1.1).20 The primary structure of a protein is the sequence of amino 
acids that comprise the protein.20 Secondary structure refers to regular local conformations of the 
protein that are generally stabilized by short-range backbone-backbone hydrogen bonding.20  
Tertiary structure is a description of the completely folded protein that includes the packing of 
the secondary structural units by long-range interactions.20 Finally, quaternary structure describes 
the structure of a protein that contains separate subunits that assemble.20   
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Figure 1.1: Depiction of the primary, secondary, tertiary, and quaternary levels of protein folding. 
 Figure adapted with permission from Figure 3.23 from Lehninger principles of biochemistry 7ed by David L. 
Nelson and Michael Cox. Copyright 2017 by W.H. Freeman and Company. Used by permission of the 
publisher Macmillan Learning. Data from PDB ID 1HGA, R. Liddington et al., J. Mol. Biol. 228:551, 1992.   
 
1.2.1  Peptide Backbone Torsion Angles 
A protein or peptide’s secondary structure is predominately defined by three torsion 
angles of the peptide backbone denoted Ψ (psi), Φ (phi), and ω (omega) (Figure 1.2).21 The ω 
angle describes rotation around the Ci-Ni+1 bond. Because the Ci-Ni+1 bond has partial double 
bond character, the ω torsion angle is restricted to predominantly ~180°. Because the ω angle 
rotation is restricted, a peptide’s secondary structure can be described by the Ψ and Φ torsion 
angles for each of its peptide bonds.21 
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Figure 1.2: Peptide backbone showing the Ψ, Φ, and ω torsion angles.  
  
The Ψ torsion angle describes rotation of the Cαi-Ci bond and is defined as the dihedral 
angle between the NiCαiCi and CαiCiNi+1 planes. The Φ torsion angle describes rotation of the Ni-
Cαi bond and is defined as the dihedral angle between the Ci-1NiCαi and NiCαiCi planes. Φ and Ψ 
torsion angles of 0° denote the cis conformation for the torsion angle. Clockwise rotation of the 
respective bond is denoted by positive angles while counterclockwise rotation is denoted by 
negative angles (Figure 1.3).   
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Figure 1.3: Neumann projections of the Φ and Ψ torsion angles showing the dependence of the 
angle on bond rotation.  
 
A peptide’s secondary structure can be visualized by plotting the backbone torsion angles 
on a Ramachandran plot where the Φ angle is the abscissa and the Ψ angle is the ordinate (Figure 
1.4). As observed in Figure 1.4, certain regions of the Ramachandran plot are essentially 
forbidden due predominantly to steric restrictions.21 Also, different protein secondary structures 
populate different regions of the Ramachandran plot. Thus, knowledge of a protein’s 
Ramachandran Ψ and Φ angles allows for a detailed determination of its secondary structure.    
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Figure 1.4: Ramachandran plot of common Ψ and Φ torsion angles. Dark blue shading indicates commonly 
populated regions while light blue shading indicates slightly less populated regions. White portions of the plot 
are rarely populated. The position of common secondary structures is indicated on the Ramachandran plot. 
Horton, Robert A; Moran, Laurence A.; Scrimgeour, Gray; Perry, Marc; Rawn, David, Principles Of 
Biochemistry, 4th, ©2006. Reprinted by permission of Pearson Education, Inc., New York. 
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1.2.2   Amino Acid Side Chain Structure 
The amino acid side chain structures can also be defined by the torsion angles of rotatable 
bonds that comprise the side chain. The side chain torsion angles are denoted as χ1, χ2, χ3, etc. 
where χ1 describes rotation of the Cα-Cβ bond, χ2 describes rotation of the Cβ-Cγ bond, and so on 
(Figure 1.5). The possible conformations of side chains are dependent on the peptide backbone 
secondary structure with different secondary structures sterically forbidding certain side chain 
conformations.22,23     
 
 
Figure 1.5: Arginine amino acid with side chain atoms and torsion angle labeled. 
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1.3 Secondary Structure Motifs 
1.3.1  Helix Structures 
There are a variety of helical peptide backbone conformations each with a different 
number of amino acids per helical turn (Figure 1.6a). The α-helix is a right handed helix that 
contains 3.6 amino acid residues per turn of the helix and has characteristic backbone (Φ,Ψ) 
angles of (-57°,-47°).21,24,25 α-helix structures are stabilized by hydrogen bonding interactions 
between the C=O group of every ith residue with the N-H group of every i+4th residue.21 
In contrast, the 310-helix (Figure 1.6b) contains 3 residues per helical twist with 
characteristic (Φ,Ψ) angles of about (-49°,-26°) in peptides.21,24,25 The 310-helix is stabilized by 
the ith residue backbone C=O hydrogen bonding to the i+3rd N-H group.21 The backbone 
hydrogen bonding in the 310-helix is weaker than that of the α-helix.26 As a result, the 310-helix 
conformation is less stable and less common compared to α-helices.26,27 
Another helical structure is the π-helix (Figure 1.6c),which consist of a right handed helix 
with (Φ,Ψ) angles of (-57°,-70°).24,25 The π-helix contains 4.4 residues per helical turn and is 
stabilized by hydrogen bonding between the C=O group of the ith residue and the N-H group of 
the i+5th residue of the helix.26 As with the 310-helix, the π-helix is less common than the α-helix 
because the hydrogen bonding interactions stabilizing the π-helix are less favorable.26  
The polyproline II (PPII) -helix (Figure 1.6d)contains (Φ,Ψ) angles of (-75°,150°).28 The 
PPII-helix conformation does not allow for the formation of backbone-backbone hydrogen bonds 
and has a large exposed surface allowing for extensive water-peptide hydrogen bonding.29   
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Figure 1.6: Backbone structure of an (a) α-helix, (b) 310-helix, (c) π-helix, and (d) PPII-helix.   
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1.3.2  β-Sheet and β-Strand Structures 
β-strand structures are extended peptide chain conformations. Multiple adjacent β-strands 
can form inter-β-strand hydrogen bonds to form a β-sheet. Adjacent β-strands within a β-sheet 
can either be oriented in the same N- to C- terminal direction, parallel β-sheet (Figure 1.7a), or in 
the opposite N- to C- terminal direction, antiparallel β-sheet (Figure 1.7b). The inter-β-strand 
hydrogen bonds in parallel β-sheets are weaker compared to that in the antiparallel β-sheets. As a 
result the antiparallel β-sheet structure is more stable compared to the parallel β-sheet.21 The Φ 
and Ψ angles in β-sheets occupy a broad region of the Ramachandran plot.21 Antiparallel β-
sheets have (Φ,Ψ) angles found at about (-139°,135°) while that of parallel β-sheets have (Φ,Ψ) 
angles found at about (-119°,113°).24,25    
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Figure 1.7: Structure of (a) antiparallel and (b) parallel β-sheets.  The dotted lines show inter-β-strand 
hydrogen bonding. 
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1.3.3  Intrinsically Disordered Proteins 
Intrinsically disordered proteins (IDP) or protein domains contain little secondary and 
tertiary structure. Instead they have a flexible, random-coil-like behavior that is thought to play 
an important role in their biological functions.30   
 
1.4 Polyglutamine Peptide Structure 
1.4.1  Solubilization of PolyQ Peptides 
In general polyQ peptides have low solubility in water.31 The solubility of polyQ peptides 
can be increased by adding polar amino acids to the C- and N-termini of  polyQ tracts32, 
however, even with the addition of polar residues, long polyQ tracts (Q>~20) are generally 
observed to be insoluble in water.31 This severely hinders experimental investigations of 
solution-state polyQ peptide structures and their aggregation mechanism(s).  
To circumvent this, Chen et al. developed a procedure to solubilize polyQ peptides.31 
This procedure involves dissolving and incubating polyQ in a 1:1 hexafluoroisopropanol (HFIP) 
trifluoroacetic acid (TFA) mixture. After 0.5-4 hours of incubation at room temperature, the 
HFIP/TFA solvent is evaporated, and the peptide is re-dissolved in water or buffer. This 
procedure is known as disaggregation because the procedure is thought to remove the presence 
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of small aggregates that seed aggregation without affecting the structure of the peptide.33 
However, the mechanism by which disaggregation solubilizes polyQ peptide is not completely 
understood.   
1.4.2  Proposed Solution-State Structures 
Experimental34–36 and computational37–39 studies suggest that polyQ peptides are 
predominantly disordered in solution. However, there is evidence that polyQ tracts can adopt 
transient secondary structures that may play a role in polyQ aggregation.16,40 The structure of 
solution-state polyQ peptides was found to be similar, regardless of polyQ tract length.37,38,41,42 
This includes polyQ tract lengths below and above the pathogenic threshold.  
The disordered structure of polyQ tracts was found to significantly differ from a true 
random coil polymer.37 Experimental studies have shown that longer polyQ peptides have a more 
collapsed structure.43,44 It is thought that this is caused by a decrease in the water solvent quality 
for longer polyQ peptides with water being a good solvent for Q<16, a theta solvent for Q=16, 
and a poor solvent for Q>16.43–45 The decrease in solvent quality with increasing polyQ length is 
thought to drive the formation of inter- and intra-peptide hydrogen bonds promoting polyQ 
aggregation.  
1.4.3  Proposed Fibril Structures 
PolyQ peptide aggregates grown in vitro exhibit many amyloid-like features, including 
fibril-like morphologies in electron microscopy (EM) images,33,46 β-sheet structural features,47–50 
thioflavin T (ThT) binding,35 and cross-β-like X-ray diffraction patterns.32,46,49 Early structural 
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models of polyQ fibrils were based on X-ray diffraction data. Because single crystalline polyQ 
fibrils could not be prepared, X-ray diffraction cannot provide atomic resolution structures. As a 
result, the structural models derived from X-ray powder patterns can be interpreted in multiple 
ways.    
In 1994, from x-ray diffraction data, Max Perutz and coworkers proposed a polar zipper 
structure for fibrils grown from the peptide D2Q15K2.
32 In this model polyQ forms a cross β-
structure composed of β-sheets, where the β-strand direction is perpendicular to the long axis of 
the fibril. However, Perutz et al.51 later proposed a water-filled nanotube structural model from 
the same x-ray diffraction data (Figure 1.8a). The water-filled nanotube structure consists of a 
cylindrical β-sheet structure, where successive turns in the cylinder are stabilized by side chain-
side chain and backbone-backbone hydrogen bonds. Sikorski and Atkins49 later reinterpreted the 
X-ray diffraction data of Perutz et al.32  and proposed a cross-β fibril structure that has a different 
structure and hydrogen bonding interactions compared to the models proposed by Perutz et al. 
(Figure 1.8b).32,51 
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Figure 1.8: PolyQ fibril models. (a) water-filled nanotube model of polyQ fibrils developed by Perutz et al.51 
The red line indicates the peptide backbone, the black lines indicate Gln side chains, and the dotted lines 
indicate hydrogen bonds. (b) cross-β structural model developed by Sikorski and Atkins.49 In (b), the “a” axis 
indicates the direction of the fibril axis, the “b” axis is orthogonal to the fibril axis and β-sheet plane, and the 
“c” axis is parallel to the β-strand direction. The blue and red highlighting indicate side chain-side chain 
hydrogen bonds and the yellow highlighting indicate the canonical backbone-backbone hydrogen bonding 
found in a β-sheet. Figure (a) adapted with permission from Perutz M. F., et al. PNAS 2002, 99 (8), 5591–
5595. Copyright 2002 Proceedings of the National Academy of Sciences of the United States of America. 
Figure (b) adapted with permission from Sikorski P. et al. Biomacromolecules. 2005, 6 (1), 425–432. 
Copyright 2005 American Chemical Society.  
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In addition, various other experimental techniques, such as NMR,50,52–54 IR,55,56 and UV 
resonance Raman46,57 (UVRR) spectroscopies, have been used to obtain detailed information on 
the polyQ fibril structure. These spectroscopic studies have investigated many important 
structural aspects of polyQ fibrils, such as, for example, the structure of the Gln side chains46,52 
and the structure of fibril monomer unit.46,52,55  
1.4.4  PolyQ Aggregation 
Wetzel and coworkers have intensively investigated the kinetics and mechanism of polyQ 
peptide aggregation.33,35,48,58–60 They found that polyQ peptide aggregation consists of an initial 
lag phase before aggregation begins.33 This is consistent with a nucleation-dependent 
aggregation process. Longer polyQ peptides were found to have shorter lag phases and faster 
aggregation kinetics.33 However, when seeded with pre-formed polyQ aggregates, no lag phase 
is observed.33 From these data they propose that polyQ aggregation occurs via a nucleation-
dependent aggregation mechanism, where the nucleus is a thermodynamically unfavorable 
polyQ conformation, such as a β-hairpin structure (Figure 1.9).58 Kar et al.58 proposes that the 
nucleus size for polyQ aggregation is dependent on the peptide length, with Q>25 having 
monomeric nuclei and Q<25 having oligomeric nuclei. However, monomeric nuclei are 
uncommon in nucleation-dependent aggregation processes.35  
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Figure 1.9: Possible aggregation mechanisms of polyQ peptides. The mechanisms shaded in gray are those 
proposed by the Wetzel group, where aggregation occurs through a monomeric nucleus and monomer is then 
recruited onto the nucleus or growing fibril. The mechanism in white is that proposed by the Pappu group, 
where polyQ peptides aggregate into unordered oligomers that then convert to fibrils. Reprinted with 
permission from Vitalis A., et al.  Biophys. J. 2009, 97 (1), 303–311. Copyright 2015 American Chemical 
Society. 
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In contrast, Pappu and coworkers have used computational methods to propose an 
alternative mechanism for polyQ fibrillization.37,38,45,61 They argue that polyQ peptides form 
disordered, high molecular weight oligomers that convert into fibrils (Figure 1.9).61 Both 
computational37,38 and experimental43,44 results indicate that longer polyQ peptides increasingly 
favor peptide-peptide interactions over peptide-water interactions. Water was found to be a good 
solvent for Q<16, a theta solvent for Q=16, and a poor solvent for Q>16.43–45 The preference for 
peptide-peptide interactions in long polyQ peptides is thought to drive polyQ aggregation and 
eventually fibril formation.43,45  
1.5 The need for Novel Techniques to Investigate Polyglutamine Structure 
As shown above, there is a lack of consensus in the current understanding of polyQ 
peptide solution-state structure, fibril structure, and aggregation mechanism. Numerous 
techniques, such as NMR, IR, and X-ray crystallography, have provided great insight into the 
structures of polyQ peptides. Each technique provides a unique way of investigating polyQ 
structure and elucidates different aspects of the polyQ solution and/or fibril structures. Further 
insights into the structures of polyQ peptides necessitate the development and use of new 
techniques that can investigate different structural aspects polyQ peptides. 
UVRR spectroscopy is a relatively new biophysical tool that can elucidate the structure 
proteins and peptides.62 Recently the Asher group has characterized a variety of UVRR spectral 
markers that are sensitive to peptide structure and hydration.63 This includes the structure and 
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hydration of the peptide backbone64,65 as well as a variety of amino acid side chains.66–72 These 
spectroscopic markers have been used to probe peptide and protein structure73–76 including recent 
work investigating the structure of polyQ peptides.46,57 The work described in this dissertation 
continues to develop and use UVRR spectroscopy as a tool for the investigation of polyQ 
structure.   
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2.0 Raman Scattering 
When light is incident on a molecule, a fraction of that light is scattered. Most of the 
scattered light is at the same frequency as the incident light. This elastic scattering is referred to 
as Rayleigh scattering. In contrast, Raman scattering is an inelastic light scattering phenomenon 
where the scattered light is frequency shifted with respect to the incident light. The frequency 
shift of the Raman scattered light is equal to the frequency of a molecular vibration. Therefore, 
the spectrum of Raman scattered light provides a vibrational spectrum of the analyte of interest. 
Here we give a brief discussion on Raman theory topics that are important to understand this 
work.  For a complete description of Raman theory we direct you to the work of Derek A. 
Long.77    
2.1 Classical Theory of Rayleigh and Raman Scattering 
 
In Rayleigh and Raman light scattering, incident light induces an oscillation of a 
molecule’s electrons, producing an induced oscillating dipole. This induced oscillating dipole is 
the source of the scattered light. The intensity of radiation produced from an oscillating electric 
dipole is given by: 
 
 𝐼 = 𝑘 𝜔𝑠
4 𝑝0
2 𝑠𝑖𝑛2𝜃       2.1 
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where I is the intensity of the scattered light, k is a constant, ωs is the frequency of the scattered 
light, p0 is the amplitude of the dipole moment, and θ is the angle between the scattered light 
propagation vector and the dipole moment vector. The dipole moment amplitude (p0) is the 
product of the molecule’s polarizability (α) and the amplitude of the electric field (E0) produced 
by the incident light: 
 
 𝑝0 = 𝛼𝐸0 2.2 
 
where E0 is the electric field vector of coherent radiation of frequency ω1, and α is the molecule’s 
polarizability. The molecule’s polarizability is predominantly constant, resulting in an induced 
electric dipole (p0) that oscillates at the same frequency as the incident light (ωs). This results in 
scattered light at the incident frequency (ω1). However, the polarizability of the electrons in the 
molecule is dependent on the molecule’s normal coordinates. As the molecule vibrates, its 
normal coordinates and polarizability changes. This produces a component of the dipole (p0) that 
oscillates at a frequency different from that of the incident light. This component of the dipole 
produces Raman scattered light where the frequency shift of the light is equal to the frequency of 
the molecular vibration (ω1 ± ωk).   
The variation of polarizability with a molecule’s vibration can be expressed by expanding 
the polarizability in a Taylor series with respect to the vibrational normal coordinate (Qk): 
 
 
α =  α0 +∑(
∂α
∂Qk
)
0
Qk…  
k
 
                                2.3 
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where the “0” subscript denotes that the value is taken at the molecule’s equilibrium 
configuration, and k is a given normal mode of the molecule. Equation 2.3 can be written as: 
 
 α =  α0 + α′kQk                   2.4 
 
where 
 
 
α′k = ∑(
∂α
∂Qk
)
0
 
k
 
 
                2.5 
 
The time dependence of the vibrational normal coordinate (Qk) is given by equation 2.6 
assuming simple harmonic motion: 
 
 
 Qk =  Qk0 cos(ωkt + δk)          2.6 
 
where Qk0 is the vibrational amplitude, ωk is the vibrational frequency, and δk is a phase factor. 
Combining eqs. 2.5 and 2.6 we obtain the time dependence of the polarizability with respect to 
the kth normal mode.  
 
 α =  α0 + α′kQk0 cos(ωkt + δk)      2.7 
 
The incident radiation’s electric field oscillates at frequency ω1: 
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 E = E0 cos(ω1t)      2.8  
 
where E0 is the electric field amplitude. Thus, 
 
 p = αE = α0E0 cos(ω1t) + α′kQk0 E0cos(ωkt + δk) cos(ω1t) 2.9 
 
The first term of 2.9 is a component of the dipole that oscillates at the incident light 
frequency (ω1), giving rise to Rayleigh scattering. In the second term the dipole oscillates at a 
frequency dependent on the incident light frequency and kth normal mode frequency, giving rise 
to Raman scattering. It is also important to note that the magnitude of the second term in eq. 2.9, 
and thus the Raman scattering intensity, is dependent on the change in polarizability with respect 
to the normal coordinate at the equilibrium geometry (α'kQk0). This is referred to as the Raman 
polarizability. The second term in 2.9 can be reformulated using the following identity. 
 
 cos(A) cos(B) = 1/2(cos(A + B) + cos(A − B))                   2.10 
 
Thus  
 
 p = α0E0 cos(ω1t) + α
′
kQk0 E0 cos(ω1t − ωkt + δk)
+ α′kQk0E0cos(ω1t + ωkt + δk) 
            2.11 
 
Equation 2.11 shows that the Raman component of the induced dipole oscillates at the 
frequencies of ω1-ωk and ω1+ωk corresponding to Stokes and anti-Stokes Raman scattered light 
   27  
 
respectively. Equation 2.11 shows that the change in the polarizability of the molecule with 
respect to a normal mode of vibration gives rise to Raman scattered light. 
The classical description of Raman scattering is depicted in Figure 2.1. The frequency of 
the incident light (a) drives the oscillation of electrons in a molecule that radiate light. For the 
electric field interacting with the component of the polarizability that is constant (b), the 
resulting dipole oscillates at and emits radiation at the incident light frequency (c). In contrast, 
for an electric field interacting with a polarizability oscillating at the frequency of a molecular 
vibration (d), the resulting dipole oscillates as a beat frequency (e) with ω1, ω1-ωk, and ω1+ωk 
frequency components (f). 
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Figure 2.1: Effect of an oscillating molecular polarizability on the electric dipole induced by incident 
radiation. (see text for details) Adapted with permission from Long, D. A. The Raman Effect: A Unified 
Treatment of the Theory of Raman Scattering by Molecules; John Wiley and Sons Ltd.: Chichester, 2002. 
Copyright 2002 John Wiley and Sons Ltd..  
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2.2 Quantum Mechanical Treatment of Rayleigh And Raman Scattering 
The existence and frequency shifts involved in Raman scattering are correctly predicted 
from classical physics. However, to qualitatively understand scattering intensities we must obtain 
information on the molecule’s polarizability, which invokes a quantum mechanical treatment of 
Raman scattering. The quantum mechanical treatment of Raman theory treats the scattering 
molecule quantum mechanically and the radiation with classical physics. 
The processes of Rayleigh and Raman scattering can be visualized via the energy transfer 
model. Figure 2.2 depicts the energy transfers between the incident radiation and the molecule 
that occur in Rayleigh and Raman scattering. Rayleigh and Raman scattering can be thought of 
as a simultaneous absorption and emission processes. In non-resonance Raman and Rayleigh 
scattering, the incident light is not in resonance with an electronic transition in the molecule. 
Therefore, in the non-resonance case, the molecule undergoes virtual absorption to a virtual 
excited state that emits a photon as the molecule relaxes to a discrete quantum state of the 
system. Virtual absorption is absorption without the conservation of energy that excites to a 
virtual state of the system, which is not an eigenstate of the system.      
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Figure 2.2: Energy level diagram depicting the energy transfer that occurs for Rayleigh, Stokes Raman, and 
Anti-Stokes Raman processes. 
 
 
In Rayleigh scattering there is no transfer of energy between the molecule and the 
photon. A photon is virtually absorbed by the molecule, and the excited molecule emits a photon 
of the same frequency as it returns to the ground vibronic state. In contrast, in Raman scattering 
there is an energy exchange between an incident photon and the molecule. In Stokes Raman 
scattering, the incident photon is virtually absorbed, and the molecule relaxes to an excited 
vibrational state of the ground electronic state. As a result the emitted photon has a lower energy 
compared to the incident photon. The difference in energy between the incident photon and the 
Raman scattered photon corresponds to the energy difference between the initial (ground) and 
final (excited) vibrational energy level of the molecule. Therefore, the frequency shift of the 
Raman scattered light corresponds to the frequency of the molecular vibration (ωk) being excited. 
In anti-Stokes Raman scattering, the initial state of the molecule is an excited vibrational state. 
The molecule then virtually absorbs a photon and emits a photon as the molecule relaxes to a 
vibrational energy level lower than its initial vibrational energy level. The resulting scattered 
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photon has a higher energy, and frequency, compared to the incident photon. Below is a brief 
mathematical description of the quantum theory of Raman scattering following the work of 
Long.77 
In the quantum physics model, the classical dipole moment is replaced by the transition 
electric dipole (Pfi) that induces the transition of a molecule from state i to state f.  
 
 Pfi = ⟨ψ′f|P|ψ′i⟩                        2.12  
 
Here, Ψ’ are the molecule’s time-dependent perturbed wave functions for state i and f and 
can be represented by the following series expansions: 
 
 ψ′f = ψf
(0)
+ ψf
(1)
+⋯ψf
(n)
                         2.13  
 
and 
 
 ψ′i = ψi
(0)
+ ψi
(1)
+⋯ψi
(n)
                        2.14  
 
where ψ(0)i  is the unperturbed state, and ψ(n)i  is the nth order modification to the unperturbed 
state.  
By substituting eqs. 2.13 and 2.14 into eq. 2.12, we obtain expressions for the nth order 
modifications to the transition dipole moment. 
 
 P(0)fi = ⟨ψf
(0)|P|ψi
(0)⟩                          2.15  
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 P(1)fi = ⟨ψf
(1)|P|ψi
(0)⟩ + ⟨ψf
(0)|P|ψi
(1)⟩                             2.16  
 
 
 P(2)fi = ⟨ψf
(0)|P|ψi
(2)⟩ + ⟨ψf
(2)|P|ψi
(0)⟩ + ⟨ψf
(1)|P|ψi
(1)⟩                            2.17  
 
The first-order perturbed dipole moment (eq. 2.16) describes the Raman scattering 
phenomenon. The procedure for evaluating eq. 2.16 is outlined by Long77. Briefly, a relationship 
is obtained between the perturbed time-dependent wave functions and unperturbed time-
dependent wave functions assuming that the perturbation is entirely electric dipole in nature and 
is induced entirely by the incident electric field. The relationships are then substituted in eq. 2.16 
for the perturbed time dependent wave functions. The Raman component of the resulting 
equation is as follows: 
 
 
where, ωri = ωr-ωi, ωrf = ωr-ωf, ωs = ω1-ωfi, C.C. is the complex conjugate, Eσ0 is the σ component 
of the complex amplitude of the incident radiation electric field, and Γr is the damping factor of 
eigenstate (r) which is related to the full width and lifetime of state r. The equation is summed 
(Pρ
(1)
)fi =
1
2ℏ
∑ {
⟨f|p̂ρ|r⟩⟨r|p̂σ|i⟩
ωri −ω1 − iΓr
+
⟨f|p̂σ|r⟩⟨r|p̂ρ|i⟩
ωrf +ω1 + iΓr
}Eσ0 exp(−iωst)
r≠i,f
+ C. C. 
2.18  
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over all states r of the molecule. We have simplified the notation by substituting ψi for i and so 
on.  
Because P = αE, we can define the Raman transition polarizability as:  
 
 
(αρσ)fi =
1
ℏ
∑ {
⟨f|p̂ρ|r⟩⟨r|p̂σ|i⟩
ωri −ω1 − iΓr
+
⟨f|p̂σ|r⟩⟨r|p̂ρ|i⟩
ωrf +ω1 + iΓr
}
r≠i,f
 
     2.19  
 
 
For an induced oscillating dipole driven by incident light with a constant frequency and 
electromagnetic field amplitude, the intensity of the scattered light monitored at a given 
scattering angle from the dipole axis is proportional to the Raman transition polarizability 
squared (eq. 2.1). Thus eq. 2.19 provides insight into the intensity of Raman scattered light. 
2.3 Resonance Raman Scattering 
 
In resonance Raman scattering the incident light frequency is in resonance with an 
electronic transition. As a result, the initial (i) and final (f) states of the Raman process are in the 
ground electronic state and the transition state (r) is an excited vibronic eigenstate of the system 
(Figure 2.3). By invoking the Born-Oppenheimer approximation and neglecting Herzberg-Teller 
vibronic coupling, we obtain the following equation for the transition Raman polarizability:  
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(αρσ)efvf:egvi =
1
ℏ
∑ {
⟨vf|(p̂ρ)efer|v
r⟩⟨vr|(p̂ρ)ereg|v
i⟩
ωervr:egvi −ω1 − iΓr
ervr≠efvf:egvi
+
⟨vf|(p̂ρ)efer|v
r⟩⟨vr|(p̂ρ)ereg|v
i⟩
ωervr:efvf +ω1 + iΓr
} 
2.20  
 
 
 (p̂ρ)efer = ⟨e
f|p̂ρ|e
r⟩         2.21  
 
 
 ωervr:egvi = ωereg −ωvrvi         2.22  
 
 
where ef is the final electronic excited state, v
f is the final vibrational state, eg is the ground 
electronic state, vi is the initial vibrational state, er is the electronic eigenstate state r, and vr is the 
vibrational eigenstate r.  
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Figure 2.3: Difference between non-resonance Raman and resonance Raman scattering. In Raman scattering 
the energy of the incident light is far from any electronic transition. In resonance Raman the incident light 
energy is approximately equal to the energy required for an electronic transition.  
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From eq. 2.20 we can see how the resonance condition affects the polarizability and thus 
the intensity of Raman scattered light. As the incident light frequency (ω1) approaches the 
absorption frequency ωervr:egvi, the denominator of the first term in eq. 2.20 is minimized to 
−iΓr. As a result, the polarizability and Raman intensity is increased due to resonance.  
For resonance Raman, equation 2.20 can be simplified. The Raman transition 
polarizability will be dominated by the resonant electronic transition and the contribution of non-
resonant electronic transitions will be negligible in comparison. Thus, we can drop the sum over 
all electronic states r. In the resonance condition the second term of equation 2.20 is negligible 
compared to the first term and can be neglected. Finally, the Born-Oppenheimer principle allows 
us to separate the vibrational and electronic terms. Applying these simplifications produces:  
 
 
(αρσ)efvf:egvi =
1
ℏ
(p̂ρ)efer(p̂ρ)ereg∑{
⟨vf(g)|vr(r)⟩⟨vr(r)|vi(g)⟩
ωervr:egvi −ω1 − iΓr
}
vr
 
2.23 
 
 
For equation 2.23 to be non-zero the system must meet two conditions. Both transition 
dipole moments ((p̂ρ)efer  and (p̂ρ)ereg) must be non-zero and both vibrational overlap integrals 
(⟨vf|vr⟩ and ⟨vr|vi⟩) must be non-zero. If either condition is not met then the contribution of 
resonance to the transition polarizability and Raman intensity reduces to zero. 
The condition for non-zero transition dipole moments requires the electronic transitions 
to be electric-dipole allowed. For the vibrational overlap integrals to be non-zero, the vibrational 
wave functions of states of vf vr and vr vi must not be orthogonal, ie. the Frank-Condon 
overlaps must be non-zero. For the situation where the vibrations in the two electronic states eg 
and er are identical, the vibrational wave functions are orthogonal and the overlap integrals are 
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zero. For the vibrational overlap integrals to be non-zero the molecular vibration must have a 
different frequency in the excited state and/or there must be a shift in the potential energy 
minimum along the normal coordinate in the excited state (Figure 2.4).   
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Figure 2.4: Potential energy curves and Frank-Condon overlaps for a vibrational motion without a shift (top) 
and with a shift (bottom) in the potential energy minimum along the vibrational normal coordinate. Adapted 
with permission by Long, D. A. The Raman Effect: A Unified Treatment of the Theory of Raman Scattering 
by Molecules; John Wiley and Sons Ltd.: Chichester, 2002. Copyright 2002 John Wiley and Sons Ltd. 
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As a result, only vibrations with motions coupled to the resonant electronic transition are 
enhanced. This allows for the selective enhancement of a subset of a molecule’s normal modes 
and is quite useful in examining the vibrational spectra of macromolecules such as proteins. 
Large molecules contain a large number of vibrations that result in spectral crowding. This 
makes examining individual spectral bands difficult. The selectivity of resonance Raman greatly 
reduces spectral crowding. In addition, by judiciously selecting the frequency of the incident 
radiation, one can choose to enhance vibrations that are coupled to a specific chromophore in 
molecules containing multiple chromophores. A great example of this is for the resonance 
Raman spectra of myoglobin with different excitation wavelengths (Figure 2.5). Incident light at 
~200 nm is in resonance with the protein backbone π→π* amide absorption band resulting in 
selective enhancement of vibrations of the protein backbone. In contrast, excitation at ~229 nm 
and ~415 nm is in resonance with tyrosine/tryptophan side chains and the heme group, 
respectively, enhancing vibrations that couple to these transitions. The frequencies and 
intensities of the protein’s vibrations are sensitive to the structure and environment of the 
protein. Thus, as discussed in detail later, UVRR can be used to obtain detailed information on 
various chromophores within a protein. 
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Figure 2.5: UVRR selective enhancement of normal modes in myoglobin. Incident excitation within different 
absorption bands of the molecule selectively enhance the Raman scattering for vibrations coupled to the 
electronic transition. Reprinted with permission from Oladepo et al., Chem. Rev., 2012, 112(5), 2604-2628. 
Copyright 2012 American Chemical Society. 
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3.0 UV Resonance Raman of Proteins and Peptides 
The selective enhancement of UVRR makes it a powerful tool for investigating protein 
structure and environment.62,63 Careful selection of the incident light wavelength allows UVRR 
to probe vibrations found on different chromophores of a protein.62 Certain UVRR band 
frequencies and intensities are dependent on the structure and environment of the resonant 
chromophore.63 These spectroscopic markers can be used to obtain exquisite detail on protein 
structure. UVRR has extensively been used to probe the structure and solvation of the protein 
backbone2,4–10 and various side chains.46,66,70–72,82–85 In the following discussion, we will focus on 
how UVRR spectroscopy can be used to obtain information on the peptide backbone and Gln 
side chain, which is of importance to the UVRR study of polyQ tracts. 
3.1 Peptide Backbone and Gln Side Chain Amide Group Chromophores 
UVRR enhancement requires the incident light to be resonant with an absorption band of 
the analyte. Amide groups, such as the secondary amide of the peptide bond and primary amide 
of the Gln side chains, contain absorption bands in the deep UV (~180-190 nm) that can be 
probed with UVRR. Their strong absorption at ~180-190 nm results from the π→π* electronic 
transitions of the primary and secondary amide groups. Raman excitation wavelengths within the 
amide absorption bands will selectively enhance vibrations of the amide group.   
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3.2 The UVRR Spectrum of Proteins 
UVRR spectra of proteins collected with an excitation wavelength of ~200 nm are 
dominated by amide group Raman bands because the incident light is in resonance with the 
amide π→π* absorption band. This includes the secondary amide peptide bond and primary 
amide Gln side chains. Figure 3.1 shows a representative UVRR spectrum of a peptide excited 
with ~204 nm excitation. 
 
 
 
 
Figure 3.1: UVRR spectrum of a polyglutamine peptide (D2Q10K2) excited with 204 nm excitation.  Adapted 
with permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American 
Chemical Society. 
 
Backbone amide π→π* excitation results in a large elongation of the C-N bond along 
with a smaller elongation of the C=O bond and contraction of the C-Cα and N-Cα bonds.
86 A 
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similar structural dependence upon excitation was previously found for primary amides.72 Thus, 
the amide vibrations that have the most resonance enhancement generally contain C-N stretching 
motions. The dominant bands in the spectrum include the amide I (AmI), amide II (AmII), amide 
III (AmIII), and CαH bands. The AmI band has a frequency of ~1600-1700 cm
-1 and consists 
predominantly of C=O stretching motion62 while the AmII band is found at ~1550 cm-1 and 
consists of out-of-phase N-H bending and C-N stretching.  The AmIII bands are found in the 
~1200-1400 cm-1 spectral region and consist predominately of  in-phase N-H bending and C-N 
stretching.62 The CαH band is found at ~1350-1400 cm
-1 and contains Cα-H bending and C-N 
stretching motions.62 The motions of the amide vibrations are depicted in Figure 3.2. To avoid 
confusion we denote the amide bands of a primary amide with a “P” superscript (eg. AmIP) and 
that of a secondary amide with an “S” superscript (eg. AmIS).  
  
   44  
 
 
 
 
Figure 3.2: UVRR enhanced vibrational motions of amide groups.  Adapted with permission from Oladepo et 
al., Chem. Rev., 2012, 112(5), 2604-2628. Copyright 2012 American Chemical Society. 
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3.3 Separating Side Chain and Backbone Spectral Contributions  
Because the secondary amide peptide backbone and primary amide Gln side chains have 
similar vibrational frequencies and UVRR enhancement, it is difficult to discern their UVRR 
bands. Xiong et al. previously developed a method to selectively highlight the spectral 
contributions of either the peptide backbone or Gln side chain by collecting UVRR spectra at 
different excitation wavelengths.57 
Resonance Raman enhancement is proportional to the square of the molar absorptivity of 
the incident light.87,88 The π→π* absorption band of primary amides is at higher energy 
compared to that of secondary amides. Because of this, excitation deeper in the UV (~197 nm) 
increases the resonance enhancement for primary amide bands relative to secondary amide 
bands. 
  Xiong et al. showed that one can highlight the spectral contributions of the primary 
amide Gln side chains by exciting UVRR spectra of a protein at ~204 nm and ~197 nm and 
examining the 197-204 nm difference spectrum. In addition, the peptide backbone UVRR bands 
can be highlighted by subtracting the 197-204 nm difference spectrum from the 204 nm spectrum 
producing a 204-(197-204) nm difference spectrum. These techniques have been used 
extensively to differentiate the UVRR spectral contributions of a protein backbone and Gln side 
chains.46,57,81,82    
   46  
 
4.0 UVRR Spectroscopic Markers Sensitive to Protein Structure and Environment 
4.1 AmIII3 Band of Peptide Backbone Monitors the Ψ Angle 
Previously, Asher and co-workers discovered that the frequency of the AmIII3
S band of 
the peptide backbone sinusoidally depends on the Ramachandran Ψ angle.65 The sinusoidal 
frequency dependence originates from coupling of the Cα-H bending vibration (found at ~1400 
cm-1) to the N-H bending motion of the of the AmIII3
S vibration. Coupling between the Cα-H and 
N-H groups is strongest when the peptide bond in a trans configuration resulting in a downshift 
of the AmIII3
P band. Thus, strong coupling and a downshifted AmIII3
S band occurs for extended 
strand structures such as PPII and β-strand structures while weaker coupling and an upshifted 
AmIII3
S band occurs for α-helical structures.   
Mikhonin et al. characterized the effects of solution temperature and the peptide 
backbone solvation state on the AmIII3
S band frequency.64 From this, they derived a set of 
equations that can be used to calculate Ψ angle from an experimental AmIII3S frequency for a 
peptide backbone with various solvation environments and sample temperatures (Figure 4.1).  
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Figure 4.1: Sinusiodal dependence of the AmIII3S band frequency on the Ψ Ramachandran angle of the 
peptide backbone. The curves show the correlation where the backbone is (blue) fully hydrated, (purple) only 
C=O groups are peptide-peptide hydrogen bonded, (black) only N-H groups are peptide-peptide hydrogen 
bonded, and (green) N-H and C=O groups are both peptide-peptide hydrogen bonded. The red diamonds 
show experimental data points for the crystalline peptides (1) Ala-Asp, (2) Gly-Ala-Leu, (3) Val-Glu, (4) Ala-
Ser, (5) Val-Lys, (6) Ser-Ala, and (7) Ala-Ala. The black squares show experimental data points for peptides 
with various secondary structures. Reprinted with permission from Mikhonin et al. J. Phys. Chem. B. 2006, 
110 (4), 1928–1943. Copyright 2006 American Chemical Society. 
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The AmIII3
S band is inhomogeneously broadened because a peptide contains a 
distribution of Ψ angles. Assuming that the inhomogeneous broadening is solely due to the Ψ 
angle distribution, Asher et al. showed that one can estimate the peptide Ψ angle distribution 
from the homogenous broadening of the AmIII3
S band.74 First, the inhomogeneous AmIII3
S band 
is modeled as a sum of Lorentzian bands with a width equal to that of the homogenous AmIII3
S 
band. Raman shift is then converted into Ψ angle using one of the equations derived by 
Mikhonin et al.64 The resulting Ψ angle probability distribution is plotted as a histogram. 
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Figure 4.2: Calculating Ψ angle distribution from the inhomogenously broadened AmIII3S band.  (a) UVRR 
spectrum of peptide. (b) AmIII3S band of peptide. (c) AmIII3S band modeled as a sum of Lorentrzian bands 
with a breadth equal to the homogenous AmIII3S band width. (d) Ψ angle distribution obtained by converting 
Lorentzian band frequency to Ψ angle. 
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Assuming that the Raman cross section is constant across the breadth of the AmIII3
S 
band, the intensity of the Lorentzian peak reports the relative population of peptide bonds with 
that Ψ angle. In addition, by applying the Boltzmann relation, one can estimate the Gibbs free 
energy landscape along the Ψ angle coordinate of a peptide. These methodologies have been 
extensively used to investigate the structure of proteins and peptides. 2,4–10   
4.2 AmIII3 Band of Gln Side Chain Monitors the χ3 Torsion Angle 
 
Recently, Punihaole et al. discovered a UVRR marker band that reports on the Gln side 
chain χ3 (CβCγ-CδOε) torsion angle (Figure 4.3).71 The structurally sensitive band is referred to as 
the AmIIIP band because the vibration’s motions are very similar to that of the AmIIIS bands of 
the peptide backbone. The AmIIIP band contains primarily Cβ-Cγ stretching, NεH2 rocking and 
Cδ-Nε stretching motions of the Gln side chain.  
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Figure 4.3: Structure and atomic labeling scheme of Gln. The χ1, χ2, and χ3 torsion angles are labeled. 
 
The AmIIIP band shows a sinusoidal frequency dependence on the Gln χ3 torsion angle 
that originates from changes in hyperconjugation between the Cβ-Cγ σ and Cδ=Oε π* orbital as 
the χ3 angle is rotated. At χ3 angles approaching ~0° or ~180° the σ and π* orbitals do not 
overlap. In contrast, χ3 angles approaching ±90° have significant σ/π* orbital overlap. As a 
result, electron density shifts from the σ to the π* orbital, which decreases the electron density 
and bond force constant of the Cβ-Cγ bond. Thus, the AmIII
P band, which contains Cβ-Cγ 
stretching motion, downshifts in frequency as χ3 approaches ~±90°. Using a procedure similar to 
that described for the AmIII3
S band and Ψ angle correlation, one can estimate a χ3 angle 
distribution and Gibbs free energy landscape from the inhomogeneously broadened AmIIIP band 
(See Section 4.1). This correlation was used to investigate the Gln side chain structure in small 
polyQ peptides in the solution71 and fibril46 state(s).  
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Figure 4.4: Dependence of the AmIIIP frequency on the Gln side chain χ3 torsion angle.  The colored curves 
show the correlation for (black) crystalline experimental data, (blue) solvated Gln, (red) unsolvated Gln, and 
(yellow) Gln with unknown hydration.  The black squares show experimental data points for crystalline (1) 
L-Gln, (2) Gly-Gln, (3) D-Gln, (4) Gln t-butyl ester, (5) N-Acetyl-Gln, and (6) Ser-Asn. Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2015, 119 (41), 13039–13051. Copyright 2015 American 
Chemical Society. 
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4.3 AmI Band Sensitive to Hydrogen Bonding and Dielectric Environment 
The AmI band of both primary and secondary amides was previously shown to depend on 
the hydrogen bonding and dielectric environment of the amide group. Various publications have 
shown that N-methylacteamide (NMA) (a model compound for the peptide backbone) has a 
solvation dependant AmI frequency and intensity.89–93 Similarly, Punihaole et al. investigated the 
Raman spectrum solvation dependence of propanamide (a model compound for the Gln side 
chain) and found a dependence similar to that of NMA.72  
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Figure 4.5: Dependence of the propanamide UVRR spectrum on solvation state.  (a) UVRR spectra of 
propanamide in solvents containing different H2O/Acetonitrile fractions. (b) Frequency dependence of the 
propanamide AmI band on water mole fraction. Reprinted with permission from Punihaole et al. J. Phys. 
Chem. B. 2015, 119 (10), 3931–3939. Copyright 2015 American Chemical Society. 
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For both primary and secondary amides, the AmI band frequencies and intensities were 
found to decrease with increasing dielectric and hydrogen bonding environment of the solvent. 
These trends result from changes in the structure of the amide group. In a high dielectric 
environment, the amide group polar resonance structure (-O-C=NH+) increases in stability 
compared to the nonpolar structure (O=C-NH). Because the C=O bond force constant is weaker 
in the polar resonance structure, the AmI C=O stretching frequency decreases as the dielectric 
environment increases. In addition, the formation of stronger hydrogen bonds between the 
carbonyl (C=O) group and a hydrogen bond donor results in a decrease in the carbonyl force and 
a downshifted the AmI frequency.  
These structural changes also affect the AmI resonance Raman intensity. This occurs 
because changes between the ground and excited state normal coordinate displacement alters the 
Frank-Condon overlaps of the resonance Raman transition (see section 2.3). For example, the 
resonance enhancement of a totally symmetric normal mode is approximately proportional to the 
square of the displacement between the ground and excited state equilibrium geometries along 
the enhanced vibrational normal coordinate.94,95 The C-N and C=O bonds of the amide group are 
elongated in the π→π* excited state compared to the ground state.96 In a higher dielectric 
environment or in a stronger hydrogen bonding environment, the ground state C=O bond is 
elongated. This decreases the C=O bond displacement between the ground and excited state, 
resulting in less AmI band resonance enhancement. 
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5.0 Monomeric Polyglutamine Structures that Evolve into Fibrils  
Adapted with permission from: David Punihaole, Ryan S. Jakubek, Riley J. Workman, 
Lauren E. Marbella, Patricia Campbell, Jeffry D. Madura, and Sanford A. Asher. Monomeric 
polyglutamine structures that evolve into fibrils. The Journal of Physical Chemistry B, 2017, 
121(24), pp.5953-5967. Copyright © (2017), American Chemical Society. 
Author Contributions: D.P. and R.S.J. contributed equally to this work. D.P and R.S.J. 
collected, analyzed, and interpreted UVRR data. Computational work was performed by R.J.W. 
and analyzed by R.J.W with assistance by D.P., J.D.M., and R.S.J. DOSY NMR was performed 
by L.E.M and TEM images were collected by P.C. The manuscript was prepared by R.S.J., D.P., 
and S.A.A. with assistance by R.J.W.  
We investigate the solution and fibril conformations and structural transitions of the 
polyglutamine (polyQ) peptide, D2Q10K2 (Q10), by synergistically using UV Resonance Raman 
(UVRR) spectroscopy and Molecular Dynamics (MD) simulations. We show that Q10 adopts 
two distinct, monomeric solution conformational states, a collapsed β-strand and a PPII-like 
structure that do not readily interconvert. This clearly indicates a high activation barrier in 
solution that prevents equilibration between these structures. Using metadynamics, we explore 
the conformational energy landscape of Q10 to investigate the physical origins of this high 
activation barrier.  We develop new insights into the conformations and hydrogen bonding 
environments of the glutamine side chains in the PPII and β-strand-like conformations in 
solution. We also use the secondary structure-inducing cosolvent, acetonitrile, to investigate the 
conformations present in low dielectric constant solutions with decreased solvent-peptide 
hydrogen bonding. As the mole fraction of acetonitrile increases, Q10 converts from PPII-like 
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structures into α-helix-like structures and β-sheet aggregates. Electron microscopy indicates that 
the aggregates prepared from these acetonitrile-rich solutions show morphologies similar to our 
previously observed polyQ fibrils.  These aggregates re-dissolve upon the addition of water! 
These are the first examples of reversible fibril formation.  Our monomeric Q10 peptides clearly 
sample broad regions of their available conformational energy landscape. The work here 
develops molecular-level insight into monomeric Q10 conformations and investigates the 
activation barriers between different monomer states and their evolution into fibrils.   
 
5.1 Introduction 
Expansions of genomic “CAG” codon repeats are associated with at least 10 
neurodegenerative disorders, including Huntington’s disease.1 CAG repeats encode for expanded 
polyglutamine (polyQ) tracts in proteins.  These expanded polyQ tracts cause proteins to 
aggregate into amyloid-like fibrils, which are the pathological hallmarks of CAG repeat diseases. 
The penetrance and severity of these diseases correlate with the length of the polyQ repeat 
expansion. In Huntington’s disease,5,97 for example, repeats between 17–30 glutamines in the 
huntingtin protein are generally considered benign, whereas repeat lengths that exceed 36 
residues typically result in fibrils and the manifestation of disease symptoms. 
Although flanking sequences are known to influence aggregation kinetics and 
mechanisms,40,48 the expanded polyQ protein segments are the only apparent commonality 
shared by CAG repeat diseases. For this reason, investigating the structures of polyQ peptides 
enables the molecular understanding of how glutamine repeats cause protein misfolding and 
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aggregation.  Indeed, previous studies show that aggregates prepared in vitro from model polyQ 
peptides share many characteristic features with pathologically relevant amyloid-like fibrils, 
including displaying filamentous morphologies, binding Thioflavin-T, and exhibiting β-sheet-
rich structures.35,36 
Many experimental studies suggest that soluble polyQ peptides are structurally 
disordered in aqueous solution.34–36,41,98 Other studies, however, suggest that polyQ peptides 
contain small populations of “folded” structures, which are hypothesized to be putative cytotoxic 
agents.16 Computational investigations37–39,99 support the experimental finding that polyQ 
peptides, regardless of repeat length, are largely disordered, with only transient elements of 
regular secondary structures such as α-helices, β-sheets, and turns. 
Although polyQ peptides are structurally disordered, they do not behave as true random 
coil polymers.97 Several studies37,38,43–45,61,100 suggest that the end-to-end distances of polyQ 
peptides deviate significantly from random coils, since they adopt relatively collapsed, globule-
like structures. In addition, detailed analyses of circular dichroism (CD) and nuclear magnetic 
resonance (NMR) spectra98 show that that polyQ peptides possess a high propensity towards 
adopting polyproline II-like (PPII-like) secondary structures, although not necessarily forming 
long, continuous segments. 
Despite numerous studies, several important aspects of polyQ peptide structure in 
solution remain poorly understood. For example, little is known about the solution-state 
structural change(s) of polyQ peptides that lead to fibril nucleation and growth. One model, by 
Wetzel and coworkers,35 proposes that fibril nucleation is initiated by an energetically 
unfavorable structural conversion from “random” coil to β-sheet. An alternative model, proposed 
by Pappu and coworkers,38 argues that polyQ peptides adopt disordered globule structures, which 
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non-specifically aggregate into high molecular weight oligomers that subsequently convert into 
β-sheet-rich fibrils. 
A detailed understanding of the conformational energy landscape that controls the 
solution-state structural propensities of polyQ peptides would yield valuable insights that could 
resolve some of the current debates in the field. Unfortunately, standard biophysical methods 
only achieve limited insight into the solution state structure of disordered proteins and peptides, 
such as polyQ.101,102 Incisive progress requires the use of new experimental and computational 
biophysical tools. 
In the work here, we investigate the ensemble of solution-state structures and the 
conformational energy landscape of the model peptide system, D2Q10K2 (Q10), by synergistically 
utilizing UVRR spectroscopy and MD simulations. This work builds upon our previous study by 
Xiong et al.57  
Figure 5.1 schematically summarizes the new insights that we develop in this work 
regarding the conformational energy landscape of Q10. We find that Q10 can be poised to exist 
in two distinct, monomeric conformational states in aqueous solution. One of these states is in a 
collapsed β-strand-like structure (Figure 5.1a) that readily aggregates into amyloid-like fibrils 
(Figure 5.1e). The other state is a predominately PPII-like structure (Figure 5.1b) that resists 
aggregation. 
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Figure 5.1: Summary of polyQ solution energy landscapes. 
 Figures (a) and (b) show the potential wells for the aqueous Q10 β-strand and PPII states observed. 
Conformation (c) depicts the α-helix-like conformations observed in ~50% acetonitrile/water solutions. 
Conformation (d) derives from Q10 β-sheet fibrils formed in high acetonitrile concentrations. These fibrils re-
dissolve in high water content acetonitrile/water solutions. Conformation (e) derives from irreversibly formed 
Q10 β-sheet fibrils grown in water. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 
121 (24), 5953–5967. Copyright 2017 American Chemical Society. 
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The collapsed β-strand and PPII-like structures do not readily interconvert, which 
indicates that there is a large energy barrier that prevents these two states from equilibrating in 
solution.  Using metadynamics, we simulate the conformational energy landscape of Q10 and 
investigate the origin of this high energy barrier. Overall, we find excellent, quantitative 
agreement between the simulation results and our UVRR data. This enables us to use our 
experimentally validated simulations to gain detailed, molecular-level structural insights into the 
conformational ensemble of Q10 in solution.  
We also investigate the impact of low hydrogen bonding and dielectric environments on 
Q10 peptide structure. We measure the UVRR spectra of Q10 in different mixtures of 
acetonitrile and water. We find that, at moderate concentrations of acetonitrile, PPII-like 
conformations convert into structures comprised of predominately α-helix-like and turn 
structures (Figure 5.1c), while high concentrations of acetonitrile induce the formation of β-sheet 
fibrils (Figure 5.1d) and non-fibrillar aggregates. Surprisingly, fibrils prepared from high 
acetonitrile concentrations re-dissolve in water-rich solutions.    
5.2 Experimental Section 
5.2.1  Materials 
The 14-residue D2Q10K2 (Q10) peptide was purchased as a lyophilized powder from CPC 
Scientific at ≥95% purity.  Trifluoroacetic acid (TFA) and 1,1,1,3,3,3-Hexafluoro-2-propanol 
(HFIP) were purchased at ≥99% purity from Acros and Fluka, respectively. Far-UV grade 
   62  
 
acetonitrile (CH3CN) was purchased from Acros. Optima-grade H2O was purchased from Fisher 
Scientific, and D2O (99.9 atom % D) was purchased from Cambridge Isotope Laboratories, Inc. 
 
5.2.2  Sample Preparation 
Non-disaggregated Q10 (NDQ10) and disaggregated Q10 (DQ10) samples were prepared 
as described previously by Xiong et al.57 NDQ10 solutions were prepared by directly dissolving 
the peptide in pure water. DQ10 solutions were prepared by utilizing a disaggregation protocol 
based on the one developed by Wetzel and coworkers.31 Briefly, DQ10 samples were prepared 
by suspending the lyophilized peptide powder in a 1:1 (v/v) mixture of TFA and HFIP. The 
samples were sonicated for 20 min and incubated at room temperature for 2 h. The solvents were 
evaporated under a gentle stream of dry N2 gas for ∼30 min. The peptide film was dissolved in 1 
mL of water. DQ10 peptide solutions were then diluted to their final concentrations with water.  
Raising the pH of monomeric NDQ10 increases its propensity to aggregate.  To avoid this, we 
investigated both NDQ10 and DQ10 solutions at pH values that ranged between pH 2 to pH 3.  
The NDQ10 monomer solutions were also found to be very sensitive to impurities that nucleated 
aggregation into light scattering particles, which we presumed were dominated by β-sheet 
conformations. We scrupulously cleaned all vials used for sample preparation to remove 
nucleating centers.   
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5.2.3  UV Resonance Raman (UVRR) Spectroscopy 
The UVRR instrumentation used is described in detail by Bykov et al.103 The ∼204 nm 
UV light was generated by Raman shifting the third harmonic of a Nd:YAG Infinity laser 
(Coherent, Inc.) in H2 gas (∼30 psi) and selecting the fifth anti-Stokes line. The laser light was 
focused onto a spinning Suprasil quartz NMR tube containing the samples. A ∼165° 
backscattering geometry was used. The scattered light was dispersed using a home-built 
subtractive double monochromator and detected with a liquid N2 cooled, back-thinned 
Spec10:400B CCD camera (Princeton Instruments) with a Lumogen E coating. The spectrometer 
resolution was ∼5 cm−1. A detailed description of the spectral processing and fitting is given in 
Appendix A.  
 
5.2.4  NMR Diffusion Measurements 
All 1H diffusion NMR spectra were acquired with an 11.7 T magnet with a Bruker 
AVANCE III 500 console (Bruker Biopsin, Billerica, MA) at 298 K. NDQ10 and DQ10 
solutions were prepared at 1 mg·mL-1 in 90% D2O. Spectra were recorded with a stimulated echo 
bipolar pulsed field gradient pulse sequence. The WATERGATE pulse sequence was used for 
water suppression.104 The maximum strength of the gradient coil was 0.5 T·m-1 and was varied 
from 5–95% during the measurements. The decay of the NMR signal integrated area, I, as a 
function of the applied gradient strength, G, is described by the Stejskal-Tanner equation:105 
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     5.1  
 
 
 
where I0 is the initial intensity, γ is the gyromagnetic ratio of 1H, δ is the length of the gradient 
pulse (2.5 ms),  is the diffusion time (50 ms), τ is the time between bipolar gradient pulses, and 
D is the apparent diffusion coefficient. 
5.2.5  Transmission Electron Microscopy (TEM) 
Quantifoil 400 mesh copper grids were glow discharged using an EmiTech Glow 
Discharge unit for 70 s at 25 mA. Aliquots of 4 µL Q10 solutions were placed onto the freshly 
prepared glow discharged grids, rinsed with double distilled H2O, and stained with 4% (w/v) 
uranyl acetate. Samples were imaged in a FEI Tecnai 20F Electron Microscope. Images were 
collected using a Gatan Ultrascan 4K CCD camera at 30,000 and 50,000× magnification. 
5.3 Computational Methods 
5.3.1  General Simulation Details 
Metadynamics simulations were used to explore the Q10 conformational landscape. 
Constrained MD simulations were used to investigate the stabilities of the 2.51-helix and PPII 
structures. The different peptide conformations were all constructed with the Molecular 
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Operating Environment (MOE 2013.10) software suite.106 The initial, solvated Q10 peptides 
were energy minimized for 10000 steps using the conjugate gradient method. All peptide models 
were solvated with 6681 TIP3P water molecules in a periodic box with dimensions of 60 × 60 × 
60 A3. The NAMD software package (version 2.11)107 was used for all MD simulations. The 
trajectory data were analyzed using VMD 1.9.2 and native Tcl scripting.108 All MD simulations 
were run at the TACC supercomputer facility, while Q10 peptide models were prepared and 
energy minimized on a 4-core iMac desktop. 
Potential energies were calculated with the CHARMM36 force field.109 CHARMM36 
contains the CMAP110 dihedral corrections intended to decrease α-helix bias and stabilize β-
strand secondary structure. The particle mesh Ewald algorithm111 was used with a grid spacing of 
1.0 A to calculate full system electrostatics. An integration time step of 2 fs was used. All 
simulations were carried out under NPT conditions, with a Langevin thermostat and piston to 
regulate the temperature at 300 K and pressure at 1.01325 bar.112 The pair list distance was 14.0 
Å, the pair interaction cutoff was 12 .0 Å, and the switch distance was 10.0 Å. 
5.3.2  Metadynamics Simulation Details 
The initial Q10 monomer used in the metadynamics simulation was constructed by using 
a fully extended peptide with Ramachandran (Φ, Ψ) dihedral angles of 180°. The initial, solvated 
Q10 peptide systems were energy minimized for 10000 steps using the conjugate gradient 
method followed by 50 ps of equilibration. The data used to construct the free energy landscape 
was collected over the next 1.0 µs of simulation time. 
   66  
 
To specify the Q10 conformational space, we defined three collective variables that 
monitored the root mean square deviation (RMSD) of a Q10 structure relative to the idealized α-
helix, β-hairpin, and PPII reference structures. The α-helix and PPII reference structures were 
created with MOE, whereas the β-hairpin reference structure was taken from preliminary 
metadynamics simulation results (coordinate files available for download). The RMSD was 
measured using only the peptide α-carbon positions. The maximum RMSD coordinate was set to 
12.0 Å from the reference structure. This upper limit was maintained by applying a 1.0 kcal · 
mol−1 · Å−1 half-harmonic potential constraint. This three dimensional conformational energy 
landscape approach has been successfully employed by us previously.113–115 
In our metadynamics simulations, artificial potentials in the form of Gaussian functions 
were added every 500 steps. The height of added Gaussian functions started at 1.0 kcal · mol−1, 
and their width was 3.0 Å. Well-tempered metadynamics116 was used to streamline sampling of 
the conformational energy landscape. This protocol is a variation of the original metadynamics 
algorithm developed by Laio and Parrinello117 that utilized a gradual decrease in the height of 
added Gaussians throughout the simulation. This allowed shallow energy wells to be filled in 
quickly, while deeper energy wells filled more slowly. This method allows the deeper energy 
wells to be explored in finer detail during the simulation data collection run. 
Coordinates for low-energy structures were extracted from the trajectory based on RMSD 
values and the Gaussian deposition history. Hydrogen bonding analysis of structures found in 
low energy wells was performed with VMD’s Hydrogen Bond analysis module. The Ψ and χ3 
dihedral angles were extracted from the simulation trajectories with a Tcl script, which is 
available for download. A heavy atom distance of <3.5 Å and a bond angle of 18030) was used 
to define a hydrogen bond. Metadynamics free energy data and collective variable history were 
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processed with two respective Python scripts, which are available for download. Script 1 
identifies the energy landscape positions for structures of interest from the potential of mean 
force (pmf) file. Script 2 searches the metadynamics trajectory and identifies the structures that 
match the RMSD values found using script 1. 
 
5.3.3  Constrained MD Simulation Details 
We used constrained MD simulations to investigate the energies of Q10 in PPII and 2.51-
helix conformations constructed with (Φ, Ψ) angles of (−75°, 150°) and (−130°, 177°), 
respectively. In the constrained MD simulations, harmonic constraints were placed on the Φ and 
Ψ dihedral angles for the Q10 peptides. These constraints ensured that the 2.51-helix and PPII 
peptides would retain their respective secondary structures throughout the simulations. A force 
constant of 0.25 kcal · mol−1 · Å−1 was used for each dihedral constraint and the constraints were 
applied with the Collective Variables module in NAMD. 
For the constrained MD simulations the solvated Q10 peptides were energy minimized 
for 10000 steps using the conjugate gradient method. The peptide systems were equilibrated for 
1 ns, followed by data collection runs of 200 ns. Peptide potential energies were calculated using 
the NAMD Energy module. Bond, angles, dihedral angles, van der Waals interaction energies, 
and electrostatic energies were calculated for every frame of the trajectory output files. Energies 
were averaged using a simple Python script. The hydrogen bonding analysis of these constrained 
MD simulations was also performed with VMD’s Hydrogen Bond module. The hydrogen bond 
parameters were the same as those described in the metadynamics section above. 
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5.4 Results And Discussion 
To maximize clarity, we include numbered bold headings that highlight the most 
important polyQ structural discoveries made here that are visually summarized in Figure 5.1.  
5.4.1  Solution-State Structures of Q10 in H2O 
Our previous study by Xiong et al.57 examined the solution-state conformations of Q10, 
and suggested that it exists in two different solution-state conformations that depend on the 
sample preparation method. Preparing Q10 using a standard “disaggregation” protocol31 (forms a 
solution containing the peptide denoted as DQ10, see Experimental Section for details) results in 
an ensemble of predominately PPII-like peptide conformations. In contrast, non-disaggregated 
Q10 (denoted NDQ10) dissolved in water adopts a distinctly different conformation that Xiong 
et al.57 proposed was a mainly β-hairpin conformation.   
We re-measured the UVRR spectra of DQ10 and NDQ10. Figure 5.2 shows 
representative ∼204 nm excited UVRR spectra of the DQ10 and NDQ10 peptides dissolved in 
H2O. The DQ10 UVRR spectra are essentially identical to those measured previously by Xiong 
et al.,57 who investigated DQ10 peptide solutions at pH 7. In contrast, the NDQ10 UVRR spectra 
(Figure A.7) differ significantly from that of Xiong et al.57 It appears that Xiong et al’s.57 NDQ10 
samples had begun to aggregate.  The sensitivity of NDQ10 monomers to nucleation of 
aggregation may have caused these spectral differences.  Thus, we have altered our assignment 
of the NDQ10 solution monomer conformation.  
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Figure 5.2: Representative 204 nm UVRR spectra of NDQ10 and DQ10. 
 Assignments of the AmIIIS region for (a) DQ10 and (b) NDQ10 are shown. The peptide solutions were 
prepared at 0.3 mg·mL-1 concentrations. Spectra from three independent replicates were globally fit using a 
minimum sum of Gaussian and Lorentzian bands, as described in Appendix A. Reprinted with permission 
from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical 
Society.  
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5.4.2  UVRR Shows that DQ10 Populates PPII and 2.51-helix Conformations, While 
NDQ10 Populates β-strand-like Conformations 
UVRR excitation at ∼200 nm occurs within the NV1 electronic transitions of the 
secondary and primary amides of the peptide backbone and glutamine side chains57. Thus, the 
Figure 5.2 ∼204 nm excitation UVRR spectra of polyQ peptides are dominated mainly by 
resonance enhanced bands that derive from primary and secondary amide (Am) vibrations, 
which we denote with the superscripts P and S, respectively. 
The Figure 5.2 spectra show the structurally sensitive extended AmIIIS region between 
1180 to 1380 cm−1.62 The DQ10 and NDQ10 spectra were curve-fit using a new, more rigorous 
and self-consistent global analysis, as described in Appendix A (Figure A.1).  Both the DQ10 
and NDQ10 UVRR spectra show bands at ∼1355 cm−1, ∼1320 cm−1, and ∼1295 cm−1. The 1355 
cm−1 features are assigned to a mainly Cα–H rocking mode based on our previous normal mode 
analyses of glutamine.41 The peaks at 1320 cm−1 and 1295 cm−1 are the AmIIIS1 and AmIII
S
2 
bands, respectively62,64,65,118,119. However, we note that the AmIIIS1 and AmIII
S
2 overlap with 
additional weaker bands that are due to CH2 twisting modes of the glutamine side chains. 
The AmIIIS3 region of DQ10 (Figure 5.2a) is similar to that of Xiong et al. with bands at 
∼1275 cm−1, ∼1265 cm−1, ∼1250 cm−1, and ∼1215 cm−1. In contrast the AmIIIS3 region of 
NDQ10 contains bands at ∼1240 cm−1 and ∼1265 cm−1, which significantly differs from spectra 
reported by Xiong et al.57 The difference in the NDQ10 solution state spectra is most likely due 
to some aggregation of Xiong et al.’s NDQ10 sample, since their spectrum is more similar to that 
of our NDQ10 fibrils.46 Additionally, our recent insights into the UVRR spectra of glutamine 
shows that the ~1265 cm-1 band derives from CH2 wagging of the glutamine side chain instead of 
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an AmIIIS3 vibration.
71
  As discussed below, our new understanding of the UVRR spectrum of 
NDQ10 modifies our assignment of the NDQ10  solution conformation.  
 
5.4.3  Ramachandran Ψ Angle Distributions of DQ10 and NDQ10 
The AmIIIS3 band is the most structurally sensitive spectroscopic marker of the peptide 
backbone conformation because its frequency depends on the Ramachandran Ψ dihedral 
angle.64,65 As discussed in detail by Asher and coworkers,65 this sinusoidal frequency dependence 
derives from the coupling of the Cα–H bending vibration with the N–H bending component of 
the AmIIIS3. This coupling is strong for β-strand and PPII-like structures, where the Cα–H and 
N–H groups are approximately in a cis-configuration, which downshifts the AmIIIS3 frequency. 
In contrast, for α-helical structures, the Cα–H and N–H groups are in a trans configuration. This 
decouples the Cα–H and N–H bending motions, which results in an upshift of the AmIIIS3 band 
frequency. 
We utilized the structural sensitivity of the AmIIIS3 band to estimate the Ramachandran Ψ 
angle distributions for DQ10 and NDQ10 in solution. To do this, we employed the methodology 
of Mikhonin et al.64 (see Appendix A for details), which correlates the frequencies of the AmIIIS3 
band envelopes to the peptide bond Ψ angles. This enables us to roughly estimate the probability 
distribution of peptide bond Ψ angles that derive from the inhomogenously broadened AmIIIS3 
bandshape. 
Figure 5.3a and c shows the Ψ angle distributions of DQ10 and NDQ10. The Ψ angle 
distribution of DQ10 is essentially identical to that reported by Xiong et al.,57 consisting of three 
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prominent peaks located at ∼10°, ∼150°, and ∼175°. The peak located at 150° is indicative of 
PPII-like conformations, while the peak centered at 10° indicates the presence of turn-like 
structures. The peak centered at 175° suggests that a significant fraction of DQ10 peptide bonds 
adopt 2.51-helix-like conformations.  
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Figure 5.3: Comparison of Ψ and χ3 angle distributions measured by UVRR and calculated by MD. 
Comparison between DQ10 Ψ angle distributions measured by (a) UVRR to (b) MD structures found in state 
B. Comparison between NDQ10 Ψ angle distributions measured by (c) UVRR to (d) MD structures found in 
state A. Comparison between DQ10 χ3 angle distributions measured by (e) UVRR to (f) MD structures found 
in state B.  Comparison between NDQ10 χ3 angle distributions measured by (g) UVRR versus (h) MD 
structures found in state A. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 
5953–5967. Copyright 2017 American Chemical Society.  
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           The NDQ10 Ψ angle distribution (Figure 5.3c) shows a peak located at ∼140° indicative 
of β-strand conformations. In contrast to the NDQ10 Ψ angle distribution of Xiong et al., we do 
not observe a peak at Ψ ∼−40° that they assigned to turn structures.  
5.4.4  Hydrogen Bonding Environment of DQ10 and NDQ10 Side Chains 
Our previous study of primary amide vibrations shows that the AmIP and AmIIP bands 
report on the hydrogen bonding and dielectric environments of the glutamine side chain C=O and 
NH2 groups, respectively.
90 Xiong et al. showed that ∼198 nm excitation enhances the primary 
amide UVRR bands significantly more than the secondary amide bands.57 As a result, the 
primary amide bands can be selectively studied by calculating the difference spectrum between 
∼198 nm and ∼204 nm excitation UVRR spectra. 
Figure 5.4 shows the 198 nm – 204 nm UVRR difference spectra of DQ10 and NDQ10. 
The AmIP (mostly C=O stretching) and AmIIP (NH2 scissoring) bands of DQ10 are located at 
∼1680 cm−1 and ∼1614 cm−1, respectively. In NDQ10, the AmIP frequency downshifts to ∼1660 
cm−1, although a prominent shoulder remains at ∼1680 cm−1. As with DQ10, the AmIIP band of 
NDQ10 is located at ∼1614 cm−1. The most intense bands in the 198 nm – 204 nm UVRR 
difference spectra appear at ∼1437 cm−1 for DQ10 and ∼1414 cm−1 for NDQ10. We assign these 
bands to a complex vibration that contains CH2 wagging, as well as significant contributions of 
C–C stretching, CH2 scissoring, and side chain C-N stretching.  The C-N stretching component 
of this vibration likely contributes to its UVRR enhancement. 
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Figure 5.4: UVRR 198 nm – 204 nm difference spectra of Q10. The spectra are of (a) DQ10 reported by 
Xiong et al.57 and (b) NDQ10 reported in this work. Reprinted with permission from Punihaole et al. J. Phys. 
Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical Society. 
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As shown in Table 5.1, the AmIP and AmIIP band frequencies of DQ10 are similar to 
those of monomeric glutamine in water. This indicates that the primary amide C=O and NH2 
groups of DQ10 are predominately hydrogen bonded to water. In contrast, the AmIP band of 
NDQ10 is downshifted to ∼1660 cm−1, suggesting that a significant population of side chain 
C=O groups are involved in intrapeptide hydrogen bonding. Additionally, the shoulder at ∼1680 
cm−1 suggests that there is also a population of NDQ10 side chain C=O groups that hydrogen 
bond to water molecules.  
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Table 5.1: Glutamine, DQ10, and NDQ10 Primary Amide UVRR Band Frequencies in Water (cm−1). 
Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 
American Chemical Society. 
Vibration Glutamine (cm-1) DQ10 (cm-1) NDQ10 (cm-1) 
AmIP 1679 1680 1680 (sh) 
1655 
AmIIP 1620 1614 1614 
CH2 wag 1427 1437 1432 (sh) 
1414 
AmIIIP 1110 1099 1106 
 
sh: shoulder 
 
In contrast, the AmIIP band frequency of NDQ10 (~1614cm-1) indicates that its side chain 
NH2 groups predominately hydrogen bond to water. Thus, we conclude that NDQ10 side chain 
C=O moieties must be hydrogen bonded to the NH groups of the peptide backbone. This 
conclusion is supported by a recently published report by Walsh et al.120 who showed that small, 
gas phase glutamine dipeptides with a β-strand-like conformation preferentially form hydrogen 
bonds between side chain C=O groups and backbone NH groups. 
5.4.5  Glutamine Side Chain χ3 Angle Distributions of DQ10 and NDQ10 
We recently discovered a side chain UVRR primary amide vibration that shows a 
cosinusoidal frequency dependence on the O–C–C–C dihedral angles of glutamine and 
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asparagine side chains (designated as the χ3 and χ2 dihedral angles, respectively).71 This vibration, 
which we call the AmIIIP, is reminiscent of the AmIIIS3 vibration because it derives from an in-
phase combination of side chain C-N  stretching and NH2 rocking motions (instead of peptide 
backbone C–N stretching and N–H bending of the AmIIIS3). It should be noted however, that Cβ–
Cγ stretching also contributes to the AmIII
P vibration. 
The structural sensitivity of the AmIIIP derives from hyperconjugation between the side 
chain C=O π* and Cβ–Cγ σ orbitals.71 When hyperconjugation is strong (e.g. at χ3 ∼ ±90°) 
electron density is transferred from the Cβ–Cγ to the C=O bond. This elongates the Cβ–Cγ bond 
and reduces the Cβ–Cγ stretching force constant. As a result, the AmIIIP frequency downshifts. In 
the absence of hyperconjugation (e.g. at χ3 ∼0°), the Cβ–Cγ bond length shortens and the AmIIIP 
frequency upshifts. 
We examined the AmIIIP bands of the Figure 5.4 UVRR difference spectra of NDQ10 
and DQ10 to determine their χ3 angle distributions (see Appendix A for details). As discussed 
previously by Punihaole et al.,71 the AmIIIP frequency of DQ10 at ∼1099 cm−1 correlates to a χ3 
distribution centered at ∼−30° and/or ∼20° (Figure 5.3e).  This result is similar to that of aqueous 
glutamine.71 For NDQ10 (Figure 5.3g), the AmIIIP band peaks at ∼1106 cm−1, which correlates 
to χ3 angle distributions that are centered at ∼−12° and/or ∼3°.  
5.4.6  DQ10 and NDQ10 are Monomers in Aqueous Solution 
We used diffusion-ordered NMR spectroscopy (DOSY) to measure the diffusion 
coefficients of DQ10 and NDQ10. Figure 5.5a and b show representative signal decays of NMR 
peaks corresponding to Gln side chain N-1H resonance for DQ10 and NDQ10 respectively. We 
   79  
 
fit these decays to eq. 5.1 and obtained diffusion coefficients of 1.91(7) × 10−10 m2·s and 1.79(3) 
× 10−10 m2·s for DQ10 and NDQ10, respectively. Assuming a sphere, we roughly estimate that 
both coefficients are consistent with diffusion of monomeric peptides with Stokes radii of ∼13-
14 Å. The fact that DQ10 and NDQ10 are monomers in solution is also supported by our UVRR 
hydrogen-deuterium exchange (HX) measurements (see Appendix A for details). As shown in 
Figure 5.5c, the HX exchange  times of DQ10 and NDQ10 are essentially identical, ∼5.5 min, 
consistent with other monomeric peptides.121 
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Figure 5.5: DOSY NMR and HX UVRR data for DQ10 and NDQ10.  The data indicate that DQ10 and 
NDQ10 are monomers in solution. Representative DOSY NMR signal decays for (a) DQ10 and (b) NDQ10. 
The measured diffusion coefficients for DQ10 and NDQ10 are 1.91(7) × 10−10 m2/s and 1.79(3) × 10−10 m2/s, 
respectively. (c) HX kinetics of DQ10 and NDQ10 are similar, showing time constants of ∼5.5 min, which are 
similar to those of monomeric peptides of similar molecular weights. Reprinted with permission from 
Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical Society. 
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5.4.7  Qualitative Evidence of a Large Activation Barrier between the DQ10 and the 
NDQ10 Solution Monomer Conformations 
We found that the solution conformations of DQ10 and NDQ10 do not readily 
interconvert.  Additionally, Xiong et al. 23 showed that the soft, possibly-crystalline solids, 
formed upon evaporating DQ10, retain their solution-state conformation. These observations 
suggest that the NDQ10 and DQ10 solution conformations lie in separate deep energy wells. The 
high activation barrier between NDQ10 and DQ10 effectively prevent conformational transitions 
and equilibration between their respective structures.   
5.4.8  ~2-Fold Decreased H-bonding Solvent Transforms DQ10 from a PPII-like to an α-
helix-like-conformation, while a >3-Fold Decreased H-bonding Solvent Transforms DQ10 
to β-sheet Fibril Conformations. 
We investigated the conformational transitions of DQ10 in less hydrogen bonding, lower 
dielectric constant acetonitrile/water solvent mixtures. The addition of acetonitrile, is expected to 
promote inter- and intramolecular peptide hydrogen bonding by reducing the solvent’s ability to 
hydrogen bond.122 Figure 5.6a shows the UVRR spectra of DQ10 in a series of water/acetonitrile 
mixtures. Compared to DQ10 in pure water, the relative intensity of the AmIIIS3 band decreases 
as the mole fraction of water decreases to XH2O = 0.44.  At mole fractions below XH2O = 0.44, the 
AmIIIS3 band downshifts to ∼1230 cm−1 and increases significantly in relative intensity. The 
dramatic spectral changes that occur at low mole fractions of water are accompanied by the 
formation of large, visually evident aggregates. 
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Figure 5.6: Dependence of the 204 nm UVRR Spectra of DQ10 on the H2O/CD3CN solvent composition. (a) 
Dependence of the Amide III band on solvent composition. The spectra were smoothed using a Savitzy-Golay 
filter with a second order polynomial over a 15 point spectral window. (b) Calculated Q10 β-sheet (black), 
PPII-like (red), and α-helix-like (blue) UVRR basis spectra (see Appendix A, Figure A.2 for details). (c) 
Relative fractions of PPII-like (red), α-helix-like (blue), and β-sheet (black) secondary structures as a function 
of H2O mole fraction.  The error bars were determined from three independent experiments. Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American 
Chemical Society. 
  
   83  
 
 
 
The spectra shown in Figure 5.6a were modeled as a linear combination of basis spectra 
to determine the relative fraction of different secondary structures. We found that the spectra 
could be satisfactorily modeled using a linear combination of PPII-like, α-helix-like, and β-sheet 
basis spectra (shown in Figure 5.6b).  Our modeling procedure and methods used to calculate the 
basis spectra are discussed in detail in Appendix A (Figure A.1 and Figure A.2).   
Figure 5.6c shows the relative fractions of the different secondary structure 
conformations of DQ10 as a function of the acetonitrile/water solvent composition, while Figure 
5.7 shows the consequent Ψ angle distributions. The UVRR data indicate that the DQ10 peptide 
bonds adopt both PPII-like and α-helix-like conformations (Figure 5.1c) at intermediate 
water/acetonitrile mole fractions (XH2O = 0.76 or XH2O =0.42), while at lower mole fractions of 
water (χH2O = 0.24) DQ10 forms β-sheet-rich aggregates (Figure 5.1d). These data agree with our 
measured CD spectra shown in Figure A.3 of Appendix A. 
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Figure 5.7: Ramachandran Ψ Angle Distributions of DQ10 in different H2O/CD3CN Mixtures.  The 
distributions shown in red correspond to PPII-like structures, in blue to α-helix-like structures, and in black 
to β-sheet structures. The Ψ angle distributions were determined from the Figure 5.6b basis spectra (see 
Appendix A for details) and scaled according to the relative fractions of PPII-like, α-helix-like, and β-sheet 
structures reported in Figure 5.6c. Reprinted with permission from Reprinted with permission from 
Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical Society.  
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The distributions shown in Figure 5.7b and c that derive from peptide bonds in “α-helix-
like” conformations (shown in blue) possess two broad populations of Ψ angles centered at −25° 
and 100°. The distributions indicate that the peptide bonds do not derive from canonical α-helix 
conformations. Instead, they suggest that a large fraction of these structures likely derive from 
310-like helices (indicated by the distribution peak at −25°), interspersed by turn structures 
(indicated by the peak located at ∼100°). However, the breadth of these distributions indicates 
that the DQ10 peptide bonds also populate Ψ angles indicative of more canonical α-helix 
conformations, as well as small populations of π-helices. 
In addition to dominant α-helix-like and PPII-like conformations, a small population of 
peptide bonds adopt β-sheet-like structures in acetonitrile/water mixtures where XH2O = 0.44. 
However, at lower water mole fractions (χH2O = 0.30), the PPII-like and α-helix-like structures 
convert almost entirely into β-sheet structures (Figure 5.6c and Figure 5.7d, e). The formation of 
these β-sheet structures coincides with the appearance of visually evident aggregates.   
TEM images (Figure 5.8) indicate that these β-sheet aggregates consist of oligomers and 
mature amyloid-like fibrils. At χH2O = 0.44 (Figure 5.8a), we observe both fibrillar and 
oligomeric aggregates; however, at χH2O = 0.26 (Figure 5.8b), we observe essentially only fibrils.  
Replacement of water with increasing amounts of acetonitrile destabilizes PPII-like structures 
because the solvent is less competitive for hydrogen bonding to the backbone peptide bonds. As 
a result, Q10 adopts α-helix-like and turn conformations, which can satisfy hydrogen bonding 
through intramolecular interactions. However, at high concentrations of acetonitrile, hydrogen 
bonding must involve inter-peptide chain hydrogen bonding, thus forming aggregates and β-
sheet-rich fibrils.  
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Figure 5.8: Representative TEM images of DQ10 aggregates.  Aggregates were prepared in (a) XH2O =0.44 
solution and (b) XH2O = 0.26 solution. The white arrows point to non-fibrillar aggregates.  Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American 
Chemical Society.  
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The morphologies and UVRR spectra of the DQ10 fibrils prepared at low mole fractions 
of water are similar to fibrils prepared by Punihaole et al.46 in aqueous NDQ10 and DQ10 
monomer solutions at 60°C and pH 7 ( 
Figure 5.1e). Punihaole et al. found that the fibrils prepared from both DQ10 and NDQ10 
peptide solutions in this manner were composed of extended β-strands that predominately 
assembled into antiparallel β-sheets, although a minor population of parallel β-sheets were also 
observed. Here, we also observe that ∼95% of the peptide bonds adopt antiparallel β-sheet 
conformations in fibrils prepared in acetonitrile/water mixtures. 
5.4.9  Fibrils Aggregated in Low H-bonding Solvent Re-dissolve in Water into the NDQ10 
Monomer Solution Conformation. 
In contrast to fibrils prepared from DQ10 monomers by Punihaole et al. 46, those prepared 
from the acetonitrile solutions re-dissolve in water ( 
Figure 5.1a and d). These re-dissolved aggregates show a UVRR spectrum identical to 
the solution-state, monomeric NDQ10 conformations (see Figure A.4). This result significantly 
differs from fibrils formed via incubation in water, which irreversibly form fibrils.  
We investigated the side chain and backbone amide hydrogen bonding in DQ10 fibrils 
grown in acetonitrile by examining their 197–204 nm and 204-(197-204) nm UVRR difference 
spectra respectively (Figure A.8 and Figure A.9). We observe an AmIS frequency at ~1670 cm-1 
and an AmIP frequency at ~1663 cm-1. In contrast, DQ10 fibrils grown in water have AmIP and 
AmIS frequencies of 1664 cm-1 and 1661 cm-1 respectively.46 The AmIIIS3 band of fibrils 
prepared in acetonitrile is essentially identical to that grown in water.46 This suggests that the 
   88  
 
peptide backbone structures of these fibrils are essentially the same.  Thus, we conclude that the 
AmIP and AmIS frequency differences must be attributed to changes in hydrogen bonding of the 
side chain and backbone amide groups respectively. Based on this conclusion, our data suggest 
that, compared to aqueous solution, fibrils prepared from DQ10 in acetonitrile have similar side 
chain C=O and NH2 hydrogen bonding strengths, but much weaker peptide backbone hydrogen 
bonding strengths. The weakened backbone hydrogen bonding interactions may destabilize the 
fibril structure causing fibrils grown in acetonitrile to dissolve when exposed to more water.         
Interestingly, DQ10 fibrils grown in ~90% acetonitrile and re-dissolved in 50% 
acetonitrile/50% water show CD spectral signatures characteristic of NDQ10 collapsed β-
strands, with no indication of α-helix-like conformations (Figure A.5). At intermediate 
acetonitrile concentrations, DQ10 PPII-like structures are in equilibrium with α-helix-like 
conformations.  These α-helix-like structures convert back into PPII-like conformations upon 
further dilution with water (Figure A.5).  
At high acetonitrile mole fractions (χH2O=0.26), NDQ10 shows a Raman spectrum 
characteristic of β-sheet fibrils; however, unlike DQ10, these solutions are not turbid. Upon 
centrifugation (~20,000 × g), solutions of NDQ10 with high acetonitrile mole fractions do not 
form pellets. Thus, it appears that NDQ10 solutions with high acetonitrile mole fractions do not 
form high molecular weight aggregates. Copious water addition to NDQ10 in 90% acetonitrile, 
results in a conformational transition to its original structure (Figure A.10).  
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5.4.10  Metadynamics Simulations of Q10 
We used metadynamics MD simulations to obtain insights into the conformational 
equilibrium and the high activation barrier between the DQ10 and NDQ10 monomer forms. 
Metadynamics simulations are ideal for characterizing the conformational landscapes of complex 
biophysical systems.123,124 In metadynamics, the evolution of the simulated system is biased by 
adding a history-dependent potential energy that discourages revisiting events already sampled 
and accelerates the sampling of rare events. As a consequence of the algorithm, metadynamics 
can also be utilized to estimate the conformational free energy landscape of a peptide or protein 
as a function of a suitably chosen set of reaction coordinates called collective variables.  
Figure 5.9 shows the conformational Gibbs free energy landscape of Q10 as a function of 
three collective variables, defined in terms of the root-mean-square-deviations (RMSD) from 
idealized β-hairpin, α-helix, and PPII structures. We chose these three reference structures 
because they are common secondary structure motifs that enable us to clearly distinguish 
between different possible polyQ conformations.125–127 We chose a β-hairpin structure because it 
was previously implicated as an aggregation nucleus.128   
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Figure 5.9: Conformational energy landscape of Q10 obtained from metadynamics.  The four lowest energy 
states are represented by the violet isosurfaces with representative structural ensembles shown for these low 
energy states. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. 
Copyright 2017 American Chemical Society  
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We find that the conformational energy landscape of Q10 is frustrated because it contains 
numerous shallow, local minima. However, four deep energy minima (purple regions in Figure 
5.9) are observed. These energy minima contain different structural states (A–D) that are defined 
both by their Ramachandran angles (Figure 5.10a–d), as well as their hydrogen bonding 
propensities (Figure 5.11). 
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Figure 5.10: Ramachandran (Φ, Ψ) angle distributions for metadynamics structure of Q10.  The 
Ramachandran plots are of the following: (a) collapsed β-strand structures of state A, (b) PPII-like structures 
of state B, (c) β-hairpin-like structures of state C, and (d) α-helical structures of state D. Panel (e) shows the 
(Φ, Ψ) angles of the terminal aspartic acid and lysine residues of state B while panel (f) shows (Φ, Ψ) angles of 
the glutamine residues for state B. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 
121 (24), 5953–5967. Copyright 2017 American Chemical Society  
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Figure 5.11: Number of inter-amide and amide-water hydrogen bonds formed for metadynamics structures.  
(a) Total number of glutamine side chain-water hydrogen bonds for each structure; (b) total number of 
peptide backbone-water hydrogen bonds formed for each structure; (c) total number of peptide backbone-
backbone hydrogen bonds formed for each structure; (d) total number of side chain-backbone hydrogen 
bonds for each structure; (e) total number of side chain-side chain hydrogen bonds formed for each 
structure. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. 
Copyright 2017 American Chemical Society  
foundinstatesA–Dinthemetadynamicssimulations.(a)Totalnumberofglutamineside 
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The structures found in state A possess peptide bonds with average (Φ, Ψ) angles of 
(−90°, 140°), roughly consistent with β-strand-like conformations (Figure 5.10a). These 
conformations are best described as “collapsed” β-strands, rather than β-hairpin, because they 
lack the intramolecular peptide backbone hydrogen bonding that defines canonical β-hairpins. As 
shown in Figure 5.11d, these β-strand structures form, on average, more side chain-backbone 
hydrogen bonds than the other states. These side chain-backbone hydrogen bonds, together with 
the attractive electrostatic interactions between the terminal aspartic acid and lysine residues, 
cause the β-strands to adopt more compact (i.e. collapsed) conformations.  
The (Φ, Ψ) angle distributions of state B are centered at about (−80°, −150°), which is 
characteristic of PPII secondary structures (Figure 5.10b). However, a smaller population of 
Ramachandran angles, located at approximately (−50°, −57°), indicate that state B also contains 
turn-like conformations. Taken together, these two populations of Ramachandran angles indicate 
that state B consists of irregular structures that are characterized by short PPII helices 
interspersed by turn conformations or bends. In addition, our hydrogen bonding analysis (Figure 
5.11) indicates that, compared to collapsed -strand structures (state A), both the peptide 
backbone and side chains of PPII-like structures (state B) are preferentially hydrogen bonded to 
water. 
The structures found in state C possess peptide bonds whose (Φ, Ψ) angles are centered at 
(−135°, 135°), indicative of β-strand structures (Figure 5.10c). A smaller population of peptide 
bonds adopts Type I’ turn Ramachandran angles (−40°, −85°). In contrast to the state A collapsed 
-strand structures, the state C -hairpin structures are calculated to form more hydrogen bonds 
between backbone peptide bonds (Figure 5.11c). These backbone-backbone hydrogen bonds are 
between β-strands and are characteristic of canonical β-hairpins defined by Milner et al.129 In 
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addition, the side chains of these β-hairpin structures are more solvated than those of the 
collapsed β-strand structures found in state A (Figure 5.11a).  
The structural ensemble of state D is comprised mostly of α-helical conformations. As 
shown in Figure 5.10e, the (Φ, Ψ) angles are distributed narrowly around (−50°, −65°). These 
structures show substantial amount of backbone-backbone hydrogen bonding (Figure 5.11c), as 
expected for α-helices, while the side chains are well solvated. 
The collapsed -strand (State A) occurs at the global minimum in the conformational 
energy landscape, while the extended PPII conformation (state B), the -hairpin (state C), and 
the -helix (State D) occur at 0.5 kcal · mol−1, 0.66 kcal · mol−1, and 1.0 kcal · mol−1 higher in 
energy, respectively. A 3-6 kcal · mol−1 activation  energy barrier separates States A and B.  In 
contrast, states C and D are both isolated from each other and isolated from states A and B by a 
6-15  kcal · mol−1 energy barrier.  
 
5.4.11  Consistency of MD Simulation and UVRR Results     
Our interpretation of the Ramachandran Ψ and Φ angle distributions for the simulated 
states A-D (Figure 5.10a–d) indicate that the state A (collapsed -strand) and state B (PPII-like) 
structures resemble the UVRR measured solution structures found for the NDQ10 and DQ10 
monomers, respectively. To validate the simulation results, we compared the UVRR 
experimentally measured Ψ and χ3 angles of DQ10 and NDQ10 to the corresponding 
distributions obtained from the MD structures populating the states A and B energy wells (Figure 
5.3).  Overall, agreement between the experimentally measured Ψ angle distributions and those 
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obtained from the simulations is excellent. In contrast, the side chain χ3 angle distributions 
obtained from the MD simulation show poor agreement with the UVRR data. 
Figure 5.3a–d compare the Ψ angle distributions of DQ10 and NDQ10 with those of 
states A and B from the simulations. The corresponding experimentally measured and 
computationally derived Ψ angle distributions are in overall good agreement.  The only major 
discrepancy is that the calculated distribution of state B (Figure 5.3b) lacks a peak at ∼175° that 
corresponds to 2.51-helix conformations. This apparent discrepancy is discussed in detail below.  
Metadynamics show that the χ3 distributions for states A and B are bimodal (Figure 5.3f 
and h). Both distributions show peaks centered at ∼−70° and ∼110°. These χ3 angle distributions 
differ significantly from those measured experimentally by UVRR.  An analysis of a side chain 
rotamer database by Dunbrack and Shapovalov23,71 shows that glutamine residues typically 
possess χ3 angles that are distributed between ∼−90 to 90°, which is inconsistent with the 
distributions shown in Figure 5.3f and h. 
We conclude that the large differences between our UVRR measurements and our MD 
simulated χ3 angle distributions derive from a lack of parameterization for non-rotameric side 
chain dihedral angles in the CHARMM36 force field. It is known, for example, that the χ1 and χ2 
dihedral angles of amino acid side chains have been optimized in CHARMM36 using 
experimental data.130 However, the non-rotameric dihedral angle, such as the χ3 angle of the 
glutamine side chain, have not been similarly treated in CHARMM36. 
We compared the backbone and side chain amide hydrogen bonding environments 
observed by UVRR measurements (NDQ10 and DQ10) to those calculated from the 
metadynamics calculated structures of states A and B (Figure 5.11). Our computational results 
are in excellent agreement with our experimental findings.  The state B structures of the 
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metadynamics contains side chain and backbone peptide bonds predominantly hydrogen bonded 
to water, while the state A structures show a significant inter-amide hydrogen bonding. 
The metadynamics data validate the observation of a large activation barrier between the 
NDQ10 PPII (state B) and the DQ10 β -strand (state A) conformations.  We calculate that the 
barrier between states A (β-strand) and B (PPII) is 3-6 kBT. In addition, the simulated MD energy 
barrier region between states A and B also contains ≥ 8 local energy minima, with energy well 
depths of ~ 1.0 kcal · mol−1 (Figure A.6). These local energy minima define metastable states 
along the energy barrier region. Even if Q10 can overcome the large energy barrier, the kinetics 
of conformation equilibration will be slowed by these multiple wells to prevent PPII-like to β-
strand structural transitions. 
 
5.4.12  Origin of Q10 2.51-helix Conformation Stabilization 
Our DQ10 UVRR studies surprisingly detect a significant population of the 2.51-helix 
conformation previously proposed by Krimm and coworkers131–133, and observed for PLL and 
PGA peptides by Asher and coworkers.119   The 2.51-helix conformation consists of an extended, 
left-handed, β-strand-like structure with ~ 2.5 residues per helical turn and (Φ,Ψ) angles of 
roughly (−130°, 170°).  
Asher and Krimm’s work indicate that the 2.51-helix conformations in PLL and PGA 
derive mainly from the electrostatic repulsions between their charged amino acid side chains 
forcing them to splay out.119 Based on this understanding, it is surprising that a predominately 
polyQ-rich peptide such as Q10 (which only has four charged residues) would show a significant 
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population of peptide bonds with 2.51-helix-like Ψ angles (Figure 5.3a). Another disquieting fact 
is that our MD simulations of the state B structures (Figure 5.3b) appear unimodal, consisting of 
Ψ angles indicative of the PPII conformation. This lack of predicted 2.51-helix conformations is 
troubling because it could signal misinterpretations of the UVRR data.  
We used classical MD simulations to more deeply examine the factors that stabilize 2.51-
helix conformations in Q10. We simulated three different Q10 peptide structures. One structure 
has its backbone dihedral angles constrained to the canonical 2.51-helix conformation, the second 
structure has a PPII conformation, and the third structure has alternating PPII/2.51-helix dihedral 
Ramachandran angles. We identified the overall lowest energy structure of each of the 
constrained simulations.  We then calculated, for each Q10 structure, the energy contributions of 
bond stretches, bond angle bending, dihedral angle rotation, electrostatics, and van der Waals to 
the overall potential energy of the system (Table 5.2).  Neglecting the influence of solvating 
waters, our simulations indicate that the potential energy of the 2.51-helix is ∼50 kcal · mol−1 
lower than that of the PPII structure, mainly due to intrapeptide electrostatics.  
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Table 5.2: Potential Energies (kcal·mole-1) for Q10 Peptides in PPII-like and 2.51-helix Conformations. 
Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 
American Chemical Society 
 PPII PPII/2.51-helix 2.51-helix 
Energy Terms 
all 
residues 
glutamine 
residues 
all 
residues 
glutamine 
residues 
all 
residues 
glutamine 
residues 
bonds 44(5) 33(5) 44(5) 32(5) 43(5) 32(5) 
angles 134(10) 96(8) 134(10) 95(8) 134(10) 96(8) 
torsions 146(5) 107(4) 160(5) 121(4) 174(6) 131(4) 
van der Waals −14(4) −11(3) −16(4) −14(4) −15(4) −14(4) 
electrostatics −436(29) −318(10) −461(35) −331(8) −487(37) −330(9) 
 
To determine the electrostatic potential energy contributions of the charged terminal 
residues, we compared the electrostatic energy terms of just the glutamine residues of Q10 for 
the 2.51-helix and PPII structures. We find that, for glutamine residues, the electrostatic potential 
energy difference between the 2.51-helix and PPII structures is only ∼10 kcal · mol−1. Thus, the 
charged terminal residues contribute most heavily to the electrostatic potential energy difference 
between the PPII and 2.51-helix structures. 
We also compared the (Φ, Ψ) angle distributions of the glutamine residues and the 
charged flanking residues for state B structures. As shown in Figure 5.10e, the terminal aspartic 
acid and lysine residues preferentially adopt (Φ, Ψ) angles centered roughly at (−115°, −160°), 
closer to the (Φ, Ψ) angles of the canonical 2.51-helix conformation. In contrast, the glutamine 
residues (Figure 5.10f) adopt (Φ, Ψ) angles of (−80°, −150°) and (−50°, −57°), indicative of PPII 
and turn-like conformations, respectively. This suggests that the 2.51-helix-like conformations 
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are selectively localized to the peptide bonds of the charged terminal residues, while the 
glutamine residues occur in a predominately PPII conformation. 
Thus, the UVRR DQ10 results appear consistent with the MD simulations. Assuming 
equal Raman cross sections, we roughly estimate from the integrated intensities of the AmIIIS3 
bands (Figure 5.2a) that 43% of peptide bonds adopt PPII-like Ψ angles, 22% of peptide bonds 
adopt 2.51-helix Ψ angles, and 35% of the peptide bonds adopt turn structure Ψ angles. Based on 
these percentages, we calculate that a single DQ10 peptide has 2–3 peptide bonds involved in a 
2.51-helix conformation.  These 2.51-helix conformation peptide bonds most likely occur on the 
terminal charged residues. However, the MD simulations indicate that the state B 2.51-helix-like 
(Φ, Ψ) angles are centered around −160°, very close to that of canonical PPII structures centered 
at −150°. This significantly differs from the Ψ = −175° value measured for DQ10 by UVRR, and 
causes the calculated Ψ angle distribution of state B (Figure 5.3b) to appear unimodal.  
We attribute the discrepancy in the Ψ angle values for the 2.51-helix-like peptide bonds in 
the simulated state B structures to an inadequacy of the CHARMM36 force field. In the case of 
CHARMM36, parameters for backbone dihedral angles are optimized from globular protein X-
ray crystal structures and QM data for the dialanine peptide.134 The 2.51-helix is an uncommon 
structure that forms in the presence of adjacent charged amino acids and is unlikely to be well 
represented in the X-ray structures used to parameterize CHARMM36. This conclusion is 
supported by Liqi Feng who showed that metadynamics of poly-l-lysine, using the CHARRM36 
force field, fail to show a Ψ angle distribution at ~170°, indicative of 2.51-helix conformations.135 
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5.4.13  Comparisons to Other Studies 
The solution-state structures of polyQ-rich peptides and proteins have been studied in 
detail.37,43,45,99,136,137 Many of the important computational studies were conducted by Pappu’s 
group.37,45,99 For example, Wang et al.,37 characterized the conformational ensemble of N-acetyl-
Q5-N’-methylamide (Q5) and N-acetyl-Q15N’-methylamide (Q15), that are somewhat similar to 
our Q10 peptide. 
From their MD simulations, Wang et al.37 conclude that the conformational energy 
landscapes of Q5 and Q15 are frustrated, since they observe numerous metastable and glassy 
states. Their simulations find essentially no global energy minimum structures. They show that 
Q5 and Q15 are structurally disordered in aqueous solution, with only transient stretches of 
regular secondary structure elements, such as PPII-helices, β-strands, and α-helices occurring. 
They also show that both Q5 and Q15 peptide bonds have a strong propensity to adopt PPII-like 
and α-helix-like (Φ, Ψ) angles. 
Wang et al’s.37 simulations also suggest that structurally disordered, monomeric polyQ 
peptides form a significant number of inter-amide hydrogen bonds, with side chain-backbone 
hydrogen bonding being the most prevalent. This is ostensibly supported by the NMR 
measurements by Darnell et al.138 that find nuclear Overhauser effect (NOE) cross peaks between 
the Cγ protons of glutamine side chains and Cα protons of the backbone in R3GQ3GY and 
R3GQ3P11GY peptides that adopt predominately PPII structures. Darnell et al. interpret these 
signals to mean that in PPII-rich polyQ peptides, the glutamine side chains adopt “folded-over” 
conformations (see Figure 5.12) that enable hydrogen bonding to the backbone amides. To our 
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knowledge, this is the only experimental evidence of significant side chain-backbone hydrogen 
bonding in PPII-rich polyQ peptides.  
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Figure 5.12: Proposed polyQ side chain conformations.  (a) shows Q10 in a PPII conformation with extended, 
solvated side chains and (b) shows side chains hydrogen bonded to the peptide backbone as proposed by 
Darnell et al.138 The structure shown in panel (a) is of the PPII state (State B) found in our metadynamics 
simulations and validated by our UVRR measurements of DQ10. The structure shown in panel (b) was 
created using a Q10 peptide with Ramachandran angles constrained to PPII values in which the side chain 
structure was modified to adopt side chain-backbone hydrogen bonds between the C=O and NH moieties of 
the side chains and backbone, respectively.  We clearly do not experimentally observe significant side chain-
backbone hydrogen bonding in PPII-like DQ10 peptide monomers. Reprinted with permission from 
Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical Society  
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The simulations of Wang et al.37 lead them to hypothesize that the structural disorder of 
polyQ peptides stems from the many different possible combinations of intramolecular and 
intermolecular-amide hydrogen bonds that can form between side chain and backbone amides. 
This explains why a β-sheet-rich fibril nucleus58,139 is expected to be energetically unfavorable. 
According to their model, the multiple possible combinations of intra-peptide hydrogen bonds 
promotes disorder in the peptide backbone, disrupting the formation of backbone-backbone 
interactions that enable secondary structures such as α-helices and β-sheets. 
Some aspects of our simulation results are consistent with those of Wang et al.37 We 
observe that the conformational energy landscape of Q10 contains numerous shallow energy 
minima. Similarly, we observe that Q10 peptides can engage in a large variety of intramoleuclar 
side chain-side chain, backbone-backbone, and side chain-backbone hydrogen bonding 
interactions.  
However, there are many aspects of our results that are inconsistent with those of Wang 
et al.37 For example, our experimental and metadynamics simulation data reveal that Q10 can 
adopt stable and well-defined structural states, with deep energy wells, such as those shown in 
Figure 5.1. Interestingly, we also find that the side chains and backbone amides of the 
structurally “disordered” PPII-rich state of Q10 are predominately hydrogen bonded to water, 
which disagrees with the Wang et al.37 results. 
These disagreements raise two important questions. First, why does Wang et al.37 not 
observe any well-defined structural states for small polyQ peptides, whereas we do? And second, 
why do the simulations of Wang et al.37 indicate that there are significant numbers of inter-amide 
hydrogen bonds (particularly between the backbone and side chain amides) in structurally 
disordered Q5 and Q15 peptides, while our simulations do not find this for Q10? 
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To answer the first question, we note that the conformational energy landscape of polyQ 
peptides is frustrated, consisting of many local energy wells. Classical MD simulations generally 
do not efficiently sample different structural states in these situations. Thus, one possibility is 
that the simulated peptides in the Wang et al. study are trapped in local energy minima. Our 
metadynamics calculations enable us to robustly sample a greater ensemble of structures than 
does traditional MD simulations. Thus, we characterized the entire conformational landscape and 
discovered global minimum energy conformations.  
We are also aware that the conformational behavior of model polyQ peptides in solution 
depends both on the number of glutamine repeats and the choice of non-glutamine flanking 
groups.140 For example, the use of N-Acetyl and methylamide flanking groups in Pappu and 
coworkers’ simulations are better models for polyQ tracts in proteins.  In addition, fluorescence 
correlation spectroscopy43 data by the Pappu group and dynamic light scattering data by the 
Murphy group44 indicate that structurally disordered long polyQ peptides adopt relatively 
compact structures in aqueous solution. These compact structures presumably derive from the 
fact that inter-amide hydrogen bonding interactions become more prevalent and important in 
polyQ peptides as the glutamine repeat length increases. For example, Walters and Murphy44 
have shown that phosphate buffer is a good solvent for Q8 and Q12, a theta solvent for Q16, and 
a poor solvent for larger peptides such as Q20. Thus, the model proposed by Pappu and 
coworkers in the Wang et al.37 study may be valid in the limit of polyQ peptides with ≥20 
glutamine repeats. 
The answer to the second question may lie in the differences of the force field and water 
model used by our study compared to Wang et al.37 As discussed by Wang et al.,37 the hydrogen 
bonding interactions observed in a simulation will vary depending on the force field utilized. Our 
   106  
 
use of the TIP3 water model and the CHARMM36 modern force-field results in different 
hydrogen bonding interactions compared to that of the MD simulations of Wang et al.37 The 
hydrogen bonding interactions predicted by our metadynamics are in excellent agreement with 
our UVRR experimental data, which shows that our choice of force-field appropriately models 
the hydrogen bonding interactions in Q10. 
The congruence of both our simulation and experimental data gives us confidence in the 
relative accuracy and robustness of the CHARMM36 force field used in this study. Despite this, 
we do not dispute the validity of the Pappu et al.’s model to describe, in general, the underlying 
physical principles that govern the structural disorder of larger polyQ peptides, or the energetic 
unfavorability of the coil to β-sheet transition. However, we do believe that the importance of 
side chain-side chain and side chain-backbone interactions in describing the structural disorder of 
PPII-rich polyQ peptides may be over-stated, at least in the context of small peptide systems, 
such as Q5, Q10, and Q15. 
5.5 Conclusions 
We investigated the structural ensemble of the Q10 polyQ peptide in solution. From our 
UVRR, CD and MD data, we constructed a molecular-level model for the structure and part of 
the energy landscape of DQ10 and NDQ10 monomers in aqueous solution. We show that, in 
DQ10, the charged, terminal residues adopt 2.51-helix conformations, while the central 
glutamine residues adopt short PPII segments that are interspersed with turn structures (Figure 
5.1b). In contrast, we find that NDQ10 exists in a collapsed β-strand conformation (Figure 5.1a). 
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There is a large activation barrier between these conformations in solution that prevents their 
interconversion. 
Our study achieves new insights into the hydrogen bonding environments and glutamine 
side chain conformations of Q10. The DQ10 side chains are predominately hydrogen bonded to 
water, whereas the NDQ10 side chains form relatively more inter-amide hydrogen bonds. We 
were also able to determine that DQ10 possesses χ3 angle distributions centered at ∼−30° and/or 
∼20°. In contrast, NDQ10 has a χ3 angle distribution centered at ∼−12° and/or ∼3°.  
We also monitored the PPII to β-sheet structural transition of DQ10 in acetonitrile/water 
mixtures. Acetonitrile is a secondary structure inducing solvent because it promotes intra- and 
inter-peptide hydrogen bonding. At intermediate acetonitrile concentrations, we observe a 
significant amount of α-helix-like secondary structures in DQ10 (Figure 5.1c).  At high 
acetonitrile concentrations, we observe a transition to β-sheet conformations and the formation of 
visible aggregate light scattering (Figure 5.1d). The higher acetonitrile concentrations promote 
intra- and inter-peptide hydrogen bonding by first forming α-helix-like structures, and at higher 
acetonitrile concentrations forming β-sheet aggregates that include fibrils. The DQ10 fibrils and 
β-sheet aggregates formed in acetonitrile/water solutions re-dissolve upon addition of water.  We 
find that the re-dissolved fibrils have a UVRR spectrum identical to monomeric NDQ10 
indicating a collapsed β-strand structure. To our knowledge, this is the first report of re-
dissolvable polyQ fibrils.  
In contrast to DQ10, NDQ10 at high acetonitrile concentrations does not become turbid 
and does not form a pellet upon centrifugation. Thus, we conclude that NDQ10 does not form 
high molecular weight aggregates at high acetonitrile concentrations. However, the UVRR 
spectra of NDQ10 at high acetonitrile mole fractions are similar to that of fibrils and show a Ψ 
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angle distribution characteristic of β-sheet. This NDQ10 collapsed β-strand to β-sheet transition 
upon the addition of acetonitrile is reversible.    
We also used metadynamics to investigate the energy barriers between the collapsed β-
strand and the DQ10 PPII/2.51 helix conformation. We calculate a 3-6 kBT activation barrier with 
additional smaller minima along the reaction coordinate between these conformations (Figure 
5.1a and b). This is consistent with our experimental observation that NDQ10 and DQ10 
conformations do not readily interconvert.  
Another important result of this study is that we rigorously bench-marked the 
CHARMM36 force field against experimental data and determined both the strengths and 
limitations of this force field’s accuracy. We will continue to investigate and improve the utility 
of CHARMM36 in describing 2.51-helix structures, as well as the non-rotameric χ3 dihedral 
angles calculated for glutamine side chains.  
Until now investigations of the aggregation mechanisms of polyQ peptides and proteins 
have been hindered by the inability to study intermediate polyQ species along the aggregation 
and fibril formation reaction coordinate.  The fact that we can poise our Q10 peptide in different 
conformations and reversibly transition these conformations along reaction coordinates that form 
β-sheet aggregates, such as fibrils, makes us hopeful that this simple Q10 system will enable 
elucidation of fibril aggregation mechanisms. We will be examining polyQ structural changes in 
physiologically relevant polyQ peptides in future studies. 
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5.6 Associated Content 
Supporting Information is in Appendix A. Supporting Information includes further 
information on UVRR spectral processing and fitting, determination of Ψ and χ3 angle 
distributions, hydrogen-deuterium exchange experiments, and CD measurements. 
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6.0 Interaction Enthalpy of Side Chain and Backbone Amides in Polyglutamine Solution 
Monomers and Fibrils 
Adapted with permission from: David Punihaole, Ryan S. Jakubek, Riley J. Workman, 
and Sanford A. Asher. "Interaction Enthalpy of Side Chain and Backbone Amides in 
Polyglutamine Solution Monomers and Fibrils." The journal of physical chemistry letters, 2018, 
9, 8 1944-1950. Copyright © (2018), American Chemical Society 
Author Contributions: DP and RSJ contributed equally to this work. DP and RSJ 
analyzed the Raman data and developed the theory. RSJ developed error estimations for 
experimental results with assistance from the University Of Pittsburgh, Department Of Statistics.  
RJW performed computational work and analyzed it with the assistance of DP and RSJ. The 
manuscript was prepared by DP, RSJ, and SAA. 
We determined an empirical correlation that relates the Amide I vibrational band 
frequencies of the glutamine (Q) side chain to the strength of hydrogen bonding, van der Waals, 
and Lewis acid-base interactions of its primary amide carbonyl. We use this correlation to 
determine the Q side chain carbonyl interaction enthalpy (ΔHint) in monomeric and amyloid-like 
fibril conformations of D2Q10K2 (Q10). We independently verified these ΔHint values through 
molecular dynamics simulations that showed excellent agreement with experiments. We find that 
side chain-side chain and side chain-peptide backbone interactions in fibrils and monomers are 
more enthalpically favorable than are Q side chain-water interactions. Q10 fibrils also show a 
more favorable ΔHint for side chain-side chain interactions compared to backbone-backbone 
interactions. This work experimentally demonstrates that inter-amide side chain interactions are 
important in the formation and stabilization of polyQ fibrils. 
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6.1 Introduction 
Ten neurodegenerative diseases, including Huntington’s, are linked to mutational 
expansions of polyglutamine (polyQ) repeats in proteins.1 The increase in polyQ repeats greatly 
enhances misfolding and aggregation of affected proteins. Although the exact mechanism of 
neurotoxicity is still heavily debated, the pathological hallmark of all these diseases is the 
formation of neuronal aggregates composed of β-sheet-rich amyloid-like fibrils.33,141,142 Given 
their potential role in neurotoxicity, there is great interest in understanding polyQ fibril 
formation, as well as developing therapeutic strategies to inhibit aggregation. 
PolyQ peptides contain both primary amides from their glutamine (Q) side chains, and 
secondary amides from their backbone peptide bonds.  Despite the hydrophilic nature of the Q 
side chain, experimental studies indicate that polyQ peptides with pathologically-relevant repeat 
lengths adopt structurally disordered collapsed conformations, which suggests that water is 
acting as a poor solvent.34–36,41,44,143 These findings are also supported by computational 
studies,37–39,99 which suggest that polyQ peptides are largely disordered due to the multiplicity of 
different hydrogen bonding interactions that form between side chain and backbone amides. 
Other computational studies suggest that inter-amide hydrogen bonds between side chains 
contribute most significantly to the structural stability of polyQ amyloid-like fibrils.144 
These and other studies1,145 underscore the crucial role that Q side chain hydrogen 
bonding interactions play in dictating the solution-state conformational behavior and the strong 
aggregation propensities of polyQ peptides. Surprisingly, however, no experimental studies have 
quantified the relative energetic favorability of side chain versus backbone amide hydrogen 
bonding interactions in polyQ peptides. Thus, developing new experimental tools that can 
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quantify the relative energies of different side chain and backbone hydrogen bonding interactions 
is important to formulating a more complete, molecular-level understanding of polyQ fibril 
formation mechanisms. 
6.2 Results and Discussion 
Infrared and Raman spectroscopies can specifically probe interactions between different 
molecular species. One approach is to correlate the solvatochromatic frequency shifts of specific 
vibrational bands in solvents of different polarities to variations in interaction energies and 
hydrogen bonding strengths,146  as first shown by Badger and Bauer.147 Recent work by the 
Boxer group148,149  and others,150,151  however,  have shown that the solvatochromatic shifts of 
many probes can often, but not always, be attributed to the vibrational Stark effect. 
Consequently, frequency shifts due to the vibrational Stark effect can be used to determine the 
local electric fields felt by the probes. 
Using UV Resonance Raman (UVRR) spectroscopy, we previously showed that 
vibrational modes localized on the amide groups of Q’s side chains are sensitive to their local 
structure,71 hydrogen bonding, and dielectric environments.72 For example, the Amide I band of 
primary amides (denoted as AmIP) sensitively probe the local hydrogen bonding of the Q side 
chain carbonyl group. The carbonyl stretching AmIP band frequency and Raman cross section 
dramatically decrease in water relative to acetonitrile. Both of these spectral trends can be 
rationalized by the fact that, compared to acetonitrile, water stabilizes the primary amide ground 
state –O−C=NH2+  resonance structure compared to the O=C−NH2 resonance structure.71 
 
   113  
 
6.2.1  Relation Between Gln Side Chain AmI Frequency and ΔHint 
The well-studied Amide I bands of secondary amides (denoted as AmIS) similarly show 
sensitivities to the solvation and local hydrogen bonding of the peptide bond backbone carbonyl 
groups.89–93  Wang et al.93 previously showed that the AmIS frequency is linearly dependent on  
the solvent’s acceptor number (AN), which is a measure of the strength of the solvent’s hydrogen 
bonding, Lewis acid, and van der Waals interactions with solutes.152 Using the AmIS frequency-
AN correlation, Wang et al. showed that the AmIS frequency can be used to estimate the change 
in enthalpy due to these interactions (∆Hint) for the secondary amide peptide bond carbonyl 
groups relative to that of these carbonyl groups in vacuum.  
Inspired by Wang et al.’s93 work, we investigated whether the AmIP frequency could be 
used to determine the ∆Hint of the primary amide carbonyl groups with their chemical 
environments. We initially focused on the small primary amide model compound formamide, 
because its ∆Hint values in various solvents are known.153 We used the formamide solvent 
dependence of the AmIP frequencies measured by Cutmore and Hallam154  and the AmIP 
frequency of formamide in water by Eaton et al.155 to determine the frequency dependence on the 
solvent AN and donor number (DN).  
Figure 6.1a shows the formamide AmIP frequency dependence on the solvent AN and 
DN. There is a robust linear correlation between the AmIP frequency and solvent AN. The least-
squares linear fit obtained from the AmIP frequency dependence on the solvent AN is: 
  
AmIP = b +m(AN) = 1715cm-1 + (-0.50cm-1acc#-1)(AN)        6.1  
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where b=1715 cm-1 and m=-0.50 cm-1 acc #-1 for formamide.  
The donor number is a measure of a solvent’s hydrogen bond accepting strength and 
Lewis basicity, which do not affect solvent-amide carbonyl group interactions.93 Therefore, as 
expected, there is no correlation between the AmIP frequency and solvent DN.  
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Figure 6.1: AmIP frequency dependence of formamide on (a) solvent acceptor number, solvent donor 
number, and (b) interaction enthalpy. The number labels in the figure correspond to the following solvents: 1.  
triethylamine;  2.  pyridine; 3.  acetonitrile; 4. nitromethane; 5. chloroform; 6. ethanol; 7. methanol; 8. H2O; 
9. Vapor phase. The frequency dependence of formamide on the different solvents was obtained from data of 
Cutmore and Hallam154 and Eaton et al.33 Reprinted with permission from Punihaole et al. J. Phys. Chem. 
Lett. 2018, 9, 8 1944-1950. Copyright 2018 American Chemical Society.  
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We also examined the AmIP frequency dependence on the ∆Hint between the formamide 
carbonyl and different solvents using previously reported thermodynamic data.153 For example, 
the ∆Hint values for the formamide carbonyl group in hydrogen bonding donor solvents such as 
ethanol, methanol, chloroform, and in the vapor phase are −4.8, −4.5, −3.2, and 0 kcal · mol−1, 
respectively (Figure 6.1b), indicating that the AmIP frequency linearly depends on ∆Hint, with 
m’=8.8 cm−1 kcal−1 mol and b’=1735 cm-1 for formamide.  
 
 𝐴𝑚𝐼𝑃 = 𝑏′ +𝑚′(Δ𝐻𝑖𝑛𝑡) = 1735 𝑐𝑚
−1 + (8.8 𝑐𝑚−1𝑘𝑐𝑎𝑙−1𝑚𝑜𝑙)(Δ𝐻𝑖𝑛𝑡) 6.2  
 
Numerous studies have characterized the dependence of the AmIP frequencies on the 
solvent AN. Unfortunately, few studies have characterized the dependence of the AmIP 
frequencies on ∆Hint.  Fortunately, we can convert the AmIP frequency dependence upon AN to 
its dependence upon ∆Hint by relating eqs.  
6.1 and 6.2, as prescribed by Wang et al.93  
First, the AN value of the solvent “vacuum” is determined by equating eqs.  
6.1 and 6.2, for formamide in vacuum. We calculate that AN = −40 (acc #) for the 
“vacuum solvent”. Thus, the eq. 6.2  intercept is b’=b +m (-40 (acc #)). The AN of vacuum, as 
well as that of other solvents, is independent of the solute present. Thus, the intercept of eq. 6.2 
can be determined for any primary amide as long as the AmIP frequency dependence on AN is 
known.  
The AmIP frequency is linearly proportional to both AN and ΔHint. Thus, we can 
calculate the conversion factor between AN and ∆Hint for formamide from the slopes of eqs.  
6.1 and 6.2:   
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𝑚 =
−0.50 𝑐𝑚−1
1 𝑎𝑐𝑐#
= 𝑚′ =
8.8 𝑐𝑚−1
1 𝑘𝑐𝑎𝑙 𝑚𝑜𝑙−1
 
 
 
 
 
(1 𝑎𝑐𝑐#−1) =
8.8 𝑐𝑚−1𝑘𝑐𝑎𝑙−1𝑚𝑜𝑙
−0.50 𝑐𝑚−1
= −18 𝑘𝑐𝑎𝑙−1 𝑚𝑜𝑙 
     6.3 
 
Assuming that the conversion factor is constant for all primary amide compounds, eq. 6.2 
can be written as follows: 
 
 𝐴𝑚𝐼𝑃 = 𝑏′ +𝑚′(Δ𝐻𝑖𝑛𝑡) 
= (𝑏 +𝑚(−40 𝑎𝑐𝑐#)) + (−18 𝑘𝑐𝑎𝑙−1 𝑚𝑜𝑙 𝑚(Δ𝐻𝑖𝑛𝑡)) 
6.4  
 
Using eq. 6.4, we can estimate ΔHint for any primary amide compound from its AmIP 
frequency dependence on AN. 
6.2.2  Determining Side Chain ΔHint in Polyglutamine Peptides 
Because Q and polyQ peptides have very limited solubility in low AN solvents, we often 
utilize propanamide as an alternative compound to model the Q side chains.71,72,82 We previously 
found, using UVRR spectroscopy, that the AmIP frequency of propanamide (CH3CH2CONH2) is 
1669 cm−1 in water and 1692 cm−1 in acetonitrile.72 Because the AN of water is  54.8, while that 
of acetonitrile is 18.9156, we can  calculate the linear dependence of the propanamide AmIP 
frequency on AN. We find that m = −0.64 cm-1 (acc #)-1  and b= 1704 cm-1 for propanamide. By 
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substituting these values into eq. 6.4, we derive eq. 6.5 which can be used to estimate ΔHint for 
propanamide.  
 
 𝐴𝑚𝐼𝑃(𝑐𝑚−1) =   1730 (𝑐𝑚−1) + (12 𝑐𝑚−1 𝑘𝑐𝑎𝑙−1 𝑚𝑜𝑙)(Δ𝐻𝑖𝑛𝑡)  6.5  
 
 
Because propanamide models the Q side chain, we can use eq. 6.5 to estimate the ∆Hint of 
side chain carbonyl groups in monomeric Q and in the polyQ peptide D2Q10K2 (Q10) in any 
environment. The ΔHint of each system is measured with respect to the vapor phase, where ΔHint 
is zero.  In the case of monomeric Q in aqueous solution, where the side chain carbonyl groups 
are hydrogen bonded to water, the AmIP band is located at 1679 cm−1.82 As shown in Table 6.1, 
this frequency corresponds to a ∆Hint of −4.3 kcal · mol−1.  
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Table 6.1:  Estimated ∆Hint Values for Q Side Chain Carbonyl Groups in Different Peptide Conformations. 
Reprinted with permission from Punihaole et al. J. Phys. Chem. Lett. 2018, 9, 8 1944-1950. Copyright 2018 
American Chemical Society. 
 Am IP 
(cm−1 ) 
Expt.  
(kcal·mol−1 ) 
MD (kcal·mol−1 ) H-bonding  Type 
Q amino acid 1679 -4.3 – s.c.-w 
PPII 1680 -4.2 -4.4 s.c.-w 
β-strand 1660, 1679 -5.8, -4.3 -4.7, -4.4, -4.6 s.c.-p.b.,s.c.-w, 
s.c.-s.c. Fibrils  prepared from β - s t r a n d  1659 -5.9 -6.2 . . 
Fibrils  prepared from PPII  1665 -5.4 -6.2 s.c.-s.c. 
a  s.c.: side chain; p.b.: peptide backbone; w: water 
 
We recently showed that Q10 adopts two stable monomeric conformations in aqueous 
solution.82 One solution conformation is a polyproline II (PPII) like structure, which can be 
prepared using a standard “disaggregation” protocol.31 The side chain and peptide backbone 
amides of this PPII-like conformation are hydrogen bonded to water molecules. The other 
conformation is a collapsed β-strand-like conformation, which is simply prepared by dissolving 
the synthesized peptide in water. The side chains of the β-strand-like conformations are 
intramolecularly hydrogen bonded, as well as to solvating water molecules. Both PPII-like and 
collapsed β-strand-like Q10 conformations can be poised to aggregate into different amyloid-like 
fibril polymorphs when incubated in aqueous solutions at elevated temperatures for about one 
week. The cores of fibrils grown from both monomeric conformations are composed almost 
exclusively of antiparallel β-sheets, though slight structural differences between the two 
polymorphs are observed.46  Both fibril polymorphs, however, form inter-amide side chain 
hydrogen bonds between neighboring strands within a given β-sheet.46  
Our previous studies46,82 examined the AmIP frequencies of these Q10 fibrils, as well as 
of the PPII-like and β-strand-like solution monomers. Table 6.1 shows these frequencies, and 
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their corresponding estimated ∆Hint values determined using eq. 6.5. As expected, the ∆Hint of 
side chain carbonyl-water interactions in PPII-like and β-strand-like monomers are identical to 
those of monomeric glutamine in aqueous solution. In contrast, the ∆Hint of side chain carbonyl-
peptide interactions that occur in the β-strand-like monomers are −5.8 kcal · mol−1, a value 
similar to that estimated for side chain-side chain interactions in polyQ fibrils. For fibrils 
prepared from PPII-like monomers, we determine that the ∆Hint value of side chain-side chain 
interactions is −5.4 kcal · mol−1 while that prepared from β-strand-like monomers is found to be -
5.9 kcal mol-1. This result may suggest that fibrils prepared from the PPII monomer have weaker 
side chain-peptide interactions. However, the difference between ΔHint values for fibrils grown 
from the two different monomer states is within the estimated error, as discussed in Appendix B. 
In determining these ∆Hint values, we implicitly assume that there is no significant 
coupling between AmIP oscillators. Strong coupling of neighboring oscillators would cause 
“excitonic” splitting of the AmIP band frequency, which would complicate the determination of 
∆Hint.  In dilute solutions of amides, such as for monomeric glutamine in water, no coupling of 
the AmIP vibrations can occur. In the case of Q10 PPII-like and β-strand-like peptide monomers, 
we expect that coupling will likely be weak, so that the impact of band splitting on the AmIP 
frequency is essentially negligible. 
In contrast, neighboring oscillator coupling could impact the AmIP band of polyQ fibrils. 
In antiparallel β-sheet conformations, for example, the backbone AmIS frequency is impacted by 
coupling with neighboring oscillators, which results in band splitting (vide infra). However, in 
the case of the AmIP, we see no evidence of coupling between the neighboring oscillators of Q10 
fibrils. Our previously reported UVRR AmIP bands of Q10 fibrils are very narrow and consist of 
only single bands,46 suggesting no excitonic splitting. This conclusion is further reinforced by the 
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fact that the Raman AmIP frequencies of Q10 fibrils are essentially the same as reported IR 
frequencies of fibrils prepared from similar polyQ peptides.48,157 This fact precludes the 
possibility that we only observe “bright” (Raman active) exciton modes of the AmIP, but no 
“dark” (Raman inactive) modes. 
6.2.3  Determining ΔHint of Backbone-backbone Interactions in PolyQ Fibrils 
We sought to compare the ∆Hint of side chain-side chain and backbone- backbone 
hydrogen bonds in Q10 fibrils. To estimate the ∆Hint of backbone-backbone interactions, we 
used an equation derived by Wang et al.93 for the AmIS band. However, the fibril AmIS bands are 
impacted by coupling. As a result, it was first necessary to determine the uncoupled AmIS 
frequencies of Q10 fibrils prepared from PPII-like and β-strand-like monomer solutions. 
The excitonic splitting pattern of the AmIS band in antiparallel β-sheets is well 
understood. Given the approximate D2 symmetry of antiparallel β-sheets, the AmIS vibration is 
predicted to split into four vibrational states, the A, B1, B2, and B3 modes, all of which are 
Raman active. We curve fit the AmIS bands of Q10 fibrils from our previously published data 
(Figure B.1) and assigned the A, B1, B2, and B3 modes using the work of Krimm and 
coworkers35–37 as a guide. Our spectral analysis of Q10 fibrils prepared from β-strand-like 
monomer solutions indicates that the A mode is located at 1665 cm−1, the B1 mode is at 1695 
cm−1, the B2 mode is at 1625 cm
−1, and the B3 mode is at 1680 cm
−1.82 In contrast, for fibrils 
prepared from PPII-like monomers, the AmIS A, B1, B2, and B3 modes are located at 1660 cm
−1, 
1688 cm−1, 1617 cm−1, and 1675 cm−1, respectively.46 
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To estimate the unperturbed AmIS frequencies, we utilize the perturbation theory 
approach developed by Miyazawa,161 where the observed frequencies of the AmIS bands are 
given by: 
     𝐴𝑚𝐼𝑠(𝛿, 𝛿′) =  𝑣0 + ∑𝐷𝑠,𝑡 cos (𝑠𝛿) cos(𝑡𝛿
′)
𝑠,𝑡
 
             6.6 
 
where ν0 is the unperturbed AmIS frequency, and Ds,t are the interaction constants between 
peptide backbone amides separated by s amide groups and t chains along the tth peptide chain. δ 
and δ’ are the phase angles between adjacent AmIS oscillators along a given peptide chain or 
between hydrogen bonded peptide backbone amides on neighboring chains. 
Moore and Krimm158–160 have shown that, for an infinite size antiparallel β-sheet system 
(which is an appropriate limit for Q10 fibrils), eq.              6.6 can be written as: 
 
 𝐴𝑚𝐼𝑆(𝛿, 𝛿′) =  𝑣0 + 𝐷00 + 𝐷10 cos(𝑠𝛿) + 𝐷01 cos(𝑡𝛿
′) + 𝐷11 cos(𝑠𝛿) cos(𝑡𝛿
′)    6.7  
 
For antiparallel β-sheets, the following set of equations can be written from eq. 6.7 by 
assuming different combinations of 0 or π phase angles: 
 
 𝐴𝑚𝐼𝑆(0,0) = 𝑣0 + 𝐷00 + 𝐷10 + 𝐷01 + 𝐷11
 
𝐴𝑚𝐼𝑆(0, 𝜋) = 𝑣0 + 𝐷00 + 𝐷10 − 𝐷01 − 𝐷11
 
𝐴𝑚𝐼𝑆(𝜋, 0) = 𝑣0 + 𝐷00 − 𝐷10 + 𝐷01 − 𝐷11          
 
 𝐴𝑚𝐼
𝑆(𝜋, 𝜋) = 𝑣0 + 𝐷00 − 𝐷10 − 𝐷01 + 𝐷11  
 
                                   6.8 
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where AmIS(0, 0) corresponds  to the A mode, while AmIS(0, π),  AmIS(π, 0), and AmIS(π, π) 
correspond to the B1, B2, and B3 modes, respectively. The unperturbed frequency of the AmI
S 
cannot be exactly determined in eq. 6.7 since there are too many unknown coefficients to solve. 
However, we can estimate an effective unperturbed frequency by substituting 𝑣0 with: 
 
 𝑣′0 = 𝑣0 + 𝐷00                                6.9  
 
Thus, using the experimentally observed AmIS A, B1, B2, and B3 mode frequencies for Q10 
fibrils prepared from β-strand-like (PPII-like) monomer solutions, we determine ν’ to be 1663 
cm−1 (1660 cm−1), D10 to be 6.3 cm
−1 (7.5 cm−1), D01 to be −21.3 cm−1 (−21.5 cm−1), and D11 to 
be 13.8 cm−1 (14 cm−1). 
Our calculated ν’, D01, D10, and D11 constants match in sign and are close in value to 
those determined  by Krimm and coworkers for polyalanine and polyglycine antiparallel β-
sheets158–160. This gives us confidence that ν’ can be used to robustly estimate ∆Hint for inter-
amide hydrogen bonds formed between peptide bonds in the core of polyQ fibrils. 
To estimate ∆Hint from ν’, we used the following equation derived by Wang et al.93 for N-
acetyltrialanine methyl ester: 
 
 𝐴𝑚𝐼𝑆 = 1699.3 𝑐𝑚−1 + (9.46 𝑚𝑜𝑙 𝑐𝑚−1𝑘𝑐𝑎𝑙−1)(Δ𝐻𝑖𝑛𝑡) 6.10  
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Using eq. 6.10, we estimate that the ∆Hint of backbone-backbone interactions are −3.8 kcal mol−1 
for fibrils prepared from both Q10 β-strand-like and PPII-like monomers. This interaction 
strength is similar to NMA-NMA hydrogen bonding strengths previously measured.162–164 
The above ∆Hint values indicate that backbone-backbone interactions in Q10 fibrils are 
enthalpically less favorable than side chain-side chain hydrogen bonding interactions. It is 
possible that the difference in the ∆Hint values for inter-amide backbone versus side chain 
interactions results from our use of ν’0 instead of v0 when calculating ΔHint. Krimm and 
coworkers estimate that D00 is relatively small (roughly −5 cm−1). Using a D00 value of −5 cm−1, 
we roughly estimate that side chain-side chain interactions are still enthalpically more favorable 
(by ∼−1 kcal · mol−1) than backbone-backbone interactions. 
6.2.4  Comparison to MD Simulations 
In our previous work, we used metadynamics and molecular dynamics  (MD) 
simulations, in conjunction with UVRR, to investigate the monomer solution-state and fibril 
structures of Q10.46,82 Here, we use our previously simulated Q10 structures as initial coordinates 
to perform classical MD simulations on solution-state and fibril Q10 conformations. We use 
these simulations to independently calculate ΔHint values of various backbone and side chains 
interactions and compare them to that obtained via UVRR.  
Figure 6.2 shows the simulated PPII-like, β-strand-like, and fibril structures. For each 
structure, we determined the average number of inter-amide (e.g. side chain-side chain, side 
chain-backbone, and backbone-backbone) and amide-water hydrogen bonding interactions 
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formed per peptide (Figure 6.2). We define a hydrogen bond as having a geometry such that the 
heavy atom donor to acceptor distance is <3.0 Å with a bond angle of 180° (±30).  
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Figure 6.2: Structures and backbone Ramachandran angles of MD simulated Q10 structures in the (a) 
monomeric collapsed β-strand-like, (b) monomeric PPII-like, and (c) antiparallel fibril conformations. The 
bar graphs show the average number of various hydrogen bonding interactions per peptide residue. 
Reprinted with permission from Punihaole et al. J. Phys. Chem. Lett. 2018, 9, 8 1944-1950. Copyright 2018 
American Chemical Society.   
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The number of backbone-backbone hydrogen bonds is negligible for both the PPII-like 
and β-strand-like monomeric Q10 structures.  For the monomeric PPII-like structure, we find 
that 94 % of side chain amides are hydrogen bonded to water, 2 % of side chains are hydrogen 
bonded to backbone amides, and 4 % of side chains are hydrogen bonded to other side chains. 
For the β-strand-like structure, 66 % of side chain amides are hydrogen bonded to water, 20 % of 
side chains are hydrogen bonded to backbone amides, and 16 % of side chains are hydrogen 
bonded to each other.  In contrast, the Q10 antiparallel fibril structure’s interior backbone and 
side chain amides are hydrogen bonded exclusively to other backbone and side chain amides. 
From our MD simulations, we calculated average ∆Hint values for each simulated 
structure. We define ∆Hint as the sum of the Lennard-Jones (∆ELJint ) and Coulombic potential 
energy (ΔEelecint ) terms, where the ∆ signifies the difference in energy of the carbonyl oxygen 
atoms with their interacting partner atoms in close proximity relative to being infinitely 
separated. Due to the negligible change in volume throughout the simulations, the ∆Hint can be 
accurately approximated as the change in the energy of interaction (∆Eint): 
 
 Δ𝐻𝑖𝑛𝑡 ≈ Δ𝐸𝑖𝑛𝑡 = Δ𝐸𝑖𝑛𝑡
𝑒𝑙𝑒𝑐 + Δ𝐸𝑖𝑛𝑡
𝐿𝐽
 6.11 
      
When calculating ∆Hint, we define interacting groups as those with heavy atoms at 
distances of less than or equal to 5 Å.  Thus, our calculated ∆Hint is not limited to strong 
hydrogen bonding interactions, which generally occur for heavy atom distances less than 3 Å.  
For the Q10 antiparallel β-sheet conformation (Figure 6.2c), the six-innermost buried side chain 
and backbone amide groups were used to calculate the ∆Hint, since they best model the interior of 
the fibril core. 
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The ∆Hint values calculated from the MD simulated Q10 structures are shown in Table 
6.1. Overall, these calculated ∆Hint values from the MD simulations are in excellent agreement 
with our experimentally determined values. We calculate an average ∆Hint value of −6.20(± 0.63) 
kcal · mol−1 for side chain-side chain interactions and −4.30(± 0.67) kcal · mol−1 for backbone-
backbone interactions for the Q10 fibril model. For both the PPII-like and the collapsed β-strand-
like monomer structures, we determine that the ∆Hint of side chain carbonyl-water interactions is 
−4.4(±0.61) kcal · mol−1.  For the β-strand-like monomer structure, we calculate that the ∆Hint of 
side chain-backbone hydrogen bonding is −4.70(± 0.57) kcal · mol−1 while that of side chain-side 
chain hydrogen bonding is -4.63(±0.53) kcal · mol−1. 
6.3 Conclusion 
Our experimental and computational results indicate that the ∆Hint of side chain-side 
chain and side chain-backbone interactions of Q10 fibril and monomeric β-strand-like structures 
are enthalpically more favorable than side chain-water. Interestingly, our results also indicate 
that, in polyQ fibrils, side chain-side chain interactions are more favorable than backbone-
backbone interactions. The importance of this work is that, to our knowledge, these are the first 
results that experimentally quantify the relative enthalpic favorability of hydrogen bonding 
interactions in solution-state and fibril polyQ peptides.  This work further validates the 
hypothesis that inter-amide side chain and backbone interactions play important roles in 
thermodynamically driving polyQ-rich proteins towards fibril structures.  
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6.4 Computational Details 
MD simulations were performed using the NAMD software,107 and VMD was used for 
visualization and analysis. All simulations were conducted under constant atom number, pressure 
(1 atm), and temperature (300 K) (NPT). The CHARMM36109 force field was utilized for 
potential energy and force calculation. The initial coordinates of the simulated structures shown 
in Figure 6.2 were from our previously published, experimentally validated work.46,82 Each 
system was solvated in TIP3P water.165 The simulated model fibril system, including water, 
consisted of a total of 20,284 atoms. The simulations for monomeric PPII-like and β-strand-like 
Q10 structures with explicit water each consisted of 17,189 atoms. Each system was simulated 
for 5 ns, and 500 snapshots were extracted from the simulations for analysis. The initial 
coordinates of each simulated structure, as well as the scripts used in our analysis, are available 
for download. 
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7.0 UV Resonance Raman Structural Characterization of an (In)Soluble Polyglutamine 
Peptide  
Adapted with permission from: Ryan S. Jakubek, Stephen E. White, and Sanford A. 
Asher. "UV Resonance Raman Structural Characterization of an (In)soluble Polyglutamine 
Peptide." The journal of physical chemistry B, 2019, 123, 8, 1749-1763. Copyright © (2019), 
American Chemical Society 
Author Contributions: RSJ collected, analyzed, and interpreted the Raman and 
absorbance data with the assistance of SEW. SEW collected the TEM images of Q20 fibrils. The 
manuscript was prepared by RSJ and SAA with assistance by SEW. 
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Fibrillization of polyglutamine (polyQ) tracts in proteins is implicated in at least ten 
neurodegenerative diseases. This generates great interest in the structure and the aggregation 
mechanism(s) of polyQ peptides. The fibrillization of polyQ is thought to result from the 
peptide’s insolubility in aqueous solutions; longer polyQ tracts show decreased aqueous solution 
solubility, which is thought to lead to faster fibrillization kinetics. However, few studies have 
characterized the structure(s) of polyQ peptides with low solubility. In the work here we use UV 
resonance Raman spectroscopy to examine the secondary structures, backbone hydrogen 
bonding, and side chain hydrogen bonding for a variety of solution state, solid, and fibril forms 
of D2Q20K2 (Q20). Q20 is insoluble in water and has a β-strand-like conformation with extensive 
inter- and intra-peptide hydrogen bonding in both dry and aqueous environments. We find that 
Q20 has weaker backbone-backbone and backbone-side chain hydrogen bonding and is less 
ordered compared to that of polyQ fibrils. Interestingly, we find that the insoluble Q20 will form 
fibrils when incubated in water at room temperature for ~5 hours. Also, Q20 can be prepared 
using a well-known disaggregation procedure to produce a water soluble PPII-like conformation 
with negligible inter- and intrapeptide hydrogen bonding and a resistance to aggregation.   
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7.1 Introduction 
 
Expanded polyglutamine (polyQ) tracts in proteins and peptides induce aggregation and 
fibrillization.1 This polyQ-induced fibrillization is associated with at least ten neurodegenerative 
diseases, including Huntington’s disease (HD) and multiple spinocerebellar ataxias (SCAs).1 The 
mechanism of toxicity and the identity of the toxic species are still debated.14,16,166  The common 
factor for polyQ-associated neurodegenerative diseases is the presence of an expanded polyQ 
tract.1  
In polyQ repeat diseases, longer polyQ tracts are correlated with an earlier disease 
symptom age-of-onset.167 Disease symptoms are only observed when the protein polyQ tract 
length surpasses a critical length (~≥36Q for the huntingtin protein in HD).1 This polyQ tract 
length dependence of disease age-of-onset is thought to result from a length-induced increase in 
the polyQ aggregation kinetics.47,168,169  
This possibility was strengthened when Chen et al. showed that polyQ peptides with 
longer polyQ tracts have faster aggregation kinetics.47 Also, Chen et al. used aggregation rates 
calculated from polyQ peptides at high concentrations  (~5-50 μM) to extrapolate aggregation 
rates for polyQ peptides at physiological concentrations (~0.1 nM).47  In these calculations, Q47 
at physiological concentrations was calculated to aggregate in ~31 years.  This aggregation rate 
is quite similar to the HD age-of-onset (30-40 years) for patients with a Q47 tract length in the 
huntingtin protein. Also, Q36 and Q28 lengths were calculated to begin aggregating in 141 and 
1273 years, respectively, at physiological concentrations. These putative ages of disease onset 
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roughly agree with the age of onset for polyQ tracts with <36Q residues in the huntingtin protein 
that do not produce HD symptoms within a patient’s lifetime. Because of the associations 
between polyQ tract length, aggregation kinetics, and disease age-of-onset, there is much interest 
in understanding the aggregation mechanism(s) of polyQ peptides of different lengths. 
Unfortunately, these studies of polyQ peptides are limited by the accompanying low solubility of 
these polyQ peptides in water. 
For example, polyQ peptides with ~≥20 Q residues generally show low water solubility. 
To study the polyQ solution-state structure and fibrillization kinetics of long polyQ peptides, 
Chen et al. developed a “disaggregation” procedure that increases polyQ peptide solubility.31 
Their solubilization procedure is referred to as disaggregation because it is thought to remove 
trace aggregate oligomers that are believed to seed fibrillization.33 Unfortunately, the exact 
mechanism by which this disaggregation protocol solubilizes polyQ peptide monomers is poorly 
understood. Because of the low solubility of long polyQ peptides, most studies use polyQ 
peptide solutions that are disaggregated before study.  
Recently, Punihaole et al.82 used UV resonance Raman (UVRR) spectroscopy and 
metadynamics simulations to examine the solution-state structure of the small polyQ peptide 
D2Q10K2 (Q10) in its disaggregated (DQ10) and non-disaggregated (NDQ10) forms. They found 
that aqueous NDQ10 has a collapsed β-strand-like conformation with significant intra-peptide 
hydrogen bonding. In contrast, DQ10 has a Polyproline II- (PPII-) like conformation with 
negligible inter- and intra-peptide hydrogen bonding. They showed that the β-strand-like 
(NDQ10) and the PPII-like (DQ10) structures are both predominantly monomeric with large 
activation energy barriers between them that prevent interconversion between these solution-
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state monomeric structures. They also showed that NDQ10 and DQ10 are both soluble in water 
at concentrations of up to 1 mg/mL.  
Computational 37,38 and experimental 43,44 studies have shown that longer polyQ peptides 
increasingly possess peptide-peptide hydrogen bonding. Studies showed that water is a good 
solvent for Q<16, a theta solvent for Q=~16, and a poor solvent for Q>16.43–45 Apparently, the 
increasing favorability of interpeptide interactions for longer polyQ peptides results in decreased 
aqueous solubilities that are thought to drive the formation of peptide aggregates and fibrils.43,45 
The peptide-peptide interactions of dilute polyQ solutions in poor solvents are satisfied via intra-
peptide hydrogen bonds that give rise to compact collapsed structures.38,43,45 In contrast, more 
concentrated polyQ solutions will form inter-peptide interactions that result in polyQ peptide 
aggregation.38,43,45 The low solubility of longer polyQ peptides is thought to promote their 
aggregation.38,43 However, little is known about the structures and fibrillization of polyQ 
peptides with low aqueous solubility. 
Here, we use UVRR spectroscopy to examine the structures of D2Q20K2 (Q20). We find 
that non-disaggregated Q20 (NDQ20) is insoluble in water. In this work we describe a polyQ 
peptide as insoluble if the peptide forms a pellet upon centrifugation (21,130 x g for 30 min).  
Figure 7.1 summarizes the structures of Q20 observed in this study. Q20 was synthesized 
by Thermo Fisher Scientific using Fmoc-based solid-phase peptide synthesis (SPPS) (Figure 
7.1a). The peptide was purified in 0.05% TFA using reverse-phase high-pressure liquid 
chromatography (HPLC) (Figure 7.1b). The purified peptide was then lyophilized, yielding the 
solid-phase peptide synthesis Q20 (SPPS Q20) species, which occurs in the form of a white 
powder (Figure 7.1c). For all experimental work, SPPS Q20 is considered to be the initial state 
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of the peptide.  Using UVRR we find that SPPS Q20 is in a β-strand-like conformation (Figure 
7.1c). 
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Figure 7.1: Summary of the forms of Q20 examined. The blue text indicates the nomenclature for this 
particular form of Q20. The peptide models shown are from simulations previously calculated for Q10 by 
Punihaole et al.46,82 They depict the peptide structure of each state examined. The structures shaded in blue 
are found to have the backbone and Gln side chain primary amides hydrogen bonded to water, while 
structures not shaded in blue have amide groups that are not hydrogen bonded to water. These structures are 
discussed in detail within the text. Reprinted with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 
123, 8, 1749-1763. Copyright 2019 American Chemical Society.   
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SPPS Q20 added to water does not form a clear solution at 0.3 mg/mL. This state of Q20 
is designated as non-disaggregated Q20 (NDQ20) because it was not disaggregated before being 
added to water (Figure 7.1d).  We find that the secondary structure of NDQ20 is similar to that of 
the SPPS Q20. Despite the low water solubility of NDQ20, we find that NDQ20 forms β-sheet 
fibrils (Figure 7.1f) when incubated in water at room temperature. 
We also prepared aqueous Q20 using the disaggregation protocol described in the 
methods section. SPPS Q20 will dissolve in a 1:1 mixture of trifluoroacetic acid (TFA) and 
hexafluoroisopropanol (HFIP) to form a clear solution (Figure 7.1g). The TFA/HFIP solvent can 
then be evaporated, and the resulting disaggregated Q20 (DQ20) peptide (Figure 7.1h) dissolves 
in water (Figure 7.1i). Using UVRR spectroscopy we find that the DQ20 peptide has a PPII-like 
secondary structure with backbone and side chain amide groups hydrogen bonded to water. 
DQ20 forms fibrils when incubated at 37°C and neutral pH for ~1 week (Figure 7.1j).   
Finally, we find that after ultracentrifugation of NDQ20 a small amount of peptide 
remains in the supernatant (Figure 7.1e). The peptide in the NDQ20 supernatant has a PPII-like 
structure similar to that of the highly soluble DQ20. 
7.2 Materials and Methods 
7.2.1  Materials 
D2Q15K2 (Q15) (≥98% purity), D2Q20K2 (Q20) (≥98% purity), and Trifluoroacetic acid 
(TFA) (≥ 99.5% purity) were purchased from Thermo Fisher Scientific. 1,1,1,3,3,3-hexafluoro-
2-propanol (HFIP) (~99% purity) was purchased from Acros Organics. 
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7.2.2  Peptide Synthesis 
Q15 and Q20 were synthesized by Thermo Fisher Scientific using Fmoc-based solid-
phase peptide synthesis. The final peptide was cleaved from the solid support using TFA. The 
peptide was purified in 0.05% TFA using reverse-phase HPLC. The purified peptide was 
lyophilized to produce SPPS Q20 (Figure 7.1c). 
7.2.3  Sample Preparation 
NDQ20 (Figure 7.1d) was prepared by adding the SPPS Q20, as received from Thermo 
Fisher Scientific, to nanopure water. Samples were prepared in sterilized centrifuge tubes to 
prevent impurities from seeding aggregation.  
The NDQ20 supernatant (Figure 7.1e) was made by first preparing NDQ20 at 1 mg/mL. 
The mixture was vortexed for ~5 minutes to dissolve any soluble peptide. After vortexing, the 
sample remained turbid. The sample was centrifuged for 30 minutes at 21,130 x g and then for 
30 min at 355,524 x g. The top ~50% of the supernatant was used for UV absorbance and UVRR 
measurements. 
DQ20 (Figure 7.1i) was prepared by using the disaggregation procedure developed by 
Chen et al.31 To disaggregate polyQ, the peptide was incubated in a 1:1 TFA and HFIP mixture 
for ~2-4 hours (Figure 7.1g). The solvent was then evaporated with a stream of dry nitrogen gas 
(Figure 7.1h). The peptide was then dissolved in water to a concentration of 0.3 mg/mL. 
TFA samples at pH=~+0.5 were prepared by adding 10% (v/v) TFA to nanopure water. 
TFA samples (10% (v/v)) in acidic conditions, pH=~-1.5, were prepared by adding TFA to 
concentrated hydrochloric acid. TFA in basic conditions was prepared by adding a known 
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volume of 10 M NaOH to a 10% (v/v) TFA solution to a final pH of ~12. The internal UVRR 
intensity standard sodium perchlorate (NaClO4) was added to TFA samples and to the NDQ20 
supernatant by adding a known volume of 5M NaClO4 to the sample. 
7.2.4  Absorbance Measurements 
Absorbance measurements used a Cary 5000 UV-Vis-NIR Spectrophotometer (Varian, 
Inc.) with a 0.02 cm pathlength, fused silica cylindrical cuvette.  
7.2.5  UV Resonance Raman Instrumentation 
The UVRR instrumentation was described in detail by Bykov et al.103 Briefly, the third 
harmonic of an infinity Nd:YAG laser (Coherent) was Raman shifted (30 psi, H2) to 204 nm (the 
5th anti-Stokes line of hydrogen). The Raman-scattered light was dispersed using a double 
monochromator in a subtractive configuration.103 The spectrum was imaged using a liquid 
nitrogen-cooled CCD camera with a Lumagen E coating (Spec10:400B, Princeton Instruments). 
Samples were placed in a Suprasil fused silica NMR tube that was spun during the measurement 
to reduce sample photodegradation. A ~165° backscattering geometry was used to collect the 
Raman scattering.  
7.2.6  Transmission Electron Microscopy (TEM) 
TEM images of DQ20 and NDQ20 fibrils were collected using a Morgagni 268(D) 
electron microscope (FEI) at 89,000x and 140,000x magnification, respectively, using an 
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electron accelerating voltage of 80 kV. Images were recorded on a 10-megapixel ORCA camera 
(Hamamatsu). EM sample grids were prepared by incubating 3 μL of DQ20 or NDQ20 fibrils on 
carbon-coated copper EM grids for ~3 min, and excess solution was removed by blotting with 
filter paper. The grid was then stained with 3 μL of 2% (w/v) uranyl acetate solution for ~45 sec 
before blotting.  
7.2.7  UV Resonance Raman Methods 
UVRR excitation at ~204 nm is in resonance with the π→π* electronic transitions of 
amide groups, which include the secondary amide peptide bond and primary amide glutamine 
(Gln) side chains.62 This selectively enhances vibrational motions that couple to these electronic 
transitions. Thus, our UVRR spectra of polyQ peptides are dominated by vibrations localized on 
the backbone peptide bonds and the Gln side chain amide groups. This greatly simplifies the 
Raman spectra. UVRR spectra are sensitive to the structure and solvation states of the peptide.63  
7.2.8  AmIII3S Band Reports on the Backbone Ramachandran Ψ Angle 
The peptide backbone amide III3 band (AmIII3
S) frequency was shown to be sinusoidally 
correlated to the peptide backbone Ramachandran Ψ angle.64,65 Mikhonin et al. developed a 
method to calculate the  Ψ angle from an experimentally measured AmIII3S frequency for a 
peptide backbone in different solvation states and temperatures.64 Asher et al. then showed that 
we can estimate the distribution of Ψ angles in a peptide by modeling the inhomogenously 
broadened AmIII3
S band as a sum of Lorentzian bands that approximate the homogenously 
broadened AmIII3
S bands.170 These methodologies have been extensively used to examine the 
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secondary structure of peptides.46,57,62,63,76,78–80,82 A detailed discussion of the equations used to 
calculate the Ψ angle distributions in this work can be found in Appendix C. 
7.2.9  AmI Bands Report on the Hydrogen Bonding and Dielectric Environment of the 
Amide Carbonyls 
The amide I (AmI) bands of the secondary amide peptide backbone (AmIS) and the 
primary amide Gln side chains (AmIP) predominantly involve C=O stretching. The AmI band 
frequency and intensity are sensitive to the dielectric constant and the hydrogen bonding of the 
amide carbonyl groups.72,81,90–93,171 This makes the AmI band a spectral marker for examining the 
water exposure and hydrogen bonding of amide groups.63,81 An environment with a large 
dielectric constant, such as water, increases the contribution of the amide dipolar resonance 
structure (-O-C=NH+) compared to that of the less-polar resonance structure (O=C-NH). This 
decreases the C=O bond force constant and the AmI frequency.72,171 Also, stronger hydrogen 
bonding to the C=O bond decreases its bond force constant downshifting the AmI band 
frequency.72,81,93  
The dielectric constant and the hydrogen bonding of the amide group also affect the AmI 
band UVRR intensities. In general, the deep UVRR enhancement of the AmI band of primary 
and secondary amides decreases with an  increasing dielectric constant and/or increased 
hydrogen bonding to the amide C=O group.72,171 This occurs because resonance enhancement 
depends on the Frank-Condon overlap between the amide ground and resonant excited states. 
The resonance enhancement of the AmI vibration scales with the square of the displacement 
between the equilibrium C=O bond ground electronic state and the ππ*excited state along the 
AmI vibrational normal coordinate.172  The C=O bond in the ππ* excited state is typically 
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elongated compared to that in the ground state.86,96 Thus, elongation of the C=O bond in a strong 
hydrogen bonding and/or high dielectric environment decreases the C=O bond displacement 
between the ππ* ground and excited state resulting in decreased UVRR enhancement. 72,171 
However, changes in the effective dielectric constant and hydrogen bonding also affect  
the amide ππ* excited state geometry.72,86,91,92 Thus, a complete understanding of the dependence 
of the AmI UVRR intensity on environment requires knowledge on how the dielectric constant 
and hydrogen bonding of the amide group affects the C=O bond length of both the ground and 
ππ* excited state.86 Table 7.1 summarizes the effects of changes in the dielectric environment 
and hydrogen bonding of the amide group on the AmI band intensity and frequency.  
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Table 7.1: Effects of Dielectric Constant (ε) and C=O Hydrogen Bonding on the Frequency and Intensity of 
the AmI UVRR Band. Reprinted with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-
1763. Copyright 2019 American Chemical Society. 
 ε Increase ε Decrease H-bond strength Increase H-bond strength Decrease 
Δ Intensity Decrease Increase Decrease Increase 
Δ Frequency Decrease Increase Decrease Increase 
 
7.2.10  UVRR Band Assignments of PolyQ Peptides 
The UVRR spectra of solution-state82 and fibril-state46 Q10 were previously assigned in 
detail. The UVRR spectra of Q20 measured here are similar to those previously measured for 
Q10. Here, we briefly discuss the assignments of the conformationally sensitive UVRR bands. 
Please  refer to our work on Q10 fibrils46 and on Q10 in solution82 for details.  
7.2.11  AmIII3S Band Assignments 
The AmIII3
S band is found in the ~1200-1300 cm-1 spectral region. As discussed above, 
this band is sensitive to the Ψ Ramachandran angle of the peptide backbone. Punihaole et al.82 
previously found that DQ10 has AmIII3
S peaks at ~1275 cm-1, ~1250 cm-1, and ~1215 cm-1 that 
derive from Ψ angle populations centered at ~175°, ~150°, and ~10°, respectively. The ~150° Ψ 
angle distribution is characteristic of PPII-like secondary structures, while Ψ angle populations at 
10° and 175 ° are characteristic of turn-like and 2.51-helix-like structures, respectively. From the 
UVRR data along with metadynamics simulations, Punihaole et al. concluded that DQ10 
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contains short PPII-like helices separated by turn regions.82 The 2.51-helix-like conformation was 
found to be localized within the charged aspartic acid (Asp) and lysine (Lys) residues at the 
peptide N- and C-termini, respectively. 
In contrast, NDQ10 has a single Raman AmIII3
S band at ~1240 cm-1. This corresponds to 
a Ψ angle distribution centered at ~140°, which is characteristic of a β-strand-like conformation. 
From the AmIII3
S band as well as metadynamics simulations, Punihaole et al. concluded that 
NDQ10 occurs in a collapsed β-strand-like conformation.82 A list of AmIII3S band frequencies 
and secondary structure assignments for DQ10 and NDQ10 is shown in Table 7.2. 
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Table 7.2: AmIII3S Band Assignments and Structures for NDQ10 and DQ10. Reprinted with permission from 
Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
 AmIII3
S Band 
Freq. (cm-1) 
Ψ Angle (°) Secondary 
Structure 
DQ1082 ~1275 ~175 2.51-Helix-Like 
DQ1082 ~1250 ~150 PPII-Like 
DQ1082 ~1215 ~10 Turn-Like 
NDQ1082 ~1240 ~140 β-Strand-Like 
 
7.2.12  AmI Band Assignments 
The AmIS and AmIP bands are both found in the ~1650-1700 cm-1 spectral region and 
spectrally overlap. Xiong et al.57 showed that the AmIP and AmIS bands can be separately 
highlighted in the UVRR spectrum by collecting UVRR spectra at two different excitations 
wavelengths: 197 nm and 204 nm. Because the ππ* transition of primary amides is at higher 
energy than secondary amides, excitation deeper in the UV (197 nm) increases the resonance 
enhancement of the AmIP band relative to the AmIS band. By subtracting the 204 nm UVRR 
spectrum from that of 197 nm excitation (197-204 nm) we highlight the primary amide 
vibrations, including the AmIP band. In addition, we can highlight the secondary amide 
vibrations, such as the AmIS band, by subtracting the 197-204 nm difference spectrum from the 
204 nm spectrum (204-(197-204) nm).   
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Punihaole et al. previously examined the AmIP and AmIS bands of NDQ10 and DQ10 
peptides in their solution-82 and fibril-state46 conformations. The AmIP bands of Gln side chains 
hydrogen bonded to water have low UVRR intensities and are broad, with center frequencies of 
~1680 cm-1. A low AmI UVRR intensity and a frequency of ~1680 cm-1 was previously 
observed for the AmIP band of aqueous Gln71 as well as for the water hydrogen bonded amides 
of Gln side chains of aqueous polyQ peptides.82 Similarly, the AmIS band of water hydrogen 
bonded secondary amides has a low UVRR intensity and a frequency of ~1700 cm-1.93  
Gln side chain and peptide backbone amide groups involved in peptide-peptide hydrogen 
bonding will be partially shielded from water. Thus, they will experience an environment with 
stronger hydrogen bonding and a lower dielectric constant compared to that of fully water 
exposed amide groups. For Gln side chain and peptide backbone amides involved in peptide-
peptide hydrogen bonding, we experimentally observe intense AmIP and AmIS bands located at 
~1660 cm-1. This was previously observed for the AmIP bands of Q10 in the solution-state82 and 
in Q10 fibrils46 as well as for the AmIS bands of Q10 fibrils.81  
Wang et al.93 showed that the frequency of the AmIS band of the peptide backbone is 
correlated to the enthalpy of interaction (ΔHint) between the backbone amide C=O groups and 
their environment. The ΔHint is dominated by strong interactions such as hydrogen bonds.152 This 
allows for the calculation of the strength of a hydrogen bond between the backbone C=O groups 
and a hydrogen bond donor.81,93 Punihaole et al.81 later expanded this technique to examine the 
ΔHint of Gln side chain C=O groups with their environment. They derived the following equation 
to estimate the interaction enthalpy of the Gln side chain: 
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𝐀𝐦𝐈𝐏(𝐜𝐦−𝟏) = 𝟏𝟕𝟑𝟎 (𝐜𝐦−𝟏) + (𝟏𝟐 𝐜𝐦−𝟏𝐤𝐜𝐚𝐥−𝟏 𝐦𝐨𝐥)(𝚫𝐇𝐢𝐧𝐭)                7.1            
 
Using eq. 7.1, Punihaole et al.81 estimated the strengths of Gln side chain hydrogen 
bonding in solution-state polyQ peptides, and backbone and side chain hydrogen bonding in 
polyQ fibrils. They found that in both solution and fibril-state polyQ, side chain-side chain and 
side chain-backbone (~-5.9 kcal/mol)  hydrogen bonding interactions are stronger than that of 
side chain-water (~-4.3 kcal/mol), backbone-water (~-4.3 kcal/mol), and backbone-backbone (~-
3.8 kcal/mol)  hydrogen bonding.81  
It is important to note that calculating ΔHint from an AmI frequency assumes that the AmI 
frequency is only dependent on ΔHint. However, the AmIS frequency of the peptide backbone is 
also strongly dependent on the peptide secondary structure.173 This occurs predominantly 
through changes in the transition dipole coupling (TDC) of adjacent AmIS oscillators.173 As a 
result, the determination of peptide backbone ΔHint is confounded by TDC. In contrast, TDC is 
weak and can be neglected for Gln side chain AmIS oscillators because of the larger distances 
and decreased order between adjacent oscillators.81 Punihaole et al. demonstrated this by 
showing that, in polyQ fibrils, the AmIS band is split due to TDC while the AmIP band consists 
of a single narrow peak that indicates negligible coupling.81  
From the AmI frequency we can determine if the Gln side chain and backbone amide 
C=O groups are hydrogen bonded to water or peptide. However, the AmIP and AmIS bands have 
the same frequency (~1660 cm-1) for C=O hydrogen bonding to backbone NH and Gln side chain 
NH hydrogen bond acceptors.46,81 Therefore we cannot differentiate between backbone-side 
chain and backbone-backbone hydrogen bonding as well as side chain-backbone and side chain-
side chain hydrogen bonding. In this paper side chain-peptide (backbone-peptide) hydrogen 
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bonding denotes that a side chain (backbone) carbonyl hydrogen bond acceptor is hydrogen 
bonded to either a side chain or backbone hydrogen bond donor. Table 7.3 summarizes the AmI 
band frequencies, intensities, and interaction enthalpies for polyQ peptide amide groups involved 
in different hydrogen bonding interactions. 
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Table 7.3: Characteristic AmI Frequencies and UVRR Intensities for Side Chain and Backbone Amide 
Groups Involved in Peptide-Peptide or Peptide-Water Hydrogen Bonding. Reprinted with permission from 
Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
Hydrogen Bonding Interaction AmI 
Freq. 
(cm-1) 
Relative AmI 
UVRR 
Intensity 
Interaction Enthalpy 
(kcal/mol) 
Sample(s) 
Sidechain C=O-Water ~1680 
(AmIP) 
Weak ~-4.381 DQ1081,82, 
NDQ1081,82, 
Gln71 
Sidechain C=O-Backbone NH ~1660 
(AmIP) 
Strong ~-5.981 NDQ1081,82 
Sidechain C=O- Sidechain NH ~1660 
(AmIP) 
Strong ~-5.981 NDQ1081,82, 
NDQ10 
Fibrils46,81, 
DQ10 Fibrils46,81 
Backbone C=O-Water ~1700 
(AmIS) 
Weak ~-4.393 NAcA3ME
93 
Backbone C=O- Backbone NH ~1660 
(AmIS) 
Strong ~-3.881 NDQ10 
Fibrils46,81, 
DQ10 Fibrils46,81 
NAcA3ME, N-aceyletrialanine methyl ester 
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7.3 Results and Discussion 
7.3.1  Solubility of Q10, Q15, and Q20 
We qualitatively examined the solubility of DQ15, NDQ15, DQ20, and NDQ20 by 
adding these peptides to water, vortexing, and examining the sample for separation upon 
standing or centrifugation at 21,130 x g for 30 minutes. We find that NDQ15, DQ15, and DQ20 
all form apparently clear, homogenous solutions in water, as observed by eye, at 1 mg/mL 
concentrations. They do not form pellets upon centrifugation.  Additionally, Punihaole et al. 82 
previously showed that NDQ10 and DQ10 form clear solutions in water at 1 mg/mL 
concentrations, and they showed using diffusion-ordered NMR spectroscopy (DOSY) that these 
peptides are predominately monomeric. Also, using DOSY we find that DQ15 and DQ20 diffuse 
at a rate consistent with a monomeric peptide (data not shown). A detailed description of the 
DQ15 and DQ20 DOSY  data will be presented in a future publication. 
In contrast, NDQ20 does not form a clear, homogenous solution in water at 1 mg/mL 
concentration (Figure 7.1d). NDQ20 begins separating within minutes upon standing and forms a 
large, easily observable pellet and a clear supernatant when centrifuged at 21,130 x g for 30 min.  
7.3.2  UVRR Characterization of DQ20 
We used UVRR spectroscopy to investigate the secondary structure of DQ20 (Figure 
7.1i). We find that the UVRR spectrum (Figure 7.2) and secondary structure (Figure 7.3) of 
DQ20 is similar to those previously reported for DQ10.82 DQ20 contains AmIII3
S peaks at ~1215 
cm-1, ~1275 cm-1, and ~1250 cm-1, which result from  Ψ angle distributions characteristic of turn-
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like (Ψ = 10°), 2.51-helix-like (Ψ = 175°), and PPII-like (Ψ = 150°) secondary structures, 
respectively (Figure 7.3). From this we conclude that DQ20 has a predominantly PPII-like 
conformation interspersed with turn regions and with terminal residues in a 2.51-helix-like 
conformation, as previously found for DQ10.82 
 
 
 
Figure 7.2: UVRR spectra of (blue) DQ10 and (red) DQ20. The DQ10 spectrum was previously measured by 
Punihaole et al.82 Reprinted with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. 
Copyright 2019 American Chemical Society. 
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Figure 7.3: UVRR determined Ψ angle distributions of (a) DQ20, (b) NDQ20 supernatant, and (c) DQ10. The 
Ψ distribution for DQ10 was previously calculated by Punihaole et al.82 Reprinted with permission from 
Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
  
   154  
 
7.3.2.1 DQ20 Contains Gln Side Chains Hydrogen Bonded to Water 
 
DQ20 has overlapping AmIS and AmIP bands at ~1677 cm-1. To identify the frequency of 
the AmIP band we examined the 197-204 nm difference spectrum of DQ20 (Figure 7.4a). We 
find that the AmIP band is located at ~1681 cm-1. Using eq. 7.1 we estimate that the ΔHint is ~-4.1 
kcal/mol, which is similar to the ΔHint between the Gln side chain and water.81 Our results show 
that DQ20 has Gln side chains that are hydrogen bonded to water (Figure 7.1i). 
 
 
 
Figure 7.4: (a) 197-204 nm difference spectrum and (b) 204-(197-204) nm difference spectrum of DQ20. The 
AmIP band is located at ~1681 cm-1 and the AmIS band is located at ~1675 cm-1. Reprinted with permission 
from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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We also examined the  204-(197-204) nm difference spectrum of DQ20 to determine its 
AmIS frequency (Figure 7.4b). We find that DQ20 contains a broad AmIS band centered at 
~1675 cm-1. Previously, Punihaole et al.81 observed the frequency of the AmIS band to be ~1660 
cm-1 in β-sheet Q10 fibrils with strong backbone-backbone hydrogen bonding. As discussed 
above, weaker hydrogen bonding upshifts the AmI band frequency. Thus, the fact that the AmIS 
frequency of DQ20 is upshifted compared to that of fibrils suggests that the peptide backbone of 
DQ20 involves weaker hydrogen bonding than that of β-sheet fibrils. This is expected for PPII-
like secondary structures that generally have water exposed peptide backbones.  
 
7.3.2.2 Fibrillization of DQ20 
 
At room temperature and low pH (pH = ~+2-3) the DQ20 monomers are stable for >>1 
week. However, incubation of DQ20 at 37°C and pH=~+7 results in fibril formation in ~1 week 
(Figure 7.1j). The UVRR spectra of DQ20 fibrils are similar to those previously observed for 
DQ10 fibrils (Figure 7.5a).46 The AmIII3
S and AmI bands of DQ10 and DQ20 fibrils are similar, 
indicating that their secondary structures and hydrogen bonding interactions are similar (Figure 
C.2). The UVRR spectra of DQ20 fibrils show AmIII3
S bands at ~1230 cm-1 and ~1210 cm-1 that 
derive from Ψ angle distributions centered at ~145° and ~123° (Figure 7.6a). As discussed 
previously by Punihaole et al., Ψ angle distributions centered at ~145° are characteristic of 
antiparallel β-sheet structures, while those centered at ~123° are characteristic of parallel β-sheet 
structure.  
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Figure 7.5: (a) 204 nm, (b) 197-204 nm, and (c) 204-(197-204) nm UVRR spectra of DQ20 fibrils. Reprinted 
with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American 
Chemical Society. 
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Figure 7.6: (a) Ψ angle distribution and (b) TEM image of DQ20 fibrils. Reprinted with permission from 
Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society.  
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In the 197-204 nm difference spectrum, the AmIP band maximum of DQ20 fibrils occurs 
at ~1662 cm-1 (Figure 7.5b).  As discussed above, this is characteristic of Gln side chain C=O 
groups involved in strong side chain-side chain and/or side chain-backbone hydrogen bonding. 
Using eq. 7.1 we estimate that the ΔHint for Gln side chain C=O groups in DQ20 fibrils is ~-5.7 
kcal/mol, similar to that previously found for DQ10 fibrils.81 Similarly, an AmIS band is 
observed in the 204-(197-204) nm difference spectrum (Figure 7.5c) of DQ20 fibrils at ~1663 
cm-1 that is characteristic of backbone amides involved in β-sheet backbone-backbone hydrogen 
bonding as previously observed for Q10 fibrils.46,81 Overall, the AmIP and AmIS band 
frequencies show that both backbone and side chain amide C=O groups in DQ20 fibrils are 
involved in strong peptide-peptide hydrogen bonding. 
7.4 Solubility of NDQ20  
As discussed above, NDQ20 does not form clear solutions in water (Figure 7.1d). We 
used UV absorbance to detect the presence of any soluble peptide in the supernatant after 
ultracentrifugation of NDQ20. We found that the NDQ20 supernatant contains significant 
absorbance; suggesting the presence of soluble peptide (Figure 7.7). Using UV absorbance and 
UVRR spectroscopies we calculate that the NDQ20 supernatant contains ~0.076 mg/ml of 
peptide. The supernatant peptide concentration calculations are discussed in detail below. 
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Figure 7.7: Absorption spectrum of NDQ20 supernatant. Reprinted with permission from Jakubek et al.  J. 
Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
 
7.4.1  Soluble NDQ20 Supernatant Fraction Contains a PPII-like Peptide Conformation 
We used UVRR to examine the structure of the peptide in the NDQ20 supernatant 
(Figure 7.1e). The UVRR spectrum of the NDQ20 supernatant is similar to that of DQ20 (Figure 
7.8). We observe AmIII3
S bands at ~1250 cm-1, ~1215 cm-1, and ~1275 cm-1, which derive from  
Ψ angle distributions centered at ~150°, ~10°, and ~175° respectively (Figure 7.3b). As 
discussed above for DQ20, these Ψ angles are characteristic of PPII-like, turn-like, and 2.51-
helix-like secondary structures, respectively. From the Ψ angle distributions we conclude that the 
peptide in the NDQ20 supernatant has the same secondary structure as DQ20. However, the 
widths of the PPII-like and 2.51-helix-like Ψ angle distributions (and AmIII3S bands) of the 
NDQ20 supernatant are larger than that of DQ20 (Figure 7.3). This indicates that the PPII-like 
and 2.51-helix-like structures of the NDQ20 supernatant is less ordered compared to that of 
DQ10. Also, we find that the AmIP and AmIS bands of the NDQ20 supernatant are found at 
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~1680 cm-1, which is similar to that of DQ20 and indicates Gln side chains that are hydrogen 
bonded to water.  
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Figure 7.8: UVRR spectra of (a) TFA and (b) the NDQ20 supernatant with (blue) and without (red) 
subtraction of TFA. (c) UVRR spectral comparison of (red) DQ20 and (blue) the NDQ20 supernatant with 
TFA subtracted. Reprinted with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. 
Copyright 2019 American Chemical Society. 
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7.4.2  TFA Contamination in NDQ20 Supernatant 
In the NDQ20 supernatant UVRR spectra, we observe a strong, dominant peak at ~1435 
cm-1 and a weaker peak at ~1205 cm-1 that result from trifluoroacetic acid (Figure 7.8a and b). 
These bands derive from CO stretching and asymmetric C-F stretching bands of the 
trifluoroacetate ion.  
Thermo Fisher Scientific synthesized our Q20 using an Fmoc solid-phase peptide 
synthesis where TFA was used for peptide cleavage and as a cosolvent for HPLC purification 
(see Methods Section). As a result, TFA is a common impurity in our Q20 peptides.174 When 
NDQ20 is centrifuged most of it pellets out. However, because of TFA’s miscibility with water it 
remains in the supernatant. 
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Figure 7.9: UVRR spectra (204 nm) of 10% (v/v) TFA in water at (a) pH=~-1.5, (b) pH=~+0.5, and (c) 
pH=~+12. At pH=~+12 TFA is deprotonated and at pH=~-1.5 TFA is predominantly protonated. Reprinted 
with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American 
Chemical Society. 
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Figure 7.9b shows the 204 nm UVRR spectrum of 10% (v/v) TFA (pKa=~+0.5)
175 in 
water at pH=~+0.5. This spectrum is consistent with that previously reported for deprotonated 
TFA (trifluoroacetate).176,177 Also, the Figure 7.9b UVRR spectrum is identical to that of 
deprotonated TFA (Figure 7.9c) indicating that the trifluoroacetate ion is selectively resonance 
enhanced at 204 nm. In contrast, the UVRR spectrum of protonated TFA (Figure 7.9a) 
significantly differs from that of trifluoroacetate and has a much smaller 204 nm UVRR 
crosssection.  
We assign the spectrum of trifluoroacetate based on the assignments of Robinson and 
Taylor,176 and Klemperer and Pimentel.177  The most intense peak in the TFA UVRR spectrum is 
located at ~1435 cm-1 and is assigned to symmetric carboxylate stretching motion.  We also 
observe peaks at ~1205 cm-1 and 1620 cm-1 that were previously assigned to asymmetric C-F 
stretching176 and asymmetric carboxylate stretching,176,177 respectively.  
We assign our UVRR spectrum of protonated TFA based on the assignments of Fuson et 
al.178 For protonated TFA, the most intense UVRR peaks are found at ~1795 cm-1 and ~1772 cm-
1.  We assign these bands to C=O stretching of TFA based on the work by Fuson et al.178 We also 
observe a band at ~1452 cm-1 that is assigned to C=O deformation.178 The bands at ~1014 cm-1 
and 1177 cm-1 and ~1273 cm-1 are assigned to OH out-of-plane deformation, C-F stretching, and 
OH in-plane deformations, respectively, of protonated TFA.178   
We found that the NDQ20 supernatant has a pH of ~+3.5. Therefore TFA is 
predominantly deprotonated in the NDQ20 supernatant. The peaks at ~1435 cm-1 and ~1205 cm-1 
in the NDQ20 supernatant are assigned to the strongly resonance enhanced carboxylate 
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stretching and the C-F stretching bands of the trifluoroacetate ion. Subtraction of the TFA UVRR 
spectrum from that of the NDQ20 supernatant reduces the intensity of the ~1435 cm-1 and ~1205 
cm-1 bands with little effect on the other UVRR bands, including the structurally sensitive 
AmIII3
S and AmI bands (Figure 7.8b).  
7.4.3  Concentration of TFA in the NDQ20 Supernatant 
The NDQ20 supernatant contains both TFA and the Q20 peptide. We determined the 
concentration of TFA in the NDQ20 supernatant from its UVRR spectrum. To do this we first 
calculated the Raman cross section of the ~1435 cm-1 band of trifluoroacetate using the 
following equation: 
𝜎𝑖 =
𝐼𝑖𝑘𝑟𝐶𝑟𝜎𝑟
𝐼𝑟𝑘𝑖𝐶𝑖
(
𝐴𝑖 + 𝐴𝑒𝑥
𝐴𝑟 + 𝐴𝑒𝑥
)                                                          
 
where σi is the Raman cross section of the trifluoroacetate ~1435 cm-1 band, σr is the Raman 
cross section of an internal standard Raman band, Ii is the intensity of the ~1435 cm
-1 
trifluoroacetate band, and Ir is the intensity of the internal standard Raman band. The factors kr 
and ki are the spectrometer efficiencies for the Raman bands of trifluoroacetate and the internal 
standard, respectively, and Cr and Ci are the concentrations of trifluoroacetate and the internal 
standard, respectively. The term in parentheses approximately corrects for sample self-absorption 
where Aex is the sample absorbance at the excitation frequency, Ai is the sample absorbance at 
the trifluoroacetate Raman band of interest, and Ar is the sample absorbance at the internal 
standard Raman band.  
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To determine the 204 nm UVRR cross section for the ~1435 cm-1 band of trifluoroacetate, 
we measured the UVRR spectrum of TFA at pH=~+12 using sodium perchlorate (NaClO4) as an 
internal Raman cross section standard. Raman cross section of NaClO4 was estimated to be 
~1.18x10-27 cm2 molecule-1 sr-1 for 204 nm excitation by extrapolating the Raman cross section 
measurements of Dudik et al.179 From eq.                                                7.2 we calculate that the 
204 nm Raman cross section of the ~1435 cm-1 trifluoroacetate band is ~1.08(±0.01)x10-26 cm2 
molecule-1 sr-1.  
Using the Raman cross section of trifluoroacetate we can determine the concentration of 
TFA in the NDQ20 supernatant. Rearrangement of eq.                                                7.2 gives: 
 
                                            𝑪𝒊 =
𝑰𝒊𝒌𝒓𝑪𝒓𝝈𝒓
𝑰𝒓𝒌𝒊𝝈𝒊
(
𝑨𝒊+𝑨𝒆𝒙
𝑨𝒓+𝑨𝒆𝒙
)                                                              7.3 
      
We collected UVRR spectra of the NDQ20 supernatant using sodium perchlorate as an 
internal standard. The NDQ20 supernatant has a pH of ~+3.5; thus, essentially all of the TFA in 
the supernatant will be deprotonated and contribute to the ~1435 cm-1 band of trifluoroacetate. 
Because we know the 204 nm Raman cross section of the ~1435 cm-1 trifluoroacetate band, we 
can calculate the concentration of TFA in the NDQ20 supernatant using eq.                                                       
7.3. We find that the concentration of TFA in the NDQ20 supernatant is ~810±70 μM.  
7.4.4  Concentration of Peptide in the NDQ20 Supernatant  
Using the concentration of TFA in the supernatant, calculated above, we determined the 
absorbance due to TFA at 214 nm in the NDQ20 supernatant. We constructed a calibration curve 
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for TFA in the NDQ20 supernatant at 214 nm using a standard addition method (Figure 7.10a). 
From the calibration curve we calculate that 810 μM TFA should result in an absorbance of 
~0.0006 at 214 nm. For the NDQ10 supernatant we find an absorbance of ~0.0113±0.002 at 214 
nm (Figure 7.7). Thus, the absorbance of the peptide in the NDQ20 supernatant is ~0.0107. We 
constructed a calibration curve using highly soluble DQ20 peptide to determine the concentration 
of peptide in the supernatant (Figure 7.10b). At 214 nm, DQ20 has a molar absorptivity of 
~19220 M-1 cm-1. From the DQ20 calibration curve we calculate that the NDQ20 supernatant 
contains ~0.076 mg/mL (~24.8 μM) of the Q20 peptide.   
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Figure 7.10: Absorbance calibration curve at 214 nm for (a) TFA and (b) DQ20. Reprinted with permission 
from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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7.4.5  TFA used in Solid-Phase Peptide Synthesis may Induce PPII-Like Conformation 
Our results show that the peptide in the NDQ20 supernatant has a PPII-like structure 
similar to that of disaggregated peptides and contains TFA. This is consistent with, Thakur and 
coworkers180,181 who showed that TFA alone causes disaggregation of polyQ peptides. Further, 
disaggregated polyQ peptides have previously been found to occur in PPII-like conformations.82  
Thus, we hypothesize that the PPII-like structure observed in the NDQ20 supernatant results 
from the use of TFA during peptide synthesis. However, the mechanism by which TFA induces 
structural change in polyQ peptides remains poorly understood.   
 
7.5 Structure of SPPS Q20 and NDQ20  
7.5.1  UVRR Characterization and Ψ Angle Distribution of SPPS Q20  
The UVRR spectrum of SPPS Q20 is similar to that of NDQ1082, which was found to 
have a collapsed β-strand-like conformation (Figure 7.11).82 The SPPS Q20 UVRR spectrum 
shows an AmIII3
S frequency of ~1245 cm-1, which is 5 cm-1 upshifted compared to that of 
NDQ10 (~1240 cm-1). This ~5 cm-1 AmIII3
S frequency difference between SPPS Q20 and 
NDQ10 likely results from differences in peptide backbone hydration.  
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Mikhonin et al. previously correlated the AmIII3
S frequency to the Ψ angle for peptides in 
a variety of backbone solvation states.64  They found that the frequency of the AmIII3
S band is 
sensitive to water solvation of the peptide backbone. Comparison of the AmIII3
S frequency–Ψ 
angle correlations for crystalline peptides and solvated peptides shows an ~4 cm-1 upshift of the 
AmIII3
S band in peptide crystals compared to peptides in aqueous solution. This is similar to the 
~5 cm-1 upshift of the AmIII3
S band we observe for SPPS Q20 compared to aqueous NDQ10. 
Thus, the AmIII3
S frequency differences between NDQ10 and SPPS Q20 are most likely to result 
from water exposure of the peptide backbone. In agreement, the AmIP band of SPPS Q20 
indicates that the side chain amide groups are not hydrogen bonded to water (see below) while 
NDQ10 side chain and backbone carbonyl groups are hydrogen bonded to water.82 See below for 
a detailed discussion of the SPPS Q20 AmI bands.  
 
 
 
Figure 7.11: UVRR spectra of (red) NDQ10 and (blue) SPPS Q20.  Reprinted with permission from Jakubek 
et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
 
 
Punihaole et al.82 previously calculated the Ψ angle distribution of the NDQ10 peptide 
from the AmIII3
S band using an equation derived by Mikhonin et al.64 for peptides in aqueous 
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solution with an unknown hydrogen bonding environment (eq. C.4). Using this equation, 
Punihaole et al. calculated that aqueous NDQ10 has a Ψ angle distribution centered at ~140°, 
characteristic of a β-strand-like secondary structures.82  
Here, we use the AmIII3
S band of SPPS Q20 to calculate its Ψ angle distribution. 
However, because the AmIII3
S frequency depends on both the Ψ angle and hydrogen bonding to 
the amide C=O and N-H groups,64,90 we must account for the AmIII3
S frequency shift resulting 
from differences in hydrogen bonding between dissolved NDQ10 and SPPS Q20. Therefore, 
instead of using C.4 for aqueous peptides, we used the measured AmIII3
S frequency-Ψ angle 
correlation for crystalline peptides derived by Mikhonin et al.64 (equation C.5). This equation 
best models the hydrogen bonding and solvation environments expected for SPPS Q20. Using 
this equation we calculate that SPPS Q20 has a Ψ angle distribution centered at ~138°, which is 
characteristic of β-strand-like structures (Figure 7.12b) such as that observed for NDQ10 (Ψ = 
~140°).82 Also, it is important to note that the AmIII3
S band and Ψ angle distribution of SPPS 
Q20 is significantly broader than that of NDQ10. This indicates that the β-strand-like 
conformation of SPPS Q20 is less ordered and contains more conformational variations 
compared to that of NDQ10.   
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Figure 7.12: Ψ angle distribution of (a) NDQ10 (b) SPPS Q20, and (c) NDQ20. Reprinted with permission 
from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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7.5.2  UVRR Characterization and Ψ Angle Distribution of NDQ20 
We investigated the structure of NDQ20 (Figure 7.1d) by measuring its UVRR spectrum 
(Figure 7.13). We find that the UVRR spectrum of NDQ20 in water is very similar to that of 
SPPS Q20 (Figure 7.12b) with an AmIII3
S band at ~1246 cm-1. Using eq. C.5, we calculate that 
the NDQ20 Ψ angle distribution is centered at ~138°, which is characteristic of a β-strand-like 
conformation (Figure 7.12c).  
 
 
 
Figure 7.13: UVRR spectra of (blue) SPPS Q20 and (red) NDQ20 in water. Reprinted with permission from 
Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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7.5.3  Side Chain and Backbone Hydrogen Bonding in SPPS Q20 and NDQ20 
At 204 nm excitation, SPPS Q20 and NDQ20 both contain broad (~70 cm-1 FWHH) AmI 
bands centered at ~1670 cm-1 (Figure 7.14). In contrast to SPPS Q20, NDQ20 also contains a 
narrow AmI peak at ~1660 cm-1, which indicates strong peptide-peptide hydrogen bonding. 
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Figure 7.14: UVRR AmI spectral region of (a) NDQ20 and (b) SPPS Q20.  The spectra were modeled as a 
sum of Gaussian and Lorentzian bands, shown in black, as described in Appendix C. The AmI bands are 
labeled in each spectrum. Reprinted with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 
1749-1763. Copyright 2019 American Chemical Society. 
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We examined the 197-204 nm difference spectra of SPPS Q20 and NDQ20 to highlight 
the contributions of the AmIP bands (Figure 7.15a and c). We find that SPPS Q20 and NDQ20 
both contain narrow AmIP bands located at ~1666 cm-1 and ~1662 cm-1 respectively. These 
frequencies are indicative of strong side chain-side chain and/or side chain-backbone hydrogen 
bonding such as that found in polyQ fibrils.46 Using eq. 7.1 we estimate that the Gln side chain 
ΔHint = ~-5.3 kcal/mol for SPPS Q20 and ~-5.6 kcal/mol for NDQ20.  
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Figure 7.15: 197-204nm UVRR difference spectra of (a) NDQ20 and (c) SPPS Q20, and 204-(197-204)nm 
difference spectra of (b) NDQ20 and (d) SPPS Q20. Reprinted with permission from Jakubek et al.  J. Phys. 
Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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The increased relative intensity of the ~1662 cm-1 AmIP band in the UVRR spectra of 
NDQ20, compared to that of SPPS Q20, indicates that NDQ20 contains a larger population of 
Gln side chains involved in strong side chain-peptide hydrogen bonding. Also, the lack of an 
~1680 cm-1 AmIP band in NDQ20 and SPPS Q20 indicates that neither species contains a 
significant population of Gln side chains hydrogen bonded to water.  
From the 204-(197-204) nm spectra (Figure 7.15b and d), we find that both NDQ20 and 
SPPS Q20 have an AmIS frequency of ~1675 cm-1. This frequency is upshifted from that of 
polyQ fibrils (~1660 cm-1) indicating that NDQ20 and SPPS Q20 contain weaker backbone-
peptide hydrogen bonding. Also, the AmIS bands of NDQ20 and SPPS Q20 are broad (~70 cm-1 
FWHH) suggesting that the peptide backbone amides are found in a variety of hydrogen bonding 
environments that inhomogenously broaden the AmIS band.  
 
7.6 Stability and Activation Barrier Between the PPII-Like and β-Strand-Like Structures 
of PolyQ 
Punihaole et al.82 previously showed that the PPII-like and β-strand like conformations do 
not interconvert because of a high activation barrier between them. We find that the PPII-like 
polyQ structure of DQ1082 and DQ20 contains negligible peptide-peptide hydrogen bonding and 
extensive peptide-water hydrogen bonding.  PPII conformations are thought to be stabilized by 
peptide backbone-water hydrogen bonding182,183 and/or the low-energy water-water hydrogen 
bonding structure of the PPII peptide solvation shell. 29,182,184–188 Thus, it is likely that the polyQ 
PPII-like structure is also stabilized by these interactions. A PPII-like → β-strand-like polyQ 
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structural transition would have to overcome the energy barrier(s) associated with breaking 
peptide backbone-water hydrogen bonds and/or disrupting the water-water hydrogen bonding of 
the PPII solvation shell.   
In contrast, the β-strand-like structure of NDQ1082 and NDQ20 contains significant side 
chain-peptide hydrogen bonding. β-strand structures are stabilized by peptide-peptide hydrogen 
bonding between neighboring β-strands. 21 Thus, polyQ β-strand conformations are likely 
stabilized by their side chain-peptide hydrogen bonding. A β-strand-like → PPII-like polyQ 
structural transition would have to overcome the energy barrier associated with breaking peptide-
peptide hydrogen bonds. 
7.7 NDQ20 Fibrillization 
To determine if NDQ20 (Figure 7.1d) will from fibrils, we examined the UVRR 
spectrum of aqueous NDQ20 after incubation for ~5 hours at room temperature (~18°C) and low 
pH (pH = ~+2-3) (Figure 7.1f). Incubation of NDQ20 resulted in a UVRR spectrum similar to 
that of NDQ10 fibrils reported by Punihaole et al. (Figure 7.16b).46 After incubation, the AmIII3
S 
band downshifts to ~1233 cm-1, which is characteristic of the antiparallel-β-sheet structure of 
polyQ fibrils (Ψ = ~148°) (Figure 7.17b) that contain dry fibril cores.46 We also observe a low 
intensity AmIII3
S band at ~1210 cm-1 that corresponds to a Ψ angle distribution centered at 
~123°. As discussed previously by Punihaole et al., Ψ angles of ~123° arise from sub-
populations of parallel β-sheet in polyQ fibrils.46 The widths of both the parallel and antiparallel 
β-sheet Ψ angle distributions are larger for NDQ20 fibrils compared to NDQ10 fibrils. This 
   180  
 
indicates that the secondary structure of the NDQ20 fibrils is less ordered compared to NDQ10 
fibrils. 
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Figure 7.16: (a) UVRR spectra of NDQ20 (blue) and NDQ20 fibrils (red). (b) Comparison of the UVRR 
spectra of NDQ20 fibrils (red) and NDQ10 fibrils (blue) previously collected by Punihaole et al.46 Reprinted 
with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American 
Chemical Society. 
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Figure 7.17: Ψ angle distribution of (a) NDQ10 fibrils and (b) NDQ20 fibrils.  Both NDQ10 fibrils and 
NDQ20 fibrils contain Ψ angle distributions that peak at ~148° and ~123°, which are characteristic of 
antiparallel β-sheet and parallel β-sheet conformations respectively. Reprinted with permission from Jakubek 
et al.  J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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Additionally, the AmI band downshifts to ~1660 cm-1 and increases in relative intensity 
as a result of formation of strong peptide-peptide hydrogen bonds, as previously observed in Q10 
fibril formation.46 To determine the frequency of the AmIP and AmIS bands, we examined the 
197-204nm and 204-(197-204) nm UVRR spectra of NDQ20 after incubation (Figure 7.18a and 
b). We find that the AmIP band is located at ~1665 cm-1, which corresponds to a side chain ΔHint 
of ~-5.4 kcal/mol. This is similar to that previously observed for Q10 fibrils.46,81 Also, we find 
that the AmIS band is located at ~1665 cm-1, which suggests strong backbone-backbone 
hydrogen bonding, as previously observed in polyQ fibrils.46 
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Figure 7.18: (a) 197-204 nm and (b) 204-(197-204) nm difference spectra of NDQ20 after ~5 hours of 
incubation. Reprinted with permission from Jakubek et al. J. Phys. Chem. B., 2019, 123, 8, 1749-1763. 
Copyright 2019 American Chemical Society. 
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To confirm formation of fibrils, we collected TEM images of NDQ20 after incubation for 
~1-2 days at room temperature and low pH (pH = ~+2-3). Figure 7.19 shows TEM images of 
NDQ20 fibrils and NDQ10 fibrils. The TEM images of NDQ10 fibrils were previously collected 
by Punihaole et al.46 We find that NDQ20 contains amyloid-like fibril aggregates with a similar 
morphology to that observed for NDQ10.46 These images confirm that NDQ20 forms fibrils 
when incubated at room temperature (~18°C) and low pH (pH = ~+2-3). 
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Figure 7.19: TEM images of (a) NDQ10 fibrils and (b) NDQ20 fibrils (Figure 7.1f). Reprinted with permission 
from Jakubek et al. J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society.  
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7.8 Comparison to Other Results 
Our insights into the structures of SPPS Q20 and NDQ20 generally agree with results 
recently published by Burra and Thakur.189 They investigated the structures of the insoluble 
polyQ peptide K2Q9PGQ4AQ4PGQ9PGQ9K2 (PGQ9A) in the solid-phase synthesis lyophilized 
powder (SPPS PGQ9A) and non-disaggregated (NDPGQ9A) forms using FTIR and CD 
spectroscopies. 
Burra and Thakur189 found that SPPS PGQ9A contains predominantly antiparallel β-sheet 
structure with minority populations of random coil and turn conformations. They conclude that 
SPPS PGQ9A must have weaker peptide-peptide hydrogen bonding compared to β-sheet fibrils 
because turn and random coil conformations have a less optimal hydrogen bonding pattern.189 
This is in agreement with our UVRR data showing that SSPS Q20 is in a β-strand-like 
conformation with weaker hydrogen bonding compared to fibrils.  
In contrast to SPPS PGQ9A, Burra and Thakur showed that NDPGQ9A contains only 
antiparallel β-sheet conformation.189 Since random coil and turn conformations were not 
observed in NDPGQ9A, they concluded that NDPGQ9A must contain stronger peptide-peptide 
hydrogen bonding compared to SPPS PGQ9A.
189 Their conclusions agree with our results 
showing that NDQ20 contains a β-strand-like structure and stronger peptide-peptide hydrogen 
bonding compared to SPPS Q20.  
Additionally, Burra and Thakur do not observe signs of NDPGQ9A fibrillization after 
incubation in water for 3 hours.189 In contrast, we find that NDQ20 forms fibrils after ~5 hours of 
incubation in water. It is possible that Burra and Thakur did not observe fibrillization of 
NDPGQ9A because it requires an incubation time longer than 3 hours to form fibrils.  
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The work by Burra and Thakur189 qualitatively examined the secondary structures of 
SPPS PGQ9A and NDPGQ9A. From the secondary structures, they predicted the hydrogen 
bonding in each species. Our measurements quantitatively extend the work of Burra and 
Thakur189 by quantifying the peptide Ψ angle distribution and by directly measuring the peptide 
backbone and Gln side chain hydrogen bonding interactions for SPPS Q20 and NDQ20. As 
described above, our measurements provide new insights into the specific secondary structures 
and hydrogen bonding interactions experienced by insoluble polyQ species. 
 
7.9 Implication of NDQ20 Fibrillization on the PolyQ Fibrillization Mechanism 
Currently, there are two major models for the polyQ fibrillization mechanism. The first 
model, proposed by Wetzel and coworkers47,58, argues that polyQ aggregation occurs via 
nucleated growth. In this mechanism, the nucleus is thought to be a thermodynamically 
unfavorable conformation of the peptide monomer, and fibrils elongate by the recruitment of 
monomeric units to the growing fibril.36,47  
The second model for the polyQ aggregation mechanism, developed by Pappu and 
coworkers, proposes that polyQ peptides form inter- and intra-peptide hydrogen bonds that lead 
to the formation of non-fibrillar polyQ aggregates.37,38,43 They propose that these aggregates can 
undergo a conformational change to form fibrils.61 
Here, we show that the insoluble NDQ20 (Figure 7.1d) peptide will convert from non-
fibril aggregates to fibrils in water. This result suggests that non-fibril polyQ aggregates in water 
can undergo a conformational transition into fibrils.   
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7.10 Conclusion 
 
The results of this work are summarized in Table 7.4.  
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Table 7.4: Summary of Secondary Structure and Hydrogen Bonding for Forms of Q20 Examined in this 
Study. Reprinted with permission from Jakubek et al. J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 
2019 American Chemical Society.  
 AmIP υ 
(cm-1) 
Side 
Chain H-
Bonding 
AmIS υ 
(cm-1) 
Backbone 
H-
Bonding 
Ψ Angle (°) Secondary structure 
DQ20 ~1681 S.C.-W. ~1675 B.B.-W. ~10, ~175, 
~150 
Turn, 2.51-Helix, 
PPII 
DQ20 Fibrils ~1662 S.C.-P. ~1663 B.B.-P. ~145, ~123 P-β-Sheet,  
A-β-Sheet 
NDQ20 ~1662 S.C.-P. ~1672 B.B.-P. ~138 β-Strand 
NDQ20 
Supernatant 
~1680 S.C.-W. ~1680 B.B.-W. ~10, ~175, 
~150 
Turn, 2.51-Helix, 
PPII 
SPPS Q20 ~1666 S.C.-P. ~1672 B.B.-P. ~138 β-Strand 
NDQ20 
fibrils 
~1665 S.C.-P. ~1665 B.B.-P. ~148, ~123 P-β-Sheet,  
A-β-Sheet 
S.C., side chain; W., Water; P., Peptide; B.B., Backbone; P-β-Sheet, parallel β-Sheet; A-β-
Sheet, antiparallel β-Sheet 
 
We used UVRR spectroscopy to investigate the structures of Q20. NDQ20 is essentially 
insoluble in water (Figure 7.1d). In contrast, we find that disaggregation of Q20 renders the 
peptide (DQ20) highly soluble (Figure 7.1i). Using UVRR spectroscopy we find that DQ20 is in 
a PPII-like conformation with backbone and side chain amide groups hydrogen bonded to water.  
To examine the solubility of NDQ20 (Figure 7.1d), we collected UV absorption spectra 
of the NDQ20 supernatant (Figure 7.1e) after ultracentrifugation. We find that the supernatant 
has weak absorbance. Using UV absorbance and UVRR we find a concentration of ~0.076 
mg/mL for the peptide in the NDQ20 supernatant. Using UVRR spectroscopy we find that the 
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soluble fraction of NDQ20 is in a PPII-like conformation (Figure 7.1e) with Gln side chains and 
peptide backbone hydrogen bonded to water, similar to that of DQ1082 and DQ20. The presence 
of PPII-like peptide structure in the NDQ20 supernatant could result from the use of TFA in the 
peptide synthesis, which can disaggregate polyQ in the absence of HFIP.180,181 
We used UVRR spectroscopy to investigate the structures of SPPS Q20 (Figure 7.1c) and 
NDQ20 (Figure 7.1d). We find that SPPS Q20 and NDQ20 are in β-strand-like conformations 
(Ψ=~138°) similar to that previously observed for NDQ10.82  Using UVRR spectroscopy, we 
also probed the backbone and side chain amide hydrogen bonding interactions in SPPS Q20 and 
NDQ20. We find that both NDQ20 and SPPS Q20 contain backbone amides with weaker inter- 
and intra-peptide hydrogen bonding compared to that found in fibrils. In contrast the side chain 
amide groups in SPPS Q20 and NDQ20 are involved in strong side chain-peptide hydrogen 
bonding. The number of side chain-peptide hydrogen bonds in NDQ20 is greater than that of 
SPPS Q20.  
Upon incubation for ~5 hrs, we find that NDQ20 converts to fibrils (Figure 7.1f).46 These 
fibrils have a β-sheet secondary structure with side chain and backbone amides involved in 
strong peptide-peptide hydrogen bonding. This result, along with the observation that NDQ20 
contains more side chain-peptide hydrogen bonds compared to SPPS Q20, suggests that high 
molecular weight, non-fibrillar polyQ aggregates can undergo a conformational transition into 
fibrils. The discovery that apparently insoluble polyQ peptides can form fibrils may allow for 
fibrillization studies on NDQ peptides in a β-strand-like conformation without the need for 
disaggregation.  
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8.0 Polyglutamine Solution-State Structural Propensity is Repeat Length Dependent 
Adapted with permission from: Ryan S. Jakubek, Riley J. Workman, Stephen E. White, 
and Sanford A. Asher. Polyglutamine Solution-State Structural Propensity is Repeat Length 
Dependent. The Journal of Physical Chemistry B, 2019, 123(19), 4193-4203. Copyright 2019 
American Chemical Society. 
Author Contributions: R.S.J. collected, analyzed, and interpreted the Raman and CD 
data with the assistance of S.E.W. R.J.W. performed the computational work and interpreted the 
data with assistance by R.S.J. and S.E.W. The manuscript was prepared by R.S.J. and S.A.A. 
with assistance by R.J.W. and S.E.W. 
Expanded polyglutamine (polyQ) tracts in proteins, which are known to induce their 
aggregation, are associated with numerous neurodegenerative diseases. Longer polyQ tracts 
correlate with faster protein aggregation kinetics and a decreased age of onset for polyQ disease 
symptoms. Here, we use UV resonance Raman spectroscopy, circular dichroism spectroscopy, 
and metadynamics simulations to investigate the solution-state structures of the D2Q15K2 (Q15) 
and D2Q20K2 (Q20) peptides. Using metadynamics, we explore the conformational energy 
landscapes of Q15 and Q20 and investigate the relative energies and activation barriers between 
these low-energy structures. We compare the solution-state structures of D2Q10K2 (Q10), Q15, 
and Q20 to determine the dependence of polyQ structure on the Q tract length. We show that 
these peptides can adopt two distinct monomeric conformations: an aggregation-resistant PPII-
like conformation and an aggregation-prone β-strand-like conformation. We find that longer 
polyQ peptides have an increased preference for the aggregation-prone β-strand-like 
conformation. This preference may play an important role in the increased aggregation rate of 
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longer polyQ peptides that is thought to lead to decreased neurodegenerative disease age of onset 
for polyQ disease patients.  
8.1 Introduction 
The expansion of CAG codon repeats in DNA encodes for elongated polyglutamine 
(polyQ) tracts in proteins.1 Expanded polyQ tracts in proteins and peptides induce aggregation 
and fibrillization. This aggregation is associated with numerous neurodegenerative diseases, 
including Huntington’s disease.1 However, the identity of the toxic species is still 
debated.14,16,190,191 
For polyQ diseases, the length of the expanded polyQ tract affects the severity of the 
disease.  Patients with longer polyQ tracts have an earlier disease age of onset, and disease 
symptoms are only evident if the protein’s polyQ tract surpasses a critical length.5,47,167 For 
example, clinical presentation of Huntington’s disease is only observed in patients with a polyQ 
tract ≥36 residues long in the huntingtin protein.1 Additionally, in vitro studies of polyQ peptides 
show that longer polyQ tracts have increased aggregation rates that may be related to the disease 
age of onset.47,192 
Because of the dependence of aggregation rate and disease age of onset on the length of 
the polyQ tract, there is great interest in determining the structural differences between polyQ 
tracts of different length. Most experimental34–36,41 and computational37–39,99 studies conclude 
that solution-state polyQ peptides are intrinsically disordered regardless of the polyQ tract 
length. However, some studies suggest the existence of small populations of secondary structure 
that may play a role in aggregation and cytotoxicity.6,10,11  
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UV resonance Raman (UVRR) spectroscopy has provided detailed insight into the 
secondary structures of polyQ peptides.46,82,193 UVRR spectroscopy is a powerful tool for 
studying protein structure, solvation, and hydrogen bonding interactions.62,63,81 Excitation in the 
deep UV (~200 nm) selectively enhances vibrations of the secondary amide peptide backbone 
and primary amide glutamine (Gln) side chains.57,194 These resonance-enhanced bands are 
sensitive to the structure and environment of the peptide backbone and Gln side chains.63 
Recently, Punihaole et al. used UVRR spectroscopy and metadynamics simulations to 
investigate the solution-state structures of D2Q10K2 (Q10).
82 They found that when Q10 is 
dissolved in water it exists in a well-defined, collapsed β-strand-like conformation. This peptide 
form is referred to as non-disaggregated Q10 (NDQ10). In contrast, when disaggregated using 
the methodologies of Chen et al.31, Q10 exists in a predominantly polyproline II (PPII)-like 
structure.  This peptide conformation is referred to as disaggregated Q10 (DQ10). NDQ10 and 
DQ10 were found to have a large activation barrier preventing these two conformations from 
interconverting.82 Disaggregated peptides, including DQ10, are more resistant to aggregation and 
fibrillization compared to non-disaggregated peptides.31,46,57    
In this study we use UVRR spectroscopy, circular dichroism (CD), and metadynamics 
simulations to investigate the solution-state structures of D2Q15K2 (Q15) and D2Q20K2 (Q20) in 
their disaggregated (D) and non-disaggregated (ND) forms. We compare our results with those 
previously published for Q1082 and Q20193 to investigate the dependence of the solution-state 
polyQ structures on repeat length. We find that disaggregated Q15 (DQ15) has predominately 
the same PPII-like structure as previously found for DQ1082 and disaggregated Q20 (DQ20).193 
Also, non-disaggregated Q15 (NDQ15) has predominately the same collapsed β-strand-like 
conformation as previously found for NDQ10.82 Unlike NDQ10 and NDQ15, non-disaggregated 
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Q20 (NDQ20) is insoluble in water. The structures of NDQ20 were previously described in 
detail.193 
Using CD spectroscopy, we show that disaggregated polyQ (DQ) peptides, while 
predominantly in a PPII-like conformation, have a significant population of collapsed β-strand-
like conformation that increases with polyQ length. Our metadynamics simulations show that the 
relative energies of the PPII-like structures increase and the relative activation energy of the PPII 
→ β-strand conformational transition decreases with increasing polyQ length. From these data 
we conclude that longer polyQ peptides have an increased preference for the aggregation-prone 
collapsed β-strand-like conformation compared to the aggregation-resistant PPII-like 
conformation. This structural preference may in part explain why proteins containing longer 
polyQ tracts have an increased aggregation rate, which is associated with a decrease in the 
neurodegenerative disease age of onset.  
8.2 Materials and Methods 
8.2.1  Materials 
The peptides Q15 and Q20 were purchased from Thermo Fisher Scientific at ≥ 95% 
purity. Trifluoroacetic acid (TFA) was purchased from Thermo Fisher Scientific at ≥ 99.5% 
purity, and 1,1,1,3,3,3,-hexafluoro-2-propanol (HFIP) was purchased from Acros Organics 
at ~99% purity.  
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8.2.2  Sample Preparation 
NDQ15 was prepared by dissolving the peptide in nanopure water. Solution-state, non-
disaggregated polyQ peptides are sensitive to impurities that can nucleate aggregation. NDQ15 
was prepared in sterile centrifuge tubes to remove any nucleating centers.   
DQ15 and DQ20 were prepared using the disaggregation protocol developed by Chen et 
al.31 Briefly, the peptide was dissolved in 1:1 TFA/HFIP by sonication (~15 min) and incubated 
for ~2 hours at room temperature. The TFA/HFIP solvent was then evaporated with a stream of 
dry nitrogen and the peptide was dissolved in water to the desired concentration (0.3 mg/ml for 
UVRR and CD measurements).    
8.2.3  UV Resonance Raman Spectroscopy 
The UVRR instrumentation used in this work was previously described by Bykov et al.103 
An Infinity Nd:YAG laser (Coherent, Inc.) was used to generate ~204 nm light by Raman-
shifting the third harmonic with H2 gas (30 psi) and using the fifth anti-Stokes line. We 
generated 197 nm laser excitation using the 4th harmonic of a tunable Ti:sapphire laser (Positive 
Light). Samples were contained in a spinning Suprasil quartz NMR tube during spectral 
collection, and a ~165° backscattering angle was used. The scattered light was dispersed in a 
subtractive double monochromator. A back-thinned, liquid nitrogen-cooled CCD camera 
(Spec10:400B, Princeton Instruments) with a Lumagen-E coating was used to detect the Raman 
scattering.  
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8.2.4  CD Spectroscopy 
CD spectra were measured using a Jasco J-710 spectropolarimeter. Samples were placed 
in a cylindrical fused silica quartz cuvette with a pathlength of 0.02 cm. Spectra were collected 
with 0.2 nm data intervals and averaged over ~10 scans.  
8.3 Computational Methods 
8.3.1  General Simulation Details 
Metadynamics simulations were used to investigate the conformational energy landscape 
of Q15 and Q20. Subsequently, molecular dynamics (MD) simulations were performed on low-
energy conformations of the Q15 and Q20 landscapes to obtain structural information on the 
equilibrated structures. Monomeric Q15 and Q20 peptides were placed in periodic boxes of 
11665 and 18658 TIP3P165 water molecules with dimensions of 72×72×72 Å and 84×84×84 Å, 
respectively. All simulations were performed with the NAMD107 MD engine, and simulation 
trajectory data were analyzed using Visual Molecular Dynamics (VMD) 1.9.2108 with a Tcl 
scripting interface. 
Potential energies were calculated using the CHARMM36 force field.109 The particle 
mesh Ewald algorithm111 (1.0Å grid spacing) was used to calculate system electrostatics. An 
integration time step of 2 fs was used. The NPT ensemble (constant atom number, pressure, 
temperature) was used for all simulations with a Langevin thermostat and piston to maintain 
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temperature and pressure at 300 K and 1.01225 bar respectively.112 The pair list distance, 
interaction cutoff, and switch distance were 14.0, 12.0, and 10.0 Å respectively.  
8.3.2  Metadynamics Simulations 
Well-tempered metadynamics simulations were used to characterize the conformational 
free energy landscape of the Q15 and Q20 peptides. Metadynamics is a method that enhances the 
sampling of a standard MD simulation by adding artificial potentials, in the form of Gaussian 
functions, to conformations that the system previously sampled. This allows the system to escape 
deep energy wells and to sample a large region of its conformational energy landscape.116,117  
The initial Q15 and Q20 peptide monomers used in the metadynamics simulations were 
fully extended peptides with Ramachandran Φ and Ψ angles of 180°. The peptide systems were 
energy-minimized for 10 000 steps using the conjugate gradient method and then equilibrated for 
500 ps. Metadynamics was then performed on the equilibrated system for 400 ns of simulation 
time.  
To visualize the Q15 and Q20 conformational landscapes, we plotted the metadynamic 
conformations using the root-mean-square deviation (RMSD) for the α-carbon positions of 
idealized α-helix, β-hairpin, and PPII conformations of Q15 or Q20. These collective variables 
are similar to that previously used by Punihaole et al.82 Ideal α-helix, -hairpin, and PPII 
collective variable reference structures were created with Molecular Operating Environment106 
software (MOE 2013.10). The maximum RMSDs for metadynamics structures was set to 15 Å 
and 20 Å for Q15 and Q20 respectively, and this limit was maintained by a 1.0 kcal mol-1 Å-1 
half-harmonic potential constraint. Artificial potentials, in the form of Gaussian functions with a 
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height of 1.0 kcal mol-1 and a width of 0.3 Å for Q15 and 0.4 Å for Q20, were added to the 
metadynamics simulations every 100 steps. The metadynamics free energy data and collective 
variable history were processed using Python scripts to identify the landscape positions and 
structures for conformations found in local energy wells. The scripts and coordinate files used in 
the metadynamics simulations are available for download.  
Metadynamics simulation parameters were chosen to minimize error and ensure adequate 
sampling of the energy landscape following the work of Laio et al.195 Also, Laio et al.195 
empirically derived an equation to estimate the error of metadynamics simulations for systems 
with energy landscapes containing only a few well-defined energy wells. However, our system 
contains complex energy landscapes with many local energy minima. Thus, the methods 
developed by Laio et al.195 are unable to estimate the error in our simulations.  
MD simulations (10 ns) were used to obtain equilibrium structural information on the 
low-energy conformations found in the metadynamics energy landscapes. Ψ and Φ dihedral 
angles were extracted from simulation trajectories using a Tcl script in VMD.  
 
8.4 Results and Discussion 
8.4.1  UVRR Spectroscopy 
UVRR spectroscopy, with a ~204 nm excitation wavelength, is in resonance with the 
π→π* transitions of amide groups, including the secondary amides of the peptide backbone194 
and the primary amides of the Gln side chains.57,71,72 Therefore, the UVRR spectra of our polyQ 
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peptides are dominated by the resonance-enhanced vibrations located on these amide 
chromophores. This greatly simplifies the vibrational spectrum of these peptides. 
As discussed above, Punihaole et al. previously showed that NDQ10 exists in a β-strand-
like conformation while DQ10 is in a PPII-like conformation.82 Also, Jakubek et al. previously 
showed that DQ20 is also in a PPII-like conformation.193 Here, we used UVRR to investigate the 
structures of solution-state NDQ15 and DQ15.  
We previously discussed detailed UVRR band assignments for NDQ1082, DQ1082, 
NDQ20,193 and DQ20.193 Here, we find that the UVRR spectra and band assignments of NDQ15 
are essentially identical to those of NDQ10.82 Also, we find that the UVRR spectra and band 
assignments of DQ15 are essentially identical to those of DQ1082 and DQ20193 (Figure 8.1Figure 
7.1). As such, we will only discuss the assignment of the conformationally sensitive amide III3 
band of the peptide backbone (AmIII3
S). A complete discussion of assignments can be found in 
previous work by Punihaole et al.82  
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Figure 8.1: UVRR spectra (204 nm) of solution state polyQ peptides: (a) NDQ10 and NDQ15; (b) DQ10, 
DQ15, and DQ20. All spectra were normalized to the AmIII3S band. The dashed line is located at ~1240 cm-1. 
The UVRR spectra of NDQ10 and DQ10 were previously reported by Punihaole et al.,82 and the UVRR 
spectrum of DQ20 was previously reported by Jakubek et al.193 Reprinted with permission from Jakubek et 
al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American Chemical Society. 
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8.4.2  Ramachandran Ψ Angle Distributions of Q15 and Q20 
Asher et al. previously showed that the frequency of the AmIII3
S band sinusoidally 
depends on the Ramachandran Ψ angle of the peptide backbone.65 This correlation results from 
coupling of the backbone N-H bending motion of the AmIII3
S band with the CαH bending 
vibration at ~1390 cm-1.65 Mikhonin et al. later developed a method to quantitatively calculate 
the Ramachandran Ψ angle of a peptide backbone in a variety of different solvation states and 
sample temperatures.64  
Asher et al. showed that the Ψ angle distribution of a peptide can be estimated from the 
inhomogeneous line width of the AmIII3
S
  band.
74 Assuming that the inhomogeneous broadening 
is solely due to the Ψ angle distribution of the peptide, one can model the AmIII3S band as a sum 
of Lorentzian bands with a width equal to the homogenous linewidth of the AmIII3
S band. Using 
the equations derived by Mikhonin et al.64, the corresponding Ψ angle can be calculated for each 
Lorentzian band producing a Ψ angle distribution. These methodologies have previously been 
used to estimate the Ψ angle distribution in a variety of peptides62,76,78 including those of 
polyQ.46,57,82,193 
Here, we use these methods to calculate the Ψ angle distributions of NDQ15 and DQ15 
(Figure 8.2a-c) from the UVRR spectral fits (Figure 8.3). The UVRR spectrum of NDQ15 
contains an AmIII3
S band centered at ~1240 cm-1. This corresponds to a Ψ angle distribution that 
peaks at Ψ~140°, which is consistent with β-strand conformations.196 The AmIII3S band and Ψ 
angle distribution of NDQ15 are essentially identical to that of NDQ10.82 Thus, we conclude that 
the secondary structure of NDQ15 is the same as that of the NDQ10 collapsed β-strand-like 
conformation.82   
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Figure 8.2: Experimental and computational Ψ angle distributions. Experimental Ψ angle distributions of 
solution-state (a) NDQ15, (b) DQ15, and (c) DQ20. Computational Ψ angle distributions from metadynamics 
energy wells for (d) Q15 state A, (e) Q15 state B, (f) Q20 state B, and (g) Q20 state A. The experimental and 
computational Ψ angle distributions of NDQ10 and DQ10 can be found in reference 82. The experimental Ψ 
angle distribution for DQ20 was previously reported by Jakubek et al.193 Reprinted with permission from 
Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American Chemical Society.  
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Figure 8.3: Spectral fits for the AmIII3S UVRR spectral regions of (a) DQ10, (b) DQ15, (c) DQ20, (d) NDQ10, 
and (e) NDQ15. The AmIII3S bands are color-coded as described in the figure legend. Reprinted with 
permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American 
Chemical Society.  
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DQ15 contains AmIII3
S bands at ~1275 cm-1, ~1250 cm-1, and ~1215 cm-1, which 
correspond to Ψ angle distributions peaked at ~175°, ~150°, and ~10°, respectively. 
Ramachandran Ψ angles of ~175°, ~150°, and ~10° are characteristic of 2.51-helix, PPII-helix, 
and turn-like structures, respectively.64 The AmIII3
S bands and Ψ angle distribution of DQ15 are 
the same as those previously observed for DQ1082 and DQ20.193 Thus, we conclude that the 
secondary structure of DQ15 is the same as that of DQ10/DQ20.82 From UVRR and 
metadynamics simulations, DQ10 was previously found to be in a PPII-helix-like conformation 
interspersed with turn-like structures and with a subpopulation of 2.51-helix conformation 
localized on the charged terminal residues.82  Additional information regarding our Ψ angle 
distribution calculations and spectral fitting can be found in Appendix D. 
Assuming equal Raman cross sections, we roughly estimate the relative fraction of each 
secondary structure found in DQ10, DQ15, and DQ20 from the AmIII3
S band areas. We find that 
DQ10, DQ15, and DQ20 contain roughly ~55% PPII-like, ~30% turn-like, and ~15% 2.51-helix-
like conformations. 2.51-helix-like conformation (~15%) corresponds to ~2-3 peptide bonds per 
peptide.   
Punihaole et al.82 previously showed that the 2.51-helix structure of DQ10 is localized on 
the charged terminal residues. This is because the 2.51-helix conformation derives primarily from 
the electrostatic repulsions of adjacent charged amino acids.119,133 Our observation that DQ10, 
DQ15, and DQ20 contain ~2-3 peptide bonds in the 2.51-helix conformation is consistent with 
the localization of the 2.51-helix on the charged terminal residues. 
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8.4.3  Metadynamics Structures of Q15 and Q20 
To obtain further insights into the solution-state structures of Q15 and Q20, we 
performed metadynamics simulations to investigate their conformational energy landscapes. The 
use of metadynamics to examine the polyQ energy landscape was previously demonstrated by 
Punihaole et al.82 The metadynamics conformational landscapes of Q15 and Q20 are found in 
Figure 8.4. As previously observed for Q10, the energy landscapes for Q15 and Q20 are 
frustrated with many shallow local minima. For both Q15 and Q20 we find two deep, local 
energy wells on the energy landscape that correspond to different low-energy structures. We will 
designate these conformations as state A and state B. Representative structures from each energy 
well are shown in Figure 8.4. We examine the Φ and Ψ angle distributions of conformations 
found in state A and state B for both Q15 and Q20 (Figure 8.5). The state A and state B 
conformations are similar for both Q15 and Q20. 
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Figure 8.4: Conformational energy landscapes of (a) Q15 and (b) Q20 obtained from metadynamics 
simulations. Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. 
Copyright 2019 American Chemical Society.  
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Figure 8.5: Ramachandran plots for (a) Q15 state A, (b) Q20 state A, (c) Q15 state B, and (d) Q20 state B 
metadynamics structures. Darker red colors indicate an increased number of peptide bonds in a given region 
of the Ramachandran plot. Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 
4193-4203. Copyright 2019 American Chemical Society.. 
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State A of Q15 and Q20 both contain peptide bonds with (Φ, Ψ) angle populations of (-
95°,140°) and (-65°,140°), which are found in the β-sheet region of the Ramachandran plot.196 
Also, the structures of state A contain a broad Ψ angle distribution centered at ~0°, which is 
characteristic of turn-like structures.196 The Ψ angle distributions of the state A structures for 
Q15 and Q20 are centered at ~140°. This Ψ angle distribution is in quantitative agreement with 
that observed for NDQ15. Thus we conclude that state A of the metadynamics landscape 
corresponds to the structure of the non-disaggregated peptide. The structure and (Φ, Ψ) 
distributions of state A for Q15 and Q20 are similar to the state A metadynamics structure of 
Q10 previously reported.82 From our metadynamics simulations we conclude that state A 
consists of a predominately β-strand-like secondary structure with turn-like structural regions 
that allow the structure to be collapsed. 
For state B structures of Q15 and Q20, we find that the (Φ, Ψ) angle distribution peaks at 
(-65, 150°). These angles are found in the PPII region of the Ramachandran plot.197 We also find 
a significant population of Ψ angles centered at ~0° (see Figure 8.2), which is characteristic of 
turn-like conformations.196 The Ψ angle distribution of state B is centered at ~140° (see Figure 
8.2). This Ψ angle distribution is in quantitative agreement with those observed for DQ15 and 
DQ20 (Figure 8.2). Thus we conclude that state B of the metadynamics landscape corresponds to 
the structures of DQ15 and DQ20. The structure and (Φ, Ψ) distributions of state B for Q15 and 
Q20 are similar to the state B metadynamics structure of Q10 previously reported.82 From our 
metadynamics simulations we conclude that state B consists of predominately PPII-like 
secondary structures with turn-like structures enabling the structure to be collapsed. 
In the experimental Ψ angle distributions calculated from UVRR spectra of DQ10-20 we 
find a peak at ~175° which we assign to 2.51-helix conformations. However, we do not observe 
   211  
 
this peak in the state B metadynamics structure. As discussed previously by Punihaole et al.82 
and Feng135, this discrepancy likely results from an inadequacy in the CHARMM36 force field. 
The CHARMM36 force field was optimized using X-ray crystal structures of proteins.134 The 
2.51-helix is an uncommon structure that is found only in peptide sequences with adjacent 
charged amino acids.133 Thus, it is unlikely that this structure is well parameterized in the 
CHARMM36 force field. 
For Q15 and Q20, the β-strand-like energy well (state A) in the metadynamics 
simulations is conformationally broad. As a result, the metadynamics β-strand-like structure can 
vary with a low free energy cost. This suggests that the β-strand-like structure is flexible with 
significant conformational variability. In contrast, the PPII-like energy well (state B) of Q15 and 
Q20 is narrow, indicating a more well-defined structure with less structural variability.  
In contrast, metadynamics simulations of Q10 have revealed narrow energy distributions 
for both the PPII-like and β-strand-like structures.82 Our observation that the Q10 peptide 
contains less conformational variability compared to Q15 and Q20  is in agreement with the 
computational work of  Wang et al.37 They used molecular dynamics simulations to investigate 
the structures of Q5 and Q15 peptides. In contrast to this study, their results indicate that both Q5 
and Q15 are disordered in solution. However, they find that Q15 has increased conformational 
variability compared to Q5. This is thought to result from an increase in the number of possible 
peptide-peptide hydrogen bonding contacts with longer polyQ tracts. They conclude that longer 
polyQ peptides have increased aggregation kinetics because their conformational variability 
allows the peptide to sample β-sheet structures that nucleate fibrillization.37    
Overall, our metadynamics simulations agree with our UVRR data showing that the 
structure of NDQ15 is predominately a β-strand-like conformation, while the structure of DQ15 
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and DQ20 is predominantly a PPII-like conformation. This result is similar to that previously 
reported for DQ10 and NDQ10.82  
8.4.4  Circular Dichroism Spectroscopy of Q15 and Q20  
8.4.4.1 CD Spectra of DQ15, DQ20, and NDQ15  
To further investigate the structures of Q15 and Q20, we collected CD spectra of NDQ15, 
DQ15, and DQ20 (Figure 8.6). The CD spectrum of NDQ15 consists of a negative peak at ~218 
nm and a strong positive peak at ~196 nm that are characteristic of β-sheet conformations.198 In 
contrast, the spectra of both DQ15 and DQ20 have a strong negative peaks at ~200-205 nm, 
which are characteristic of PPII conformations.198 Our CD spectra are consistent with our UVRR 
measurements and metadynamics simulations, concluding that our DQ peptides are in a PPII-like 
conformation and our NDQ peptides are in a β-strand-like conformation. 
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Figure 8.6: CD spectra of NDQ15 (blue), DQ15 (green), and DQ20 (red). Reprinted with permission from 
Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American Chemical Society. 
 
8.4.4.2 DQ20 and DQ15 Have a Population of β-Strand Structures  
We compared the CD spectra of DQ15, DQ20, and DQ10 (Figure 8.7a). The CD 
spectrum of DQ10 was previously measured by Punihaole et al.82 Both the DQ20 and DQ15 
spectra show a less negative and slightly red-shifted peak at ~200-205 nm and a more positive 
peak at ~190 nm compared to DQ10. Also, the trough at ~220 nm is more negative for DQ20 
compared to that for DQ10.  To highlight the spectral differences, we subtracted the DQ10 
spectrum from that of DQ20 and DQ15 (Figure 8.7b). The difference spectra contain a negative 
weak peak at ~220 nm and a stronger positive peak at ~195 nm. This is characteristic of β-sheet 
conformations198 and is similar to the CD spectra of NDQ10 and NDQ15.  
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Figure 8.7: Comparison of DQ10-20 CD spectra. (a) CD spectra of (blue) DQ10, (red) DQ15, and (black) 
DQ20. (b) CD difference spectra of (orange) DQ20-DQ10 and (green) DQ15-DQ10. Reprinted with 
permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American 
Chemical Society. 
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We modeled the spectra of DQ15 and DQ20 as a linear combination of DQ10 and 
NDQ15 basis spectra. We chose these basis spectra because these peptides best represent the 
pure β-strand-like and PPII-like conformations of polyQ, respectively (see Appendix D for 
details).  The spectra of DQ15 and DQ20 are well modeled using NDQ15 and DQ10 CD spectra 
as basis spectra (Figure D.1 and Figure D.2). This suggests that the CD spectral differences 
between DQ10, DQ15, and DQ20 result from differing amounts of a minority β-strand-like 
population in the DQ peptides. We used our model to estimate the percentage of collapsed β-
strand-like structures in DQ15 and DQ20 (see Appendix D). We find that DQ15 and DQ20 
contain ~5% and ~15% β-strand conformation respectively. These data show that, at least for 
Q10-Q20, longer DQ peptides contain an increasing population of the β-strand-like structure.   
Our result is in great agreement with that reported by Chellgren et al. who examined the 
CD spectra of disaggregated polyQ peptides containing 1-15 Gln residues.98 They find that the 
negative peak at ~205 nm decreases in magnitude and the positive peak at ~225 nm increases in 
magnitude with increasing polyQ tract length, which is similar to what we observe for DQ10-20. 
From their CD data, Chellgren et al. conclude that longer DQ peptides have decreased PPII 
content and increased β-strand/sheet content.98 They report that their DQ15 peptide has ~7% β-
strand population, which is similar to what we observe for DQ15.  
We also compared the CD spectra of NDQ15 and NDQ10 (Figure 8.8). The CD spectrum 
of NDQ10 was previously measured by Punihaole et al.82 We find that the CD spectra of NDQ10 
and NDQ15 are essentially identical. This indicates that the NDQ10 and NDQ15 peptides do not 
have a structural dependence on polyQ length. 
 
   216  
 
 
 
Figure 8.8: CD spectra of (blue) NDQ10, (red) NDQ15, and (green) NDQ10-NDQ15 difference spectrum. 
Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 
American Chemical Society. 
 
8.4.4.3 Detectivity of UVRR Spectroscopy to Minority PPII-Like and β-strand-like 
Populations 
Our CD measurements show that DQ15 and DQ20 contain minority populations of β-
strand-like structures. However, these subpopulations are not clearly observed in our UVRR 
spectra. One possible origin for this discrepancy is that the UVRR spectra may not be adequately 
sensitive to the small subpopulation of β-strand-like secondary structures in the presence of a 
dominantly PPII-like conformation.  
 We examined the sensitivity of 204 nm excited UVRR spectroscopy to detect β-strand-
like subpopulations in DQ peptides by artificially adding a β-strand-like AmIII3S peak (1240 cm-
1, 40 cm-1 FWHH) to the spectral fit of DQ20. The area of the 1250 cm-1 PPII-like AmIII3
S band 
was reduced to conserve the total AmIII3
S band area. This spectrally models an increase in the β-
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strand-like population in the presence of a corresponding decrease in the PPII-like conformation, 
assuming equal Raman cross sections.  
We qualitatively compared the UVRR spectrum of DQ20 to spectral fits that model 10%, 
20%, 30%, 50%, and 80% β-strand-like minority populations. We find that the spectral fit does 
not significantly differ from that of the DQ20 spectrum until the β-strand subpopulation exceeds 
~20%. We conclude that the UVRR spectra have low sensitivity to β-strand-like subpopulations 
because the 1240 cm-1 β-strand-like AmIII3S band is broad (40 cm-1 FWHH) and overlaps more 
intense bands in the AmIII3
S spectral region. Our result suggests that the UVRR limit of 
detection for β-strand subpopulations is ~≥20%. 
 
8.4.5  Gibbs Free Energies and Activation Energies for PolyQ Metadynamics Structures 
The Gibbs free energies and activation barriers for the metadynamics polyQ structures 
are summarized in Figure 8.9.  
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Figure 8.9: Depiction of relative energies and activation barriers for the Q10-20 PPII-like and β-strand-like 
conformations. The activation barrier ΔG for the β-strand→PPII transitions are shown in red, the activation 
barrier ΔG for the PPII→β-strand transitions are shown in blue, and the relative ΔG of the β-strand-like and 
PPII-like minima are shown in green. Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 
2019, 123(19), 4193-4203. Copyright 2019 American Chemical Society.  
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8.4.5.1 Gibbs Free Energies of the β-Strand-Like and PPII-Like Metadynamics Structures 
Table 8.1 shows the difference in the Gibbs free energy of the β-strand-like and the PPII-
like conformations calculated for Q10, Q15, and Q20 using metadynamics. The β-strand-like 
conformation is found at the global energy minimum of the landscape for Q10, Q15, and Q20. 
We find that the difference in the Gibbs free energy between the PPII-like and β-strand-like 
conformations increases as the polyQ tract length increases. From this result, we conclude that 
the PPII-like conformation is less energetically favorable, compared to the β-strand-like 
conformation, for longer polyQ peptides.  
 
Table 8.1: Difference in the Gibbs Free Energies of the β-Strand-Like and PPII-Like Conformations of Q10, 
Q15, and Q20. Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 2019, 2019, 123(19), 4193-
4203. Copyright 2019 American Chemical Society. 
 (ΔG PPII)-(ΔG β-strand) 
(kcal/mol) 
Q10 0.5 
Q15 2.1 
Q20 2.3 
 
8.4.5.2 Activation Barriers between PPII and β-Strand Conformations   
Using metadynamics, we calculated the activation barriers for the PPII-like→β-strand-
like and β-strand-like→PPII-like conformational transitions of Q10-20. As stated above, the 
energy landscapes of Q10-20 are rough with many local minima. Thus, the activation barrier for 
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interconversion between structures heavily depends on the pathway the peptide takes through its 
conformational landscape.  
We calculated the lowest energy activation barriers for the PPII-like→β-strand-like and 
β-strand-like→PPII-like structural conversions from the metadynamics free energy landscapes. 
The lowest energy pathway between the PPII-like and β-strand-like energy wells was identified 
using a Monte Carlo method, where random pathways were sampled and their activation barriers 
minimized. The lowest activation barrier between the PPII-like and β-strand-like states was 
identified, as the Monte Carlo simulations converged upon a pathway with minimum activation 
energy. The values reported in Table 8.2 are those of the lowest energy pathways for the 
respective structural conversion. 
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Table 8.2: Activation Barrier Energies for the β-strand-like → PPII-like and PPII-like → β-strand-like 
Conformational Transitions in Q10, Q15, and Q20. Reprinted with permission from Jakubek et al., J. Phys. 
Chem. B., 2019, 2019, 123(19), 4193-4203. Copyright 2019 American Chemical Society. 
 β-Strand → PPII 
(kcal/mol) 
PPII → β-Strand 
(kcal/mol) 
(β-Strand→PPII) – 
(PPII→β-strand) 
(kcal/mol) 
Q10 5.8 5.3 0.5 
Q15 5.2 3.1 2.1 
Q20 4.6 2.3 2.3 
 
From the metadynamics simulations, we find that the PPII→β-strand activation barriers 
are lower compared to the β-strand→PPII activation barriers for Q10, Q15, and Q20. We 
observe a decrease in both the β-strand→PPII and PPII→β-strand energy barriers with 
increasing peptide length. Also, we examined the energy difference between the β-strand→PPII 
and PPII→β-strand activation barriers. We find that the PPII→β-strand activation barrier 
decreases relative to the β-strand→PPII activation energy with increasing polyQ length.  
Our metadynamics results for the relative energies and activation energies of Q15 and 
Q20 indicate that longer polyQ peptides increasingly prefer the β-strand-like conformation. This 
is in agreement with our CD data showing that, for DQ10-20, longer polyQ peptides have an 
increased population of β-strand-like conformation. Overall, these data show that the 
aggregation-prone β-strand-like conformation is increasingly preferred for longer polyQ 
peptides.  
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It is possible that increased hydrogen bonding contacts for larger polyQ peptides 
stabilizes the β-strand-like structure over the PPII-like structure. Walters et al.44 used 
fluorescence resonance energy transfer (FRET) to show that longer polyQ peptides are more 
collapsed. They hypothesized that longer polyQ peptides have increased possible peptide-peptide 
hydrogen bonding contacts resulting in an unordered collapsed structure.44 PPII structures are 
stabilized by water-peptide interactions182–186 while β-strand structures are stabilized by peptide-
peptide hydrogen bonding.21,193 Therefore, we hypothesize that longer polyQ peptides may have 
increased hydrogen bonding contacts that stabilize the β-strand-like conformation over the PPII-
like conformation. 
In addition, Walters et al.44 hypothesized that the increased number of possible peptide-
peptide hydrogen bonding contacts for longer polyQ peptides increases the probability of their 
formation. Jakubek et al.193 previously proposed that the PPII→β-strand activation energy is 
associated with the disruption of peptide-water interactions while forming intrapeptide hydrogen 
bonds. Thus, it is possible that the increased probability of longer polyQ tracts forming 
intrapeptide hydrogen bonds results in a decreased PPII→β-strand activation energy.      
 
8.4.5.3 Q15-20 Conformation and Aggregation Kinetics 
Our CD results show that, for DQ10-20 peptides, longer polyQ peptides have an 
increased population of collapsed β-strand structure. Also, our metadynamics simulations show 
that the β-strand conformation is increasingly thermodynamically favored for longer polyQ 
peptides.  These results are important because the disaggregated PPII-like conformation resists 
aggregation, while the non-disaggregated collapsed β-strand-like conformation readily 
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aggregates.46,57 Thus, the increase of collapsed β-strand population of longer DQ peptides may 
contribute to their increased aggregation kinetics.192  
Our result is similar to that of Darnell et al. who used CD spectroscopy to examine the 
structure of polyQ peptides of different lengths.199 They found that short polyQ peptides are 
found in a PPII-like conformation and that increasing the length of the polyQ tract decreases the 
PPII-like content and increases the β-sheet content of polyQ. From this, they conclude that polyQ 
peptides are in a “tug-of-war” between PPII and β-sheet structures where longer polyQ peptides 
prefer β-sheet structures, including fibrils. Our results provide further evidence that longer DQ 
peptides prefer β-strand structures. 
 
8.4.6  Temperature Dependence of the NDQ15 and DQ20 CD Spectra 
We also investigated the temperature dependence of the NDQ15 and DQ20 CD spectra 
(Figure 8.10). For NDQ15 we find that both the positive peak at ~195 nm and the negative peak 
at ~220 nm decrease in magnitude with increasing temperature. This spectral change is indicative 
of a decrease in the β-strand-like population of NDQ15 with increasing temperature. In 
agreement, the 20-50°C difference spectrum shows a positive peak at ~195 nm and negative 
peak at ~220 nm which is characteristic of β-sheet conformations. Also, this decrease in β-
strand-like conformation is reversible upon cooling the sample from 50°C back to 20°C (Figure 
8.10a).    
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Figure 8.10: Temperature dependence of the (a) NDQ15 CD spectra and (b) DQ20 CD spectra. The blue 
spectra were collected at 20°C, the red spectra were collected at 50°C, and the purple spectra are the 20-50°C 
difference spectra. The green spectra were collected after the sample was heated to 50°C and cooled back 
down to 20°C. Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. 
Copyright 2019 American Chemical Society. 
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We find that the CD spectrum of DQ20 is also sensitive to temperature. Upon increasing 
the temperature of DQ20 from 20 to 50°C we observe a decrease in intensity at ~195 nm and a 
decrease in the trough at ~220 nm. These spectral changes are consistent with a decrease in the 
β-strand-like population of DQ20 with increasing temperature. The DQ20 20-50°C difference 
spectrum shows a peak at ~195 nm which is consistent with our conclusion that the lower-
temperature DQ20 sample contains a larger population of β-strand-like structure (Figure 8.10b).  
Our result is similar to that of Bhattacharyya et al. who reports the 5-35°C difference 
spectrum of disaggregated K2Q40K2 (Q40).
40 They find that the difference spectrum contains a 
moderate negative peak at ~220 nm, a very weak negative peak at ~205 nm, and a strong positive 
peak at ~195 nm. This is similar to the CD spectrum we observe for the β-strand-like NDQ10 
and NDQ15 peptides. However, Bhattacharyya et al. conclude that this difference spectrum is 
characteristic of α-helices and that DQ40 forms α-helix conformations at low temperatures.40  
Bhattacharyya et al. may conflate the β-strand signature of the 5-35°C difference 
spectrum with that of an α-helix, which has a similar CD spectrum.40 This may be in part due to 
the presence of a very weak negative peak at ~205 nm in their 5-35°C difference spectra. The α-
helix spectrum consists of a strong positive peak at ~190 nm, a moderate negative peak at ~208 
nm, and a weak negative peak at ~222 nm.198 Thus, the presence of a peak at ~205 nm may 
suggest α-helix conformation. However, this negative peak could also arise from the incomplete 
subtraction of the PPII structure, which has a strong negative peak at ~205 nm, in the 5°C-35°C 
difference spectrum.  
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8.4.7  Non-disaggregated PolyQ Conformational Flexibility May Contribute to Fast 
Aggregation Kinetics 
As discussed above, we find that the β-strand-like energy wells in the metadynamics 
simulations are broad compared to the PPII-like energy wells for Q15 and Q20. Thus, the β-
strand-like conformation can more easily sample different structures compared to the PPII-like 
conformation. This agrees with the temperature dependence of the NDQ15 and DQ20 CD 
spectra that, in both cases, show a decrease in β-strand population with increasing temperature.   
In contrast, the metadynamics PPII-like energy wells are narrow, indicating that the PPII-
like structure cannot easily sample different conformations. This is in agreement with the 
temperature dependence of the DQ20 CD spectrum that indicates no change in the PPII-like 
structure with increasing temperature. Also, the CD spectrum of DQ15 shows less temperature 
sensitivity compared to that of DQ20 (Figure D.4). This is a result of DQ15 containing a smaller 
subpopulation of the temperature sensitive β-strand-like conformation and a larger, temperature-
insensitive PPII-like population.   
Previously, Vitalis et al. and Wang et al. proposed that the conformational flexibility of 
polyQ peptides promotes their aggregation.37,38 The flexibility of polyQ is thought to promote 
aggregation by increasing intermolecular interactions and/or increasing the probability of 
sampling β-sheet conformations that are prone to fibrillization. Both our metadynamics 
simulations and CD spectra show evidence that the β-strand-like conformation of NDQ peptides 
has more conformational freedom than the PPII-like structure of DQ peptides. In addition, it is 
well known that NDQ peptides have much faster aggregation kinetics compared to DQ 
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peptides.31,46,82 Thus, increased conformational flexibility of the β-strand-like conformation may 
contribute to the fast aggregation rate of NDQ peptides.  
8.5 Conclusions 
Here, we use UVRR spectroscopy, CD spectroscopy, and metadynamics simulations to 
investigate the structures of DQ15, NDQ15, and DQ20. We find that NDQ15 exists in 
predominately a β-strand-like conformation while DQ15 and DQ20 exist in predominately a 
PPII-like conformation. These results are similar to those previously reported for DQ10 and 
NDQ10.82  
We compare the CD spectra of DQ10, NDQ10, DQ15, NDQ15, and DQ20. We find that 
DQ peptides contain a minority population of the collapsed β-strand-like conformer. We show 
that longer DQ peptides have larger populations of the collapsed β-strand structure. Our 
metadynamics simulations show that the PPII-like conformation becomes relatively less 
energetically favorable and that the PPII → β-strand conformational transition becomes 
relatively more energetically favorable with increasing polyQ length. This indicates that longer 
polyQ peptides have an increased propensity for the aggregation-prone collapsed β-strand-like 
conformation, compared to the aggregation-resistant PPII-like conformation. Because the β-
strand-like conformation is more prone to aggregation, the increased β-strand-like 
conformational propensity in longer polyQ peptides may significantly increase the aggregation 
kinetics of longer polyQ tracts. 
We also used CD spectroscopy to investigate the effects of temperature on the structure 
of NDQ15 and DQ20. We found that increasing temperature decreases the population of the β-
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strand-like conformations in both NDQ15 and DQ20. However, we observe no changes in the 
PPII-like content of DQ10-20 peptides with increasing temperature. Metadynamics simulations 
show that the β-strand-like energy well is broad allowing for structural freedom, while that of the 
PPII-like structure is narrow suggesting a more well-defined structure with less conformational 
flexibility. Computational work previously showed that increased conformational flexibility 
promoted aggregation and fibrillization of polyQ peptides.37,38 Thus, conformational flexibility 
may play a role in the fast aggregation kinetics of NDQ peptides in β-strand-like conformations. 
Overall, our work provides crucial insights into the connection between polyQ peptide 
length, structure, and aggregation kinetics. We find that the β-strand-like conformation of polyQ 
has more conformational freedom compared to the PPII-like conformation, which may contribute 
to the faster aggregation kinetics of the β-strand-like structure. Our work also shows that longer 
polyQ peptides increasingly prefer the aggregation-prone β-strand-like conformation over the 
aggregation-resistant PPII-like conformation. This structural preference likely plays a role in 
increasing the aggregation kinetics of longer polyQ peptides, which is associated with an earlier 
age of onset for polyQ neurodegenerative diseases.  
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9.0 Structure and Hydrogen Bonding Interactions of Non-Fibrillar Polyglutamine 
Oligomers 
            Authors: Ryan S. Jakubek, Krishnan Damodaran, Stephen E. White, and Sanford A. 
Asher.  
            Author Contributions: R.S.J. collected, analyzed, and interpreted the Raman data with 
the assistance of S.E.W. K.D. collected and interpreted the DOSY data with assistance by R.S.J. 
and S.E.W. The manuscript was prepared by R.S.J. and S.A.A. with assistance by K.D. and 
S.E.W. 
Proteins containing expanded polyglutamine (polyQ) tracts aggregate into fibrils. This 
aggregation is associated with numerous neurodegenerative diseases including Huntington’s 
disease. Longer polyQ tracts have faster aggregation kinetics, which are associated with earlier 
age-of-onset for disease patients. Thus, there is great interest in understanding the dependence of 
aggregation rate on the polyQ tract length. Relevant experimental investigations are impeded by 
the poor water solubility of polyQ peptides with Q≥20. To circumvent this, polyQ peptides are 
generally subjected to a disaggregation procedure that increases their apparent solubility. Here, 
we use diffusion-ordered NMR spectroscopy (DOSY) and UV resonance Raman spectroscopy 
(UVRR) to investigate the concentrations and hydrogen bonding interactions of solution-state, 
non-fibrillar polyQ oligomers and their dependence on polyQ repeat length. We examine the 
small polyQ peptides D2Q10K2 (Q10), D2Q15K2 (Q15), and D2Q20K2 (Q20) in their disaggregated 
and non-disaggregated forms. We find that disaggregated polyQ peptides are monomeric with 
negligible inter- and intra-peptide hydrogen bonding regardless of the polyQ tract length. In 
contrast, non-disaggregated polyQ peptides contain both monomeric and oligomeric species. We 
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find that longer non-disaggregated polyQ peptides have an increasing oligomer population and 
that the formation of non-disaggregated polyQ peptide oligomers is driven predominantly by side 
chain-peptide hydrogen bonding interactions. Also, UVRR data shows that the non-
disaggregated polyQ secondary structure is not dependent on the fraction of oligomeric species. 
These results indicate that non-disaggregated polyQ in monomeric and oligomer forms have the 
same β-strand-like secondary structure.  
9.1 Introduction 
Proteins containing expanded polyglutamine (polyQ) tracts are prone to aggregate into 
fibrils. This fibrillization is associated with at least ten neurodegenerative diseases, including 
Huntington’s disease.1 Longer polyQ tracts show an increased rate of aggregation and 
fibrillization35,192 that is associated with an earlier disease age-of-onset.97 However, the 
mechanism of toxicity is still debated and evidence supports both aggregate14 and 
monomeric16,166 polyQ structures as the potential toxic agent.200  
There is much interest in understanding the mechanism by which longer polyQ peptides 
have faster aggregation kinetics. However, these studies are limited by the poor aqueous 
solubility of polyQ peptides with ≥~20 Q residues. To circumvent this, Chen et al. developed a 
“disaggregation” protocol that solubilizes polyQ peptides.31 In this method, the polyQ peptide is 
dissolved in a 1:1 mixture of trifluoroacetic acid (TFA) and hexafluoroisopropanol (HFIP). The 
peptide is incubated for 0.5-4 hours before the solvent is evaporated under a stream of inert gas. 
The peptide is then dissolved in water to the desired concentration. This method is commonly 
referred to as “disaggregation” because it is thought to remove trace aggregates that would seed 
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fibrillization without changing the secondary structure of the peptide monomer.33 However, the 
exact mechanism by which disaggregation solubilizes polyQ peptides is poorly understood. The 
disaggregated polyQ (DQ) peptide is highly soluble in water and has slower aggregation kinetics 
compared to the non-disaggregated polyQ (NDQ) species.   
Because of the limited aqueous solubility of NDQ peptides with ≥~20 Q residues, most 
investigations into the structure of polyQ peptides examine the DQ species. Thus, there are 
limited studies on the structure of solution-state NDQ peptides. The structure of solution-state 
DQ peptides have been extensively studied using circular dichroism (CD)18,34,35,98,201 and 
NMR18,41,98,201 spectroscopies. Most CD studies indicate that DQ peptides are in a random coil 
conformation. However,  the CD spectrum of unordered and polyproline II (PPII) conformations 
are similar and difficult to distinguish.198  Most NMR experiments18,41,189,201 indicate that DQ 
peptides are in a random coil conformation, however, the NMR technique used only broadly 
classifies a peptide into α-helix, β-sheet, or random coil conformations where “random coil” 
refers to any structure other than α-helices and β-sheets.202,203 In addition, MD simulations of 
polyQ peptides indicate a random coil conformation.37–39,99 However, MD simulations of polyQ 
peptides are hindered by their rough energy landscape that may prevent the polyQ peptide from 
sampling structures of its global energy minimum.82  
In contrast, Chellgren et al.98 used  total correlation spectroscopy  (TOCSY) and nuclear 
Overhauser effect spectroscopy (NOESY) NMR experiments on DQ peptides to show that  they 
contain Φ and Ψ Ramachandran angles consistent with a PPII conformation. From their NMR 
data, Chellgren et al.98 also interpreted their CD results as indicating PPII conformations.  
Recently, UV resonance Raman (UVRR)spectroscopy was used to investigate the 
structures of D2Q10K2 (Q10), D2Q15K2 (Q15), and D2Q20K2 (Q20) in their DQ and NDQ 
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forms.82,193,204 UVRR spectroscopy provides direct insight into the Ψ angle distribution64,65 and 
hydrogen bonding interactions81 in peptides. They found that DQ10, DQ15, and DQ20 all 
predominantly have the same PPII-like secondary structure while NDQ10, NDQ15, and NDQ20 
all have the same β-strand-like structure. In addition, metadyanmics simulations showed that the 
conformational energy landscapes of Q10, Q15, and Q20 contain low-energy β-strand-like and 
PPII-like conformations.82,204 Using diffusion-ordered NMR spectroscopy (DOSY) Punihaole et 
al. also showed that the Gln residues of both NDQ10 and DQ10 diffuse with rate constants 
consistent with monomeric peptides.82 Thus, they concluded that the PPII-like and β-strand-like 
structures of DQ10 and NDQ10, respectively, are that of monomeric peptide. These results 
showed that the disaggregation protocol31 changes the secondary structure of polyQ peptides 
from a β-strand-like to a PPII-like conformation. Therefore, a majority of solution-state 
polyglutamine structural and aggregation studies are specific to polyQ peptides that have had 
their secondary structures converted to a PPII-like conformation using the disaggregation 
protocol.    
Previously, we used UVRR and other techniques to investigate the structural dependence 
on the polyQ tract length for Q10, Q15, and Q20. Here we use DOSY and UVRR to investigate 
the nature of non-fibrillar, solution-state oligomers and their dependence on polyQ peptide 
length. DOSY NMR is used to examine the presence and quantity of solution-state, non-fibrillar 
oligomers while UVRR data is used to examine their hydrogen bonding interactions. Here we 
use a combination of newly reported UVRR data and data originally reported by Jakubek et 
al.193,204 and Punihaole et al.,82 to examine polyQ hydrogen bonding dependence on peptide 
length.  
   234  
 
We find that DQ10-20 peptides are monomeric, with negligible inter- and intra-peptide 
hydrogen bonding regardless of the polyQ tract length. In contrast, longer solution-state NDQ 
peptides have an increased population of non-fibrillar oligomers. Also, we find that longer 
solution-state NDQ peptides have increased side chain-peptide hydrogen bonding, but not 
backbone-peptide hydrogen bonding, that is correlated to the increased oligomer population. 
This indicates that the polyQ non-fibrillar oligomers are predominantly stabilized by side chain-
peptide hydrogen bonding.  
Also, as discussed above, NDQ10-20 species all have the same β-strand-like secondary 
structure.204 Here we show that longer NDQ peptides have increased oligomer population. These 
results indicate that polyQ peptides in non-fibrillar oligomer and monomer forms have the same 
β-strand-like structure.  
9.2 Results and Discussion 
Punihaole et al.46,82 showed that both DQ10 (PPII-like) and NDQ10 (β-strand-like) 
solution-state conformations aggregate to form fibrils. They found that both solution-state 
NDQ10 and DQ10 are stable at room temperature and low pH (pH=~2-3), showing no signs of 
aggregation for >1 week after sample preparation. However, when incubated at ~60°C and ~pH 
7, NDQ10 will form fibrils in ~1-2 days57 and DQ10 will form fibrils in ~1 week.46,57 Similarly, 
Jakubek et al.204 found that solution-state NDQ15, DQ15, and DQ20 peptides show no signs of 
aggregation for >1 week after sample preparation at room temperature and low pH (pH = ~2-3). 
Here we study the non-fibrillar, solution-state oligomers of NDQ10, DQ10, NDQ15, DQ15, 
NDQ20, and DQ20 peptides and their peptide-peptide hydrogen bonding interactions.  
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9.2.1  Diffusion-Ordered NMR Spectroscopy 
We used DOSY NMR spectroscopy to measure the translational diffusion coefficients of 
DQ15, DQ20, and NDQ15. We examined the signal decay of the lysine (Lys) and glutamine 
(Gln) side chain methylene proton resonances as a function of gradient strength (see 
Experimental Methods and Supporting Information for details). The Gln residue diffusion 
coefficients of NDQ10 and DQ10 were previously reported by Punihaole et al.82 As described by 
Jakubek et al.193, NDQ20 does not dissolve in water. Thus, we were unable to collect DOSY 
spectra of NDQ20. Figure 9.1 shows the signal decays for the 1H resonances of DQ15, DQ20, 
and NDQ15. The diffusion coefficients are listed in Table 9.1.   
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Figure 9.1: DOSY NMR signal decays for (a) NDQ15 Gln residues, (b) NDQ15 Lys residues, (c) NDQ15 Gln 
residues after centrifugation, (d) NDQ15 Lys residues after centrifugation, (e) DQ15, and (f) DQ20. Data for 
DQ10 and NDQ10 were previously collected by Punihaole et al. 82 and can be found in Figure E.3.  
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Table 9.1: Diffusion Coefficients for NDQ and DQ Peptides Measured by DOSY NMR.  
 Diffusion Coefficient (×10-10 m2/s) 
 Gln 1H Resonance  Lys 1H Resonance  
NDQ10 1.94(±0.05) 82 1.42(±0.05)  
NDQ15 
Not Centrifuged 
1.45(±0.05) 
 
0 .75(±0.05) 
NDQ15  
Centrifuged 
1.64(±0.05) 1.25(±0.05) 
DQ10 1.88(±0.05)82 1.89(±0.05)  
DQ15 1.65(±0.05) 1.64(±0.05) 
DQ20 1.51(±0.05) 1.51(±0.05) 
 
We find that DQ10, DQ15, and DQ20 have diffusion coefficients of ~1.88(±0.05)×10-10 
m2/s, ~1.65(±0.05)×10-10 m2/s, and ~1.51(±0.05)×10-10 m2/s  respectively. These values are 
consistent with the diffusion of monomeric peptides with a similar number of amino acids, such 
as Aβ(1-28) (1.39×10-10 m2/s).16 From our diffusion coefficient measurements we roughly 
estimate that the Stokes radii of DQ10, DQ15, and DQ20 are ~10.5 Å, ~12.0 Å, and ~13.2 Å, 
respectively. These data indicate that DQ10, DQ15, and DQ20 are monomeric at 1 mg/mL in 
aqueous solution. 
Our measured diffusion coefficients of DQ peptides monotonically decrease with peptide 
length. It is well known that that the reciprocal of the diffusion coefficient is linearly related to 
the van der Waals  volume of the solute.206–209 We find that this relationship also holds for 
DQ10-20 peptides (see Supporting Information). Thus, our observed decrease in diffusion 
coefficient for longer DQ peptides results from an increase in the monomeric peptide van der 
Waals volume.  
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DOSY measurements of NDQ10 indicate diffusion coefficients of 1.94(±0.05)×10-10 m2/s 
for Gln resonances and 1.42(±0.05)×10-10 m2/s for Lys resonances. The measured diffusion 
coefficient of the NDQ10 Gln residues is the same as that of the monomeric peptide DQ10 
(within error). In contrast, the Lys residues of NDQ10 have a slower observed diffusion 
coefficient compared to DQ10. This observation is discussed in detail below.  
DOSY measurements of NDQ15 report diffusion coefficients of 1.45(±0.05)×10-10 m2/s 
for Gln resonances and 0.75(±0.05)×10-10 m2/s for Lys resonances. The NDQ15 Gln and Lys 
diffusion coefficients are significantly less than that of the monomeric DQ15 peptide. In 
addition, the 1H NMR spectrum of NDQ15 shows a broad background that is not observed for 
the other peptides studied (see Figure E.1). This background likely results from peak broadening 
of oligomeric species that results from long rotational correlation times.  
To test the hypothesis that the broad background in the NDQ15 NMR spectrum results 
from oligomeric species, we collected 1H and DOSY NMR spectra of NDQ15 before and after 
ultracentrifugation (355,524 X g, 30 min). We find that after centrifugation, the NMR 
background of the NDQ15 1H NMR spectrum is reduced, but not eliminated (see Figure E.1). 
This indicates that the NDQ15 NMR background results from the presence of oligomers. In 
addition, we find that after centrifugation the NDQ15 Gln residues have a diffusion coefficient of 
1.64(±0.05)×10-10 m2/s and Lys residues have a diffusion coefficient of 1.25(±0.05)×10-10 m2/s. 
Thus, the observed NDQ15 diffusion coefficients after centrifugation are closer to that of the 
monomeric DQ15 peptide.  
As mentioned above, the Lys diffusion coefficients of NDQ10 and NDQ15 are much 
smaller (~52% and ~73%, respectively) relative to that of the peptides’ Gln residues. The 
dissimilarities between Gln and Lys diffusion coefficients can be explained by differences in the 
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mobilities of Gln and Lys residues in oligomers; numerous NMR experiments on Huntingtin 
exon 1 and small polyQ peptides show that flanking residues have significantly larger mobilities, 
compared to Gln residues, in polyQ fibrils.53,54,157,210,211  
For example, Schneider et al. showed that Lys residues in GK2Q54K2 and GK2Q38K2 
fibrils have greater mobility compared to the Gln residues.210 Because, the Gln residues have low 
mobility and are incorporated into large fibril aggregates with a slow tumbling rate, the Gln 
signal is anisotropically broadened into the spectral background and is not observed. In contrast, 
the increased mobility of the Lys residues allows sufficient molecular tumbling to suppress 
anisotropic broadening even in large molecular weight fibrils. As a result, Schneider et al.210 only 
observed Lys resonances in 1H-13C Insensitive Nuclei Enhanced by Polarization Transfer 
(INEPT) NMR experiments, while chemical shifts of the Gln residues in the rigid fibril core are 
not observed because they are broadened into the spectral background.  
The lower mobilities of the Gln residues in oligomers results in a Gln 1H signal biased 
toward monomeric and low molecular weight oligomeric species. As a result, the measured Gln 
diffusion coefficients appear similar to that of the monomer. In contrast, the increased mobilities 
of the Lys residues in oligomeric species results in a Lys 1H signal with contributions from 
monomer, low molecular weight oligomers, and high molecular weight oligomers. This results in 
a measured Lys 1H diffusion coefficient significantly lower than that of the Gln residues.  
This explanation is confirmed by the fact that after centrifugation of NDQ15 the Lys 
diffusion coefficient increases significantly more than the Gln diffusion coefficient. This result 
shows that the Lys resonances contain a much larger contribution from oligomeric species 
compared to Gln resonances. Because the Lys diffusion coefficients of both NDQ10 and NDQ15 
are smaller than that of their respective monomers (DQ10 and DQ15), we conclude that both 
   240  
 
NDQ15 and NDQ10 samples contain oligomers. In contrast, DQ10, DQ15, and DQ20 all show 
essentially the same diffusion coefficient for their Lys and Gln residues, confirming that these 
peptides are monomeric.  
As discussed above, the Gln 1H NMR peaks of NDQ10 and NDQ15 predominantly 
originate from the monomeric species because the 1H resonances of oligomeric species are 
broadened into the spectral background. In contrast, the lysine residues have relatively high 
mobility even in oligomeric conformations and are less affected by anisotropic broadening. 
Assuming that the Gln 1H NMR peak area originates from only the monomer species and that the 
Lys 1H NMR peak area includes resonance from all monomeric and oligomeric species, we can 
roughly estimate the monomer concentration in NDQ15 and NDQ10. We normalized the Gln 
2.31 ppm 1H peak area to the area of the Lys 1.36 ppm 1H peak for DQ10, DQ15, NDQ10, and 
NDQ15. We then compared the normalized Gln 2.31 ppm peak area of NDQ10 and NDQ15 to 
that of the completely monomeric DQ10 and DQ15 peptides. Using the procedure described 
above, we estimate that NDQ15 is ~59% monomeric while NDQ10 is ~80% monomeric.  
When estimating the monomeric fraction of NDQ10 and NDQ15 we assume that the Gln 
H1 resonances only contain contributions from the monomer species. However, because the Gln 
residue diffusion coefficient is different for NDQ15 before and after centrifugation we know that 
the Gln H 1 resonances must have an oligomer component. Therefore our reported monomer 
fractions for both NDQ10 and NDQ15 are overestimates.    
To ensure that aggregation and fibrillization was not occurring during our DOSY 
measurements we collected 1H NMR spectra of NDQ15 every ~30 min for 5 hrs. We monitored 
changes in the NDQ15 monomer concentration with time using the methods described above. 
We find that the monomer concentration does not change within the ~5 hour timescale of a 
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DOSY measurement (Figure E.5). This result confirms that our DOSY measurements are 
collected on a stable system.  
It is important to note that our observation that NDQ10 contains ~80% monomer 
fractions differs from the conclusions of Punihaole et al.82 who previously concluded that 
NDQ10 was 100% monomeric. This discrepancy results because Punihaole et al. previously 
examined the diffusion coefficients of only the Gln residues of NDQ10, which have a diffusion 
coefficient characteristic of monomeric peptide. Therefore, they concluded that NDQ10 was 
monomeric.   
9.2.1.1 Structure of Peptide in PolyQ Oligomers 
Previously, Jakubek et al.193,204 and Punihaole et al. 82 quantitatively examined the 
secondary structures of NDQ10, NDQ15, and NDQ20 using UVRR and CD. They showed that 
NDQ10, NDQ15, and NDQ20 all have the same β-strand-like secondary structure with 
essentially identical UVRR and CD spectra. As discussed above, we find that the non-fibrillar 
oligomer population increases with peptide length for solution-state NDQ10-20 with NDQ10, 
NDQ15, and NDQ20 containing roughly 80%, 59%, and 0% monomeric fraction respectively. 
Because no changes in secondary structure were observed with increased oligomer population, 
we conclude that the monomeric peptide has the same secondary structure as that in oligomers. 
Thus, the presence of β-strand structure is present in polyQ monomer and non-fibrillar 
oligomers. Also, this result confirms that the β-strand-like structure exists prior to the formation 
of fibrils. This result is in agreement with that of Nagai et al.16 who showed that the polyQ tract 
in thio-polyQ fusion proteins form soluble β-sheet structures before the formation of amyloid-
like fibrils.   
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9.2.2  UV Resonance Raman  
We used UVRR spectroscopy to investigate the peptide-peptide interactions of the 
disaggregated and non-disaggregated forms of Q10, Q15, and Q20. Recently, UVRR has become 
a powerful tool for investigating protein structure and solvation.62,63  We use ~204 nm excitation 
that is in resonance with the π→π* absorption band of amide groups, such as the primary amide 
Gln side chains and the secondary amide backbone peptide bonds. This allows for selective 
Raman enhancement of vibrations that couple to the resonant electronic transition. This includes 
the amide I (AmI) vibration of the primary amide Gln side chain (AmIP) and the secondary 
amide peptide backbone (AmIS). The AmIS and AmIP bands consist predominately of C=O 
stretching motions and have frequencies that are sensitive to solvation and hydrogen bonding 
environments of the amide carbonyl groups.72,81,89  
Hydrogen bonding interactions with an amide carbonyl group decreases the C=O bond 
force constant causing an AmI frequency downshift.81,89 In addition, changes in the carbonyl 
group’s dielectric environment affects the frequency of the AmI bands. Solvents with a higher 
dielectric constant increase the stability of the amide dipolar resonance structure resulting in a 
weaker C=O bond force constant and a downshift in the AmI frequency.72,89 Thus, the AmI 
frequencies of polyQ provide insight into the dielectric environment and hydrogen bonding 
interactions of the peptide backbone and Gln side chain amide groups. 
Previously, Wang et al.93 showed that the interaction enthalpy (ΔHint) between a 
backbone amide carbonyl group and its environment is linearly correlated to the AmIS frequency.  
Similarly, Punihaole et al.81 showed that the Gln side chain ΔHint is linearly correlated to the 
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AmIP frequency. Using these correlations the ΔHint for backbone and Gln side chain carbonyl 
groups can be estimated from experimentally obtained AmIS and AmIP bands, respectively.81 
Because the ΔHint is dominated by strong hydrogen bonding interactions in protic environments, 
the ΔHint values are an estimate of the hydrogen bonding strength.81,152 
 Estimating ΔHint from AmIP and AmIS frequencies requires the assumption that 
transition dipole coupling (TDC) does not affect the AmI band frequencies. The backbone AmIS 
band frequency is strongly dependent on TDC and changes depending on the peptide’s 
secondary structure. Therefore determination of backbone amide ΔHint is complicated. In 
contrast, the AmIP frequencies of solution-state polyQ peptides show negligible dependence on 
TDC, and ΔHint can be estimated for Gln side chains.81 Punihaole et al.81 previously derived the 
following equation to estimate the ΔHint for Gln side chains: 
 
𝐀𝐦𝐈𝐏(𝐜𝐦−𝟏) = 𝟏𝟕𝟑𝟎(𝐜𝐦−𝟏) + (𝟏𝟐(𝐜𝐦−𝟏 𝐤𝐜𝐚𝐥−𝟏 𝐦𝐨𝐥))(∆𝐇𝐢𝐧𝐭 (𝐤𝐜𝐚𝐥 𝐦𝐨𝐥
−𝟏))        9.1  
 
where AmIP is the frequency of the AmIP band and ΔHint is the interaction enthalpy of the 
carbonyl group. Using this equation, Punihaole et al. previously estimated ΔHint for a variety of 
hydrogen bonding interactions in polyQ peptides.81 
For polyQ peptides, primary amide Gln carbonyl groups involved in side chain-water 
hydrogen bonding have an AmIP frequency of ~1680 cm-1 and a corresponding ΔHint of ~4.3 
kcal/mol.81 In contrast amide groups involved in either side chain-side chain or side chain-
backbone hydrogen bonding have an AmIP frequency of ~1660-1665 cm-1 and a corresponding 
ΔHint of ~5.4-5.9 kcal/mol.81 Similarly, the backbone AmIS frequency of polyQ peptides is at 
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~1675 cm-1  when hydrogen bonded to water and is downshifted to ~1660-1665 cm-1 when 
involved in backbone-side chain or backbone-backbone hydrogen bonding.46,193  
Because the AmIP band frequency is similar for both side chain-side chain and side 
chain-backbone hydrogen bonding, we cannot differentiate between these two hydrogen bonding 
interactions. Also, the AmIS band frequency for backbone-backbone and backbone-side chain 
hydrogen bonding is similar preventing their discrimination. Therefore, in this work, side chain-
peptide hydrogen bonding indicates that the Gln side chain C=O groups are hydrogen bonded to 
peptide backbone NH groups and/or Gln NH2 groups.  Likewise, backbone-peptide hydrogen 
bonding indicates that the backbone C=O groups are hydrogen bonded to peptide backbone NH 
groups and/or Gln NH2 groups. 
The AmIP and AmIS bands of polyQ peptides overlap making it difficult to determine 
their individual frequencies. Xiong et al. showed that UVRR enhancement deeper in the UV 
(~197 nm) increases the resonance enhancement of the primary amide bands compared to that of 
the secondary amide vibrations.57 As a result, for ~197 nm excitation, the Gln side chain bands 
are more enhanced relative to that at ~204 nm excitation. By subtracting the 204 nm UVRR 
spectrum from the 197 nm spectrum, we can highlight the UVRR bands of the Gln side chain. 
Also, by subtracting a 197-204 nm difference spectrum from the 204 nm spectrum we can 
highlight secondary amide vibrations.  
9.2.2.1 Side Chain Hydrogen Bonding Interactions of PolyQ Peptides  
Table 9.2 reports the measured AmIP frequencies and ΔHint (calculated using eq. 1) of the 
Q10, Q15, and Q20 solution-state polyQ peptides. Punihaole et al.82 previously examined the 
AmIP bands of DQ10 and NDQ10 while Jakubek et al.193 previously examined the AmIP bands 
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of DQ20 and NDQ20. Here we investigate the AmIP bands of NDQ15 and DQ15 to elucidate the 
repeat length dependence of side chain polyQ hydrogen bonding interactions.  The 197-204 nm 
UVRR difference spectra are shown in Figure 9.2. 
Table 9.2: AmIP Frequencies of NDQ and DQ Peptides Obtained from 197-204 nm UVRR Difference Spectra.  
 AmIP (cm-1) ΔHint (kcal/mol) 
NDQ1082 ~1660, ~1679* -5.8, -4.3* 
NDQ15 ~1661, ~1682* -5.8, -4.0* 
NDQ20193 ~1662 -5.6 
DQ1082 ~1680 -4.2 
DQ15 ~1679 -4.3 
DQ20193 ~1681 -4.1 
*, Multiple values indicate multiple AmIP bands and their respective ΔHint values 
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Figure 9.2: 197-204 nm difference spectra of (a) DQ10, (b) DQ15, (c) DQ20, (d) NDQ10, (e) NDQ15, and (f) 
NDQ20. The AmIP band is found between 1650 and 1700 cm-1.  The Peak at ~1615 cm-1 is the AmIIP band. 
The feature at ~1560 cm-1 is due to subtraction of the overlapping AmIIS band (~1550 cm-1) and O2 stretching 
band (~1560 cm-1) of atmospheric oxygen. The NDQ20 and DQ20 spectra were adapted with permission from 
Jakubek, R. et al. (2019). J. Phys. Chem. B, 123 (8), 1749-1763. Copyright 2019 American Chemical Society.  
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The AmIP bands of DQ1082, DQ15, and DQ20193 are found at ~1680 cm-1, which is 
indicative of Gln side chains hydrogen bonded to water.81 Also, we do not observe an AmIP band 
at ~1660 cm-1 for DQ10, DQ15, or DQ20 indicating that there is negligible side chain-peptide 
hydrogen bonding in these peptides. These results are consistent with our DOSY measurements 
showing that DQ10-20 peptides are monomeric and contain no oligomeric species, regardless of 
the polyQ tract length (see above). Using eq. 1 the ΔHint of the side chain-water hydrogen bonds 
in DQ10, DQ15, and DQ20 are estimated to be ~-4.2 Kcal/mol81, ~-4.3 Kcal/mol and ~-4.1 
kcal/mol193, respectively. 
In contrast, NDQ10 and NDQ15 both contain AmIP bands at ~1660 cm-1 and ~1680 cm-1. 
As discussed above, the ~1660 cm-1 AmIP band is characteristic of side chain-peptide hydrogen 
bonding while the ~1680 cm-1 AmIP band is characteristic of side chain-water hydrogen bonding. 
This result indicates that NDQ10 and NDQ15 both contain a population of side chain-peptide 
and side chain-water hydrogen bonds. Using eq. 1, Punihaole et al. estimated that the ΔHint for 
the side chain-water and side chain-peptide hydrogen bonds of NDQ10 are -4.3 kcal/mol and -
5.8 kcal/mol, respectively. Using eq. 1 we estimate that the ΔHint for the side chain-water and 
side chain-peptide hydrogen bonds of NDQ15 are ~-4.0 kcal/mol and ~-5.8 kcal/mol, 
respectively. 
We find that the relative intensity of the 1680 cm-1 AmIP band (compared to the 1660 cm-
1 AmIP band) is lower for NDQ15 compared to NDQ10. This indicates that NDQ15 contains 
fewer side chain-water hydrogen bonds and more side chain-peptide hydrogen bonds compared 
to NDQ10. This result is consistent with our DOSY data showing that NDQ15 contains a larger 
population of oligomers compared to NDQ10. 
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Previously, Jakubek et al.193 examined the AmIP band of NDQ20. NDQ20 is insoluble in 
water and Raman spectra were collected of the undissolved NDQ20 peptide in water. They found 
that NDQ20 contains an AmIP band at ~1662 cm-1 with no observed band at ~1680 cm-1. This 
indicates that NDQ20 contains side chain-peptide hydrogen bonding with negligible side chain-
water hydrogen bonding. This observation is a continuation of the trend of longer NDQ peptides 
containing increased oligomerization and side chain-peptide hydrogen bonding. 
9.2.2.2 Backbone Hydrogen Bonding Interactions of PolyQ Peptides  
Table 9.3 reports the measured AmIS frequencies of the Q10, Q15, and Q20 obtained 
from their 204-(197-204) nm UVRR difference spectra (Figure 9.3). Jakubek et al.193 previously 
examined the AmIS bands of DQ20 and NDQ20. Here we investigate the AmIS bands of NDQ10, 
DQ10, NDQ15, and DQ15 to elucidate the repeat length dependence of backbone polyQ 
hydrogen bonding. 
 
Table 9.3: AmIS Frequencies of NDQ and DQ Peptides Obtained from 204-(197-204) nm Difference UVRR 
spectra.  
 AmIS (cm-1) 
NDQ10 ~1665 
NDQ15 ~1665 
NDQ20 ~1672193 
DQ10 ~1675  
DQ15 ~1675 
DQ20 ~1675193 
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Figure 9.3: 204-(197-204) nm difference spectra of (a) DQ10, (b) DQ15, (c) DQ20, (d) NDQ10, (e) NDQ15, and 
(f) NDQ20. The AmIP band is found between 1650 and 1700 cm-1.  The feature at ~1560 cm-1 is due to 
subtraction of the overlapping AmIIS band (~1550 cm-1) and O2 stretching band (~1560 cm-1) of atmospheric 
oxygen. The NDQ20 and DQ20 spectra were adapted with permission from Jakubek, R. et al. (2019). J. Phys. 
Chem. B, 123 (8), 1749-1763. Copyright 2019 American Chemical Society. 
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As discussed above, we previously showed that the AmIS band of polyQ peptides is 
found at ~1675 cm-1 when the backbone amides are hydrogen bonded to water and at ~1660-
1665 cm-1 when the backbone amides are hydrogen bonded to the peptide backbone or side chain   
groups.81,193 From the 204-(197-204) nm UVRR difference spectra, we find that DQ10, DQ15, 
and DQ20 all have AmIS band frequencies at ~1675 cm-1. These frequencies indicate that DQ10, 
DQ15, and DQ20 have a peptide backbone involved in backbone-water hydrogen bonding.  
Also, DQ10, DQ15, and DQ20 do not have AmIS bands at ~1660-1665 cm-1 indicating 
that the peptides do not contain a significant population of backbone-backbone or backbone-side 
chain hydrogen bonds. This result is in agreement with our DOSY data indicating that these 
peptides are monomeric in solution.  
In contrast, we find that NDQ10 and NDQ15 both have AmIS bands at ~1665 cm-1. This 
frequency indicates that NDQ10 and NDQ15 contain backbone-backbone and/or backbone-side 
chain hydrogen bonding. These results are in agreement with our DOSY data showing that 
NDQ10 and NDQ15 both contain oligomeric species that must have strong inter-peptide 
hydrogen bonding.  
As discussed previously,193 NDQ20 is insoluble in water and will therefore have 
negligible backbone-water hydrogen bonding. The AmIS band of NDQ20 is found at ~1672 cm-1 
which is significantly upshifted from that of NDQ10 and NDQ15.193 This upshift indicates that 
the backbone amides of NDQ20 are involved in weaker backbone-peptide hydrogen bonding 
interactions compared to that of NDQ10 and NDQ15.193 Figure 9.4 shows a depiction of the side 
chain and backbone hydrogen bonding interactions elucidated in this study. 
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Figure 9.4: Depiction of the side chain and backbone carbonyl hydrogen bonding interactions in (a) NDQ 
oligomers and (b) DQ monomers. Green dotted lines indicate peptide-peptide hydrogen bonds and pink 
dotted lines indicate peptide-water hydrogen bonds.  
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9.2.3  Increased Oligomer Population is Correlated to Side Chain-Peptide Hydrogen 
Bonding 
Above, we showed that, for NDQ peptides, the population of side chain-peptide hydrogen 
bonds and the population of non-fibrilllar oligomers increases with peptide length. In contrast, 
we do not observe an increase in backbone-peptide hydrogen bonding interactions for longer 
NDQ peptides with increased oligomer population. Therefore, we conclude that the formation of 
NDQ peptide oligomers is driven predominantly by side chain-peptide hydrogen bonding 
interactions. 
Our conclusion is in agreement with previous work by Punihaole  et al.81 who showed 
that side chain-peptide hydrogen bonding interactions are stronger than backbone-peptide 
hydrogen bonding interactions in solution-state and fibril-state polyQ peptides. From this they 
concluded that side chain-peptide hydrogen bonding plays an important role in polyQ 
fibrillization and in stabilizing the fibril structure. 
9.3 Comparisons to Other Studies 
Our results are in agreement with several findings reported by Burra et al.189 who 
examined the effects that disaggregation has on the structure and hydrogen bonding of polyQ 
peptides.  They found that the disaggregation protocol disrupts the hydrogen bonding network 
present in NDQ peptides resulting in a monomeric DQ peptide. In agreement, we find that NDQ 
peptides have extensive peptide-peptide hydrogen bonding and solution-state oligomers while 
DQ peptides contain negligible peptide-peptide hydrogen bonding and are monomeric.  
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Also, Burra et al.189 investigated the structure of DQ and NDQ polyQ peptides. They 
found that insoluble NDQ peptides exist in aggregates with β-sheet-rich structures that are less 
ordered compared to fibrils. This result is in great agreement with our results showing that 
NDQ10-15 monomers and oligomers as well as insoluble NDQ20193 are in a β-strand-like 
conformation that is less ordered compared to β-sheet fibrils.  A main discrepancy between our 
work and that of Burra et al.189 is that they identify the DQ peptide structure as a random coil 
monomer while we find that DQ peptides are in a PPII-like conformation. This discrepancy 
results from the inability of the CD198 and NMR techniques202,203 used by Burra et al.189 to 
identify the PPII conformation as discussed in the introduction.       
9.4 Conclusions 
We used DOSY to measure the diffusion coefficients and oligomerization of NDQ10, 
NDQ15, DQ10, DQ15, and DQ20 peptides. We find that DQ10, DQ15, and DQ20 all have 
diffusion coefficients consistent with monomeric peptides. In contrast, the diffusion coefficients 
of NDQ10 and NDQ15 indicate that both species form oligomers in water. From the DOSY 
spectra we estimate that ~80% of NDQ10 and ~59% of NDQ15 are in the monomer form. 
NDQ20 is insoluble in water, indicating increased oligomerization compared to NDQ15. 
Previously we showed, using UVRR and CD, that the secondary structures of NDQ10, NDQ15, 
and NDQ20 are all the same, indicating that both monomers and oligomers have the same β-
strand-like secondary structure.82,204 
We also used UVRR to investigate the hydrogen bonding interactions of NDQ10, 
NDQ15, NDQ20, DQ10, DQ15, and DQ20 peptides. We find that DQ10, DQ15, and DQ20 all 
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contain significant side chain-water and backbone-water hydrogen bonding with negligible 
peptide-peptide hydrogen bonding. In contrast we find that NDQ10, NDQ15, and NDQ20 
contain a significant population of side chain-peptide and backbone-peptide hydrogen bonding. 
The extent of side chain-peptide hydrogen bonding increases with polyQ length and oligomer 
concentration for NDQ10-20. We do not observe a correlation between NDQ10-20 peptide 
length and backbone-peptide hydrogen bonding. Therefore, we conclude that the increased 
oligomerization of NDQ10-20 with polyQ peptide length results predominantly from an increase 
in side chain-peptide hydrogen bonding.   
9.5 Experimental Methods 
9.5.1  Materials 
D2Q15K2 (Q15) and D2Q20K2 (Q20) were purchased form Thermo Scientific at ≥ 95% 
purity. TFA (purity ≥ 99.5%) and HFIP (99% pure) were purchased form Thermo Fisher 
Scientific and Acros Organics, respectively. D2O was purchased from Cambridge Isotope 
Laboratories, Inc. with a deuterium atom purity of 99.9%. 
9.5.2  Sample Preparation 
NDQ peptides were prepared by suspending Q15 and Q20 peptides in water. Sterile 
Eppendorf Biopur® centrifuge tubes were used for NDQ sample preparation to prevent 
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impurities or dust particles from seeding aggregation. DQ peptides were prepared using the 
procedures developed by Chen et al.31 and described by Punihaole et al.82 
9.5.3  UVRR Instrumentation 
The UVRR instrumentation used in this study was previously described in detail by 
Bykov et al.103 We generated 197 nm laser excitation using the 4th harmonic of a tunable 
Ti:Sapphire laser (Positive Light Co.). ~204 nm light was generated by Raman shifting the third 
harmonic of a Nd:YAG Infinity laser (Coherent Inc.) in ~30 psi hydrogen. Raman scattering was 
dispersed using a home-built subtractive double monochromator and detected using a 
Spec10:400B CCD camera (Princeton Instruments) with a Lumogen E coating. Samples were 
spun in a Suprasil quartz NMR tube. A ~160° backscattering geometry was used to collect the 
Raman scattered light. Raman spectra where collected at room temperature (~20°C). 
9.5.4  Diffusion Coefficient Measurements  
All self-diffusion coefficient measurements were performed using a Bruker Avance III 
600 MHz spectrometer with a BBFO probe with a Z-axis gradient. Temperatures were controlled 
to ±0.1 K accuracy using a Bruker BVT3000 temperature control system. Temperatures were 
calibrated with 4% Methanol in Methanol-d4 using the calctemp function in Bruker Topspin 
software. The pulsed field gradients were calibrated using a Bruker Doped Water sample to 
obtain a diffusion coefficient of 1.91x10-9 m2/s at 25oC. 
The samples were thermally equilibrated at a set temperature of 25oC for 30 min before 
the measurement. Measurements of the self-diffusion coefficients were performed by observing 
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1H NMR signals. Self-diffusion coefficients were determined using a stimulated echo pulsed 
field gradient (STE-PFG) pulse sequence with bipolar gradients.212,213 To obtain the self-
diffusion coefficients, the peak intensity vs. gradient strength data were fit to the 
Stejskal−Tanner equation105,214: 
𝐈
𝐈𝟎
= 𝐞−𝛄
𝟐𝐠𝟐𝛅𝟐(∆−
𝛅
𝟑
)𝐃
            9.2 
where, I and I0 are the signal intensities with and without gradients, respectively, γ is the 
gyromagnetic ratio, g is the gradient strength, δ is the length of the gradient pulses, Δ is the 
diffusion time between the gradient pulses, and D is the self-diffusion coefficient. The gradient 
strength was varied between 0 and 50 G/cm while the duration of the gradient δ was held 
constant throughout the experiment. δ and Δ were set to 2.7 ms and 150 ms, respectively.  
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9.7 Supporting Information  
Supporting information can be found in Appendix E and includes the following: DOSY 
NMR spectra of NDQ15, DQ15 and DQ20 with chemical shift assignments, DOSY signal 
decays for NDQ10 and DQ10, linear relationship between DQ10-20 peptide diffusion 
coefficients and peptide volume, and time dependence of the NDQ15 1H NMR spectra. 
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10.0 Conclusions 
In this work we developed and utilized UVRR spectroscopy, as well as a variety of other 
techniques, to examine the structures of polyglutamine peptides in the solution-state and 
aggregate non-fibrillar state. In this section we highlight important findings that were discussed 
in detail in chapters 5.0 - 9.0.  
Chapter 6.0 discussed the development of a technique allowing for the quantitative 
determination of glutamine side chain hydrogen bonding strengths from the frequency of the 
AmIP band. We show that the AmIP frequency is linearly correlated to the interaction enthalpy 
between a hydrogen bond donor and the Gln side chain C=O group hydrogen bond acceptor. 
Using this correlation, as well as work by Wang et al.,93 we experimentally estimated the 
hydrogen bonding strengths for side chain-peptide, side chain-water, backbone-peptide, and 
backbone-water hydrogen bonding interactions in various polyQ structures. Our results were 
quantitatively compared to those of MD simulations and showed excellent agreement. We found 
that side chain-peptide hydrogen bonding is significantly stronger than backbone-peptide and 
peptide-water hydrogen bonding. These results indicate that side chain-peptide hydrogen 
bonding plays a crucial role in polyQ fibrillization and stabilizing the fibril structure. This work 
was the first, to our knowledge, to experimentally quantify the enthalpic favorability of polyQ 
hydrogen bonding interactions that are thought to play an important role in thermodynamically 
driving polyQ-rich proteins toward fibrils structures that are associated with neurodegenerative 
diseases.  
In chapters 5.0 and 7.0 we utilized UVRR as well as other techniques to investigate the 
solution-state structures of Q10, Q15, and Q20. We found that the polyQ peptides can be 
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prepared in two different solution-state conformations. The non-disaggregated (NDQ) 
conformation is prepared by simply dissolving the peptide, produced via solid-phase synthesis, in 
water. This procedure results in a collapsed β-strand-like structure that contains significant 
peptide-peptide hydrogen bonding and is prone to aggregation. In contrast, the disaggregated 
peptide (DQ) is prepared following the procedure of Chen et al.31 This preparation resulted in a 
PPII-like solution-state structure with negligible peptide-peptide hydrogen bonding and a high 
resistance to aggregation. We quantitatively compared Ψ angle distributions between UVRR 
measurements and polyQ structures obtained from metadynamics simulations. The experimental 
and computational results are in excellent agreement, resulting in an experimentally validated 
computational model for the structures of polyQ peptides. 
Using CD spectroscopy we examined the dependence of the solution-state polyQ 
structure on the Gln repeat length. We found that longer DQ peptides, while predominantly in a 
PPII-like conformation, contain a larger subpopulation of the aggregation-prone β-strand-like 
conformation. In agreement, our metadynamics simulations found that the β-strand-like 
conformation is increasingly energetically favorable for longer polyQ peptides. We propose that 
the increase in stability of the aggregation-prone β-strand-like conformation for longer polyQ 
tracts may contribute to their increased aggregation kinetics, which is correlated with disease 
severity. These results are important because they provide insight into a possible mechanism by 
which longer polyQ peptides have faster aggregation kinetics that are correlated with earlier 
disease age of onset. 
In addition, we examined the temperature dependence of the polyQ CD spectrum. We 
found that increased temperatures result in a decrease in the β-strand-like conformation while the 
PPII-like conformation is relatively insensitive to temperature change. This result agreed with 
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our metadynamics energy landscapes showing that the energy well for the PPII-like 
conformation was narrow while that for the β-strand-like conformation was broad, allowing for 
significant structural variability. It was previously proposed that increased structural variability 
promoted aggregation and fibrillization by increasing the number of intermolecular interactions 
and the probability of forming β-sheet structures that promote fibrillization.37,38 Therefore, it is 
possible that the β-strand-like conformation is prone to fibrillization and aggregation because of 
its increased structural variability compared to that of the PPII-like structure. 
In chapter 8.0 we examined the structure of the insoluble peptide NDQ20. We found that 
NDQ20 has a β-strand-like secondary structure similar to that of the soluble NDQ10 and NDQ15 
peptides. In addition, we found that NDQ20 contains significantly weaker backbone-peptide 
hydrogen bonding compared to that of polyQ fibrils. In contrast, NDQ20 has side chain-peptide 
hydrogen bonding strengths similar to that observed in fibrils. These results indicate that the 
NDQ20 non-fibrillar aggregates are held together predominantly by side chain-peptide hydrogen 
bonding. 
In addition, the Ψ angle distribution of NDQ20 (Ψ=~138°) differs from that of polyQ 
fibrils (Ψ=~148°). Also, the NDQ20 species shows more structural disorder compared to polyQ 
fibrils. Interestingly, we found that, even though NDQ20 is insoluble in water, it can convert to 
fibrils when exposed to water. These results suggest that the polyQ fibrillization mechanism may 
include pathways were non-fibrillar polyQ aggregates convert to fibrils and provide important 
insights into the mechanism of polyQ fibrillization.        
Finally, in chapter 9.0 we used DOSY NMR and UVRR spectroscopies to investigate the 
concentrations and hydrogen bonding interactions of non-fibrillar, solution-state polyQ 
oligomers and their dependence on polyQ repeat length. We found that the disaggregated 
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peptides DQ10, DQ15, and DQ20 all have diffusion coefficients consistent with monomeric 
peptide and negligible peptide-peptide hydrogen bonding. In contrast, we found that both 
NDQ10 and NDQ15 contain a population of oligomers in water. From the DOSY data we 
estimate that NDQ10 contains ~80% monomer while NDQ15 contains ~59% monomer. As 
discussed in chapter 7.0, NDQ20 is insoluble in water (~0% monomer). Thus, the monomer 
population decreases with increasing peptide length for NDQ10, NDQ15, and NDQ20. Because 
we do not observe a significant change in secondary structure between NDQ10, NDQ15, and 
NDQ20 (see chapter 7.0), we concluded that both monomer and oligomer species have the same 
β-strand-like conformation. In addition, from UVRR data we found that the number of side 
chain-peptide hydrogen bonds in NDQ10, NDQ15, and NDQ20 increases with peptide length 
and oligomer population. However, we did not observe a correlation between peptide length 
(oligomer population) and backbone-peptide hydrogen bonding. Thus, we concluded that the 
increased oligomerization of longer non-disaggregated polyQ peptides is predominantly caused 
by an increase in side chain-peptide hydrogen bonding. These results are the first to show that 
non-disaggregated polyQ monomers and non-fibrillar oligomers have the same structure, and 
that non-fibrillar oligomers are formed predominantly through side chain-peptide hydrogen 
bonding. 
Overall, the work presented here provides numerous important insights into the structures 
and hydrogen bonding interactions experienced by polyQ tracts. These insights greatly improve 
our understanding of polyQ aggregation and fibrillization, which is important in understanding 
the pathology of CAG repeat neurodegenerative diseases.    
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11.0 Future Work 
11.1 Examining the PolyQ Length Dependence of the Fibril Structure  
In this work we utilized UVRR spectroscopy to examine the structure and hydrogen 
bonding interactions of solution-state polyQ peptides and their dependence on the length of the 
polyQ tract. Future work will include examining the hydrogen bonding and structures of polyQ 
fibrils of Q15 and Q20. We will compare these structures to those previously determined for 
Q1046 to examine the possibility of differences in the polyQ fibril structure for peptides with 
different polyQ tract lengths. PolyQ fibrils have been proposed as the toxic species in polyQ 
diseases. This work could provide insight into the role that polyQ fibrils play in CAG repeat 
diseases.    
11.2 Examining PolyQ Structure of Longer PolyQ Tracts 
CAG neurodegenerative diseases only occur when the polyQ tract in a protein exceeds a 
threshold length. The disease threshold generally occurs for polyQ tracts >~40 Gln residues.1 For 
example, the critical repeat length for Huntington’s disease is 36 Gln residues.1 Because of this, 
there is great interest in comparing the structures of polyQ tracts below and above the disease 
threshold. We have shown that UVRR, coupled with other techniques, can be used to obtain 
detailed structural information on these systems. In the future we will expand our examination of 
polyQ solution-state structure to peptides containing longer polyQ tracts that span the disease 
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threshold repeat length for many CAG repeat diseases. This work will allow for the identification 
of structural and hydrogen bonding changes in longer polyQ peptides that may have relevance to 
CAG repeat disease pathology.    
11.3 Examination of PolyQ Tract Structure with Flanking Polyproline Tract and in 
Huntingtin Exon 1 
It is well-known that the structure and aggregation mechanism of polyQ peptides are 
modified by flanking amino acid sequences.48,199 In the huntingtin protein, the polyQ tract is 
flanked by a C-terminal polyproline (polyP) sequence as well as an N-terminal sequence. In 
future work we will use UVRR to investigate the effect of these flanking sequences on the 
structure of the polyQ tract. This work will begin by examining the structure of polyQ with a 
polyP flanking sequence. Once this system is understood we will examine the structure of polyQ 
in the full huntingtin exon 1 containing both the C-terminal polyP tract and the N-terminal 
flanking residues. This work will elucidate polyQ conformations that may be important in the 
pathology of Huntington’s disease.     
11.4 Examination of Structural Changes During PolyQ Fibrillization  
The measurement time of a polyQ UVRR spectrum is seconds to minutes. This allows for 
the collection of UVRR spectra, that detail polyQ secondary structure and hydrogen bonding, on 
time scales shorter than that of polyQ fibrillization. Thus, using UVRR, one can obtain structural 
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information on the polyQ sequence throughout the time course of fibrillization. We will utilize 
UVRR to examine the structural evolution of polyQ peptides as they form fibrils. This work will 
aim to identify any intermediate structures during polyQ fibrillization and to compare the 
intermediate structures across polyQ peptides of different length. The results of this work have 
the potential to provide direct insights into the fibrillization mechanism(s) of polyQ tracts.     
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Appendix A  
Supporting Information for Chapter 5.0 
 UVRR Spectral Processing and Fitting 
UVRR Spectral Processing 
All UVRR spectra were processed using home-written MATLAB scripts to remove 
cosmic ray contributions, average, and calibrate spectra. The spectral contributions of water and 
Suprasil quartz from the NMR tubes were subtracted using a methodology described by 
Punihaole et al.46 
 
Global Fitting of UVRR Spectra 
The UVRR spectra were least-squares fit as the sum of N Gaussians and Lorentzians: 
 
 
 
   A.1 
 
where fi = 1 if the i
th band is a Gaussian, or 0 if the ith band is a Lorentzian. The parameters Hi, νi, 
and wi are the heights, center frequencies, and widths, respectively, of the Gaussian or Lorentzian 
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bands. The Hi, νi, and wi parameters were determined using a global fitting procedure where each 
parameter was fit to three different spectral replicates. The results of fitting our data using this 
global analysis are shown in Figure A.1. 
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Figure A.1: Global fitting of UVRR spectral replicatesfor: (a–c) an ensemble of PPII-/2.51-helix-like 
conformations prepared from DQ10 peptides in pure water; (d–f) Predominately antiparallel β-sheet fibrils 
prepared from DQ10 peptides in acetonitrile/water mixtures where XCD3CN = 0.74/XH2O = 0.26; (g–i) α-helix-
like structures prepared from DQ10 peptides in acetonitrile/water mixtures where XCD3CN = 0.56/XH2O = 0.44; 
and (j–l) β-strand-like structures prepared from NDQ10 peptides in pure water. Reprinted with permission 
from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical 
Society. 
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Basis Spectra Fitting 
The UVRR spectra shown in Figure 5.6a were modeled as a linear combination of 
individual basis spectra (shown in Figure 5.6b) representing PPII-like, α-helix-like, and β-sheet 
secondary structures. To do this, we utilized the classical multiple linear least-squares regression 
method described by Chi et al.:215 
 
 [S] = [R][SB] 
 
                                          A.2 
 
where [S] is the (n × 1) row vector that represents the intensities of the experimentally measured 
spectrum and [SB] is the (n × m) matrix composed of row vector elements that contain the 
different secondary structure basis spectra. The (m×1) row vector, [R], contains the least-squares 
scaling coefficients that represent the relative contributions of the [SB] basis spectra components 
to the Figure 5.6a spectra. The least-squares solution of [R] for eq. A.2 is:215 
 
 [R] = {[SB]
T[SB]}
−1[SB]
T[S]                                      A.3 
 
where {[SB]
T[SB]}
−1[SB]
T is the pseudo-inverse matrix of [SB]. The results of modeling the Figure 
5.6a spectra are shown in Figure A.2. 
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Figure A.2: Modeling of UVRR spectra of DQ10 in different acetonitrile/water mixtures as a linear 
combination of PPII-like, α-helix-like, and β-sheet basis spectra. (a–c) Modeling of 3 separate UVRR spectra 
of DQ10 peptides in water/acetonitrile mixtures where XH2O = 0.76/XCD3CN = 0.24; (d–f) Modeling of 3 
separate UVRR spectra of DQ10 peptides in acetonitrile/water mixtures where XH2O = 0.44/XCD3CN = 0.56; 
and (g–i) Modeling of 3 separate UVRR spectra of DQ10 peptides in acetonitrile/water mixtures where XH2O 
= 0.30/XCD3CN = 0.70. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–
5967. Copyright 2017 American Chemical Society. 
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 Determination of Ψ and χ3 Angle Distributions 
The distributions of Ψ and χ3 dihedral angles, shown in Figure 5.3 and Figure 5.7, were 
calculated using methodologies previously described in detail.64,71 We assume that the 
inhomogenously broadened AmIIIS3 and AmIII
P bands (B(ν)) can be modeled as the sum of M 
Lorentzian bands with identical homogeneous linewidths: 
 
 
 
                                     A.4    
 
 
where pi is the probability for the i
th band to occur at center frequency νi and Γ is the 
homogeneous linewidth of the AmIIIS3 or AmIII
P vibrations. We previously estimated from 
peptide crystals that Γ is ∼7.5 cm−1 for the AmIIIS3 and ∼6.6 cm−1 AmIIIP.71,74 After fitting the 
inhomogeneously broadened bands with Lorentzians, we calculate the different ith frequencies of 
the AmIIIS3 and AmIII
P band envelopes and their respective Ψ or χ3 dihedral angle distributions. 
 Correlating the AmIIIs3 Frequencies to Ψ Angles 
We correlated the AmIIIS3 PPII and 2.51-helix band frequencies of DQ10 to 
Ramachandran Ψ angles using eq. A.5: 
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 νi(Ψ,T) = 1256 (cm−1) − 54 (cm−1)sin(Ψ + 26 ) − 0.11 (cm−1/ °C)(T − T0)   A.5    
 
where T = 18°C is the sample temperature and T0 = 0°C. As discussed in detail by Mikhonin et 
al.,64 eq. A.5 is used for situations when the peptide bonds are fully exposed to water, such as in 
the case of PPII-like and 2.51-helices. 
Eq. A.6 was utilized to calculate the Ψ Ramachandran angles from the AmIIIS3 band 
frequencies of NDQ10: 
 
 νi(Ψ,T) = 1250 (cm−1) − 54 (cm−1)sin(Ψ + 26 ) + 0.06 (cm−1/ °C)(T − T0) A.6 
 
where parameters T and T0 are the same as in eq. A.5. Eq. A.6 is recommended by Mikhonin et 
al.64 for situations when the hydrogen bonding states of the peptide bond N–H groups are 
unknown. This situation occurs, for example, in the case of turn-like structures, where the 
peptide bonds can engage in both inter-amide and amide-water hydrogen bonds. 
 Determining the χ3 Angles from the AmIIIp Frequencies 
The χ3 angle distributions of DQ10 were determined previously by Punihaole et al.71 For 
NDQ10, we fit the AmIIIP region of the 197 nm – 204 nm UVRR difference spectrum shown in 
Figure 5.4. Based on our previous studies of glutamine,71 we assign the 1106 cm−1 band to the 
AmIIIP vibration. We used the following equation to calculate the NDQ10 χ3 angle from its 
AmIIIP band frequency: 
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 νi(χ3) = 1076 (cm−1) + 29 (cm−1)cos(2χ3) + 9 (cm−1)cos(χ3 + 99 ) 
 
                  A.7 
 
where νi is the ith AmIIIP frequency. 
Equation A.7 was derived by Punihaole et al.71 for use in situations when the hydrogen 
bonding and dielectric environments of the glutamine side chains are unknown. Our previous 
study on primary amide solvation showed that stronger (weaker) hydrogen bonding and higher 
(lower) dielectric environments upshift (downshift) the AmIIIP frequency.72 Eq. A.7 effectively 
averages these two competing effects. We used eq. A.7 because NDQ10 exhibits significant 
inter-amide hydrogen bonding (of the C=O groups), as well water-amide hydrogen bonding (of 
the NH2 groups). 
Each AmIIIP frequency can be correlated to as many as four different χ3 angles. As 
discussed in detail by Punihaole et al.,71 χ3 dihedral angles that are greater than +90° and less than 
-90° are nearly forbidden for glutamine side chains. Thus, for DQ10 and NDQ10, we only 
considered χ3 angles between -90° and +90°. 
 Hydrogen-Deuterium Exchange 
Hydrogen-Deuterium exchange (HX) measurements were used, in combination with 
DOSY NMR, to determine whether NDQ10 is monomeric or aggregated. Monomeric peptides 
are well-solvated and in intimate contact with water. Thus, HX exchange rates are relatively fast, 
∼10 min. In contrast, oligomeric or aggregated species exhibit peptide backbones that are 
shielded from solvent, and, thus, have significantly slower HX kinetics.216 If there is only one 
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species present (either monomer or aggregate), then the HX kinetics will show a 
monoexponential time dependence. If multiple species are present, then the HX kinetics will be 
more complex. 
HX measurements were carried out by initially preparing NDQ10 and DQ10 peptide 
solutions in H2O, and then rapidly mixing in D2O so that the final sample concentration was 0.3 
mg·mL−1. The dead times for all mixing experiments was ∼1 min. Sixty UVRR spectra were 
collected in succession with 1 minute accumulation time per spectrum. To increase signal-to-
noise, while still maintaining acceptable temporal resolution, we averaged 3 consecutive spectra, 
resulting in kinetic time points every 3 min during the exchange. To further increase signal-to-
noise, we smoothed the spectra using a Savitzky-Golay filter217 with a second order polynomial 
over a 15 data point interval. 
Deuteration of the peptide backbone decouples NH bending from C–N stretching in the 
AmII vibration. This decoupling results in the AmII’ vibration, which consists mainly of C–N 
stretching. We determined the HX kinetics of DQ10 and NDQ10 in water by monitoring the 
AmII’ band intensity at ∼1470cm−1. The AmII’ band intensities were normalized to calculate the 
fraction of exchanged hydrogens (fHX) using the following equation: 
 
 
 
                                         A.8 
 
where IAmII0(t) is the intensity at 1470cm
−1 at time t, IAmII0(0) is initial intensity at 1470cm
−1 in the 
absence of HX, and IAmII0(∞) is the intensity at 1470cm−1 at equilibrium. 
Figure 5.5c shows fHX as a function of time. To extract a time constant for HX, we fit the 
Figure 5.5c data to the following equation: 
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 fHX(t) = 1 − e−t/τ
 
                                         A.9 
 
where τ is the time constant of HX in min. 
Our experiments show that HX kinetics of DQ10 and NDQ10 (Figure 5.5c) show time 
constants of 5.4(2) and 5.6(4) min, respectively. These time constants are consistent with those 
measured for other monomeric peptides.121 Thus, we conclude from our HX experiments, as well 
as our DOSY NMR data and hydrogen bonding analysis, that both DQ10 and NDQ10 are 
monomers in solution.   
 Circular Dichroism (CD) Measurements 
We measured the CD spectra of DQ10 peptide solutions in acetonitrile/water mixtures 
where XCH3CN = 0, 0.24, and 0.56, as shown in Figure A.3. We did not measure the CD spectra of 
DQ10 peptides in acetonitrile/water mixtures with higher mole fractions of acetonitrile due to the 
presence of visible aggregates. The CD spectra were measured using a Jasco J-710 
spectropolarimeter and a quartz cuvette with a 0.2 mm pathlength. The CD spectra were 
collected every 0.2 nm interval and averaged over 5 scans. The spectra were smoothed using a 
Savitzky-Golay filter217 with a second order polynomial over a 15 data point interval. 
The CD spectrum of DQ10 in pure water shows a strong negative band at ∼200 nm and a 
slightly negative band at ∼220 nm. These features indicate that DQ10 adopts predominately 
PPII-like structures in water.218,219 In agreement with the UVRR results, the CD spectral changes 
that occur between XCH3CN = 0 and XCH3CN = 0.56 are indicative of a PPII-like to α-helix 
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transition. As the solvent is enriched in acetonitrile, the ∼220 nm band becomes more negative, 
while the ∼200 nm band blue-shifts and becomes positive. At XCH3CN = 0.56, an additional 
negative band, characteristic of α-helix-like structures, appears at ∼205 nm.  
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Figure A.3: CD spectra of DQ10 and NDQ10 peptides in different acetonitrile/water mixtures.  (1) DQ10 in 
pure water. (2) DQ10 in an acetonitrile/water mixture, XCH3CN = 0.24. (3) DQ10 in an acetonitrile/water 
mixture, XCH3CN = 0.56. (4) NDQ10 in pure water. The spectra were smoothed using a Savitzky-Golay filter 
with a second order polynomial over a 15 data point interval. Reprinted with permission from Punihaole et 
al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical Society. 
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 Conformational Reversibility of NDQ10 in Acetonitrile Solutions 
We discovered that at high acetonitrile concentrations NDQ10 form low molecular 
weight β-sheet structures. To test the reversibility of these β-sheet structures upon rehydration, 
we dissolved NDQ10 in a 70% acetonitrile solution. This solution was then further diluted with 
either 70% acetonitrile or H2O resulting in 0.3 mg·ml
-1 NDQ10 solutions in 70% acetonitrile and 
in 7% acetonitrile respectively. UVRR (204 nm) spectra were collected for each solution. 
NDQ10 in 70% acetonitrile shows a UVRR spectrum characteristic of the β-sheet conformation 
of fibrils, while the 7% acetonitrile solution UVRR spectrum was characteristic of aqueous 
NDQ10 in its collapsed β-strand conformation. Thus, the β-sheet structure of NDQ10 at high 
acetonitrile concentrations is reversible upon rehydration.   
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 Supplementary Figures 
 
 
 
 
Figure A.4: UVRR Spectral comparisons of fibrils formed under different conditions.  (a) Comparison of 
NDQ10 fibrils form in water (black) and monomeric NDQ10 in water (red). (b) Comparison of NDQ10 fibrils 
formed in water (black) and DQ10 fibrils (red) prepared in water. (c) Comparison of monomeric, aqueous 
NDQ10 (black) and DQ10 fibrils grown in acetonitrile and re-dissolved in water (red). Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American 
Chemical Society. 
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Figure A.5: CD spectra of DQ10 in different acetonitrile/water mixtures.  The CD spectra are of DQ10 in 
(green) 100% water, (brown) 50% H2O, (orange) 90% water after dilution from a 50% water solution, and 
(blue) 50% water of dissolved fibrils. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 
121 (24), 5953–5967. Copyright 2017 American Chemical Society. 
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Figure A.6: Q10 conformers found along the free energy barrier separating states A and B. The energy 
barrier between states A and B is circled in red. Black arrows point to the location of representative 
transition structures on the landscape. Purple arrows show the positions of low energy states A and B on the 
landscape. Reprinted with permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. 
Copyright 2017 American Chemical Society. 
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Figure A.7: Comparison of solution-state NDQ10 spectra previously reported by Xiong et al.57 (red) and 
reported in this article (black).  Spectra are normalized to the AmIII3S band for comparison. Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American 
Chemical Society. 
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Figure A.8: Comparison of the 197-204 nm difference spectra of DQ10 fibrils prepared in (red) water46 and 
(blue) 90% acetonitrile. The 197-204 nm difference spectrum highlights primary amide vibrations of the Gln 
side chain. The AmIP band is at a similar frequency (~1664 cm-1) for the two types of fibrils. Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American 
Chemical Society. 
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Figure A.9: Comparison of the 204-(197-204) nm difference spectra of DQ10 fibrils prepared in (red) water46 
and (blue) 90% acetonitrile.  The 204-(197-204) nm difference spectrum highlights secondary amide 
vibrations of the peptide backbone. The AmIS bands are at a different frequency for the two types of fibrils 
(~1660 cm-1 for fibrils prepared in water and at ~1670 cm-1 for fibrils grown in acetonitrile). Reprinted with 
permission from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American 
Chemical Society. 
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Figure A.10: Reversibility of acetonitrile induced β-sheet structure in NDQ10. UVRR spectra (204 nm) of 
NDQ10 in 100% H2O (red) and NDQ10 in 93% H2O 7% acetonitrile after dilution from 70% acetonitrile 
solution. The spectra appear essentially identical. This demonstrates the reversibility of the formation of low 
molecular weight β-sheet structures in NDQ10 at high acetonitrile concentrations. Reprinted with permission 
from Punihaole et al. J. Phys. Chem. B. 2017, 121 (24), 5953–5967. Copyright 2017 American Chemical 
Society. 
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Appendix B  
Supporting Information for chapter 6.0 
 Estimation of Error in ΔHint Measurements 
 
To estimate the error of our experimental ΔHint measurements, we estimate the error of 
the AmIP frequency measurements and its propagation when converting AmIP to ΔHint. In 
Chapter 6.0, we use eq. B.1 to calculate ΔHint from the AmIP frequency of formamide: 
 
 𝐴𝑚𝐼𝑃 = (𝑏 + 𝑚(−40 𝑎𝑐𝑐#)) + (−18 𝑘𝑐𝑎𝑙−1 𝑚𝑜𝑙 ∙  𝑚Δ𝐻𝑖𝑛𝑡) 
 
                              B.1 
where the parameters in eq. B.1 are the same as those described for eq. 6.5.  This equation can be 
re-arranged to calculate ΔHint: 
 
 
Δ𝐻𝑖𝑛𝑡 =
𝐴𝑚𝐼𝑃 − (𝑏 +𝑚(𝐴𝑁𝑣𝑎𝑐)
(𝐶𝐹)𝑚
 
 
                   B.2 
 
where CF and ANvac denotes the AN to ΔHint conversion factor and AN of the “vacuum” solvent, 
respectively. The error in eq.  propagates as:220  
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where σ denotes the error of the subscripted variable. For formamide, we determined the error of 
b (±2.82) and m (±0.092) for the linear fit to the formamide AmIP-AN dependence (eq. 6.1). 
Cutmore and Hallam154 report an error of ~±1.5 cm-1 for the determination of their band 
frequencies (σAmI).  
Determining Error in the AN of Vacuum and the AN-ΔHint Conversion Factor 
As described in Chapter 6.0, ANvac was found by equating eqs.  
6.1 and 6.2: 
 
 
𝐴𝑁𝑣𝑎𝑐𝑐 =
𝑏′ − 𝑏
𝑚
 
 
                                              B.4 
 
 
where b’ is the slope of eq. 6.2. To determine the error in ANvac, the error propagates as:220 
 
 
𝜎𝐴𝑁𝑣𝑎𝑐 = |𝐴𝑁𝑣𝑎𝑐|√(
√𝜎𝑏′2 + 𝜎𝑏2
𝑏′ − 𝑏
)2 + (
𝜎𝑚
𝑚
)2 
 
              B.5 
 
𝜎Δ𝐻 = |∆𝐻𝑖𝑛𝑡| 
√
  
  
  
  
  
  
  
  
 
(
 
 
 
 
 √𝜎𝐴𝑚𝐼2 +(√𝜎𝑏
2 + |𝐴𝑁𝑣𝑎𝑐(𝑚)|√(
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𝑚 )
2
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𝜎𝐴𝑁𝑣𝑎𝑐
𝐴𝑁𝑣𝑎𝑐
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𝐴𝑚𝐼 − (𝑏 + 𝑚(𝐴𝑁𝑣𝑎𝑐))
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+
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|𝐶𝐹(𝑚)|√(
𝜎𝐶𝐹
𝐶𝐹)
2
+ (
𝜎𝑚
𝑚 )
2
𝐶𝐹(𝑚)
)
 
2
 
 
                            
B.3 
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where the parameters in eq. B.5 are the same as that in the above equations, and σ is the error of 
the subscripted variable (σb = ±2.82, σb’ = ±5.09, and σm = ±0.092) for formamide. From eq.               
B.5, we find that σANvac = ±13.76. 
We also must determine the error of the conversion factor (eq. 6.3).  The error propagates 
as:220 
 
 
𝜎𝐶𝐹 ≈ |−18 𝑎𝑐𝑐#  𝑘𝑐𝑎𝑙
−1 𝑚𝑜𝑙 |√(
𝜎𝑚
−0.50 𝑐𝑚−1𝑎𝑐𝑐#−1
)
2
+ (
𝜎𝑚′
8.8 𝑐𝑚−1𝑘𝑐𝑎𝑙−1 𝑚𝑜𝑙
)
2
 
 
B.6 
 
where σCF is the error in the conversion factor, σm (±0.0915 cm-1 acc#-1) is the error of the slope 
of eq.6.1, and σm’ (±1.39 cm-1 kcal-1 mol) is the error of the slope of eq. 6.2.  From this, we 
calculate an error of ±4.346 acc# kcal-1 mol for CF. 
Estimation of Error for Formamide ΔHint Values 
We have the uncertainty of each parameter in eq.  and can calculate the error in ΔHint 
from our AmIP-AN dependence of formamide. The variables are as follows: m= -0.5±0.092 cm-1 
acc#-1, b=1715±2.82 cm-1, AmI= observed frequency±1.5 cm-1, ANvac= -40±13.76 acc#, CF=-
18±4.346 acc# kcal-1 mol, and ΔHint is determined by eq. B.7 from a given AmIP frequency.  
 
 
Δ𝐻𝑖𝑛𝑡 =
𝐴𝑚𝐼𝑃 − (𝑏 +𝑚(𝐴𝑁𝑣𝑎𝑐)
(𝐶𝐹)𝑚
=
𝐴𝑚𝐼𝑝 − 1735 𝑐𝑚−1
9 𝑐𝑚−1𝑘𝑐𝑎𝑙−1𝑚𝑜𝑙
 
 
                         B.7 
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Thus, ΔHint and its error depend on the experimental AmIP frequency. From eq.  we calculate the 
error in ΔHint for formamide for the average AmI frequency observed (1702 cm-1) and find an 
error of ~±1.45 kcal mol-1.  
Estimation of Error for Q10 ΔHint Values 
For our calculation of ΔHint of Q10 however, we use the AmI-AN dependence of 
propanamide instead of formamide because propanamide better models the Q side chain. 
Because we do not know the true AmIP-AN or AmIP-ΔHint dependence of Q10, we cannot obtain 
the errors in the slopes and intercepts needed to directly determine our error in calculating Q10 
ΔHint.  
 Instead, to estimate our errors for ΔHint of Q10, we assume that the correlations for Q10 
will be similar to that of formamide. However, we now use the slope (mp=-0.64 cm
-1 acc#-1) and 
intercept (bp=1704 cm
-1) of the dependence of propanamide AmIP band on AN. Also, in Chapter 
6.0, we assume that the AN-ΔHint conversion factor (CF) and the AN of vacuum (ANvac) are 
constant, and we will also assume this to be true for our error estimation. Because the values of 
m and b are different for propanamide, we use eqs.               B.5 and B.6 to recalculate the error 
in our ANvac and CF values. We find the errors to be ±10.6 acc# and ±3.38 acc# kcal
-1 mol for 
ANvac and CF respectively. In our calculation of ANvac and CF errors, we use the equations 
b’=b+m(ANvac) and m’=m(CF) from Chapter 6.0 to determine the value of b’ and m’ 
respectively.  
We now have every variable needed to estimate the error in calculating ΔHint for Q10 
from the AmIP-AN dependence of propanamide:  mp= -0.64±0.092 cm
-1 acc#-1, bp=1704±5.09 
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cm-1, AmI= observed frequency±1.5 cm-1, ANvac= -40±10.64 acc#, CF=-18±3.38 acc# kcal
-1 
mol, and ΔHint is determined by eq. B.8 for a given AmIP frequency.  
 
 
Δ𝐻𝑖𝑛𝑡 =
𝐴𝑚𝐼𝑃 − (𝑏 +𝑚(𝐴𝑁𝑣𝑎𝑐)
(𝐶𝐹)𝑚
=
𝐴𝑚𝐼𝑝 − 1730 𝑐𝑚−1
11.52 𝑐𝑚−1𝑘𝑐𝑎𝑙−1𝑚𝑜𝑙
 
 
                          B.8 
 
 
ΔHint and its error depend on the experimental AmIP frequency which ranges from ~1660 to 
~1680 cm-1 for Q10. From eq. , we estimate an error of ~±1.25 kcal mol-1 and ~±1.59 kcal mol-1 
for Q10 side chains hydrated (1680 cm-1) and in peptide-peptide interactions (1660 cm-1), 
respectively. Our estimated error is less than the ~1.7 kcal mol-1 difference in ΔHint between 
solvated side chains and side chains involved in peptide-peptide interactions. In contrast, our 
estimated error is much greater than the ~0.5 kcal mol-1 difference in ΔHint between DQ10 and 
NDQ10 fibrils.   
Error in Abscissa of Equation 6.1 (AN) Negligible 
It is important to note that our linear regression for the dependence of the AmIP frequency 
on AN (eq. 6.1) and AmIP frequency on ΔHint (eq. 6.2) assumes that there is negligible error in 
the solvent AN and ΔHint values, respectively. Here, we show that this assumption is valid by 
comparing the errors of the measured AN and ΔHint values to that of the AmIP frequency.  
Solvent AN values were determined via NMR measurements of triethylphosphine 
(Et3OP) by Mayer et al.
156 The 31P chemical shift of Et3PO was measured with an error of <±0.05 
ppm. The AN value is calculated from the chemical shift using the following formula:156  
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𝐴𝑁 =
𝛿𝑐𝑜𝑟𝑟
𝛿𝑐𝑜𝑟𝑟(𝑆𝑏𝐶𝑙5 ∙ 𝐸𝑡3𝑃𝑂)
× 100 
 
                                     B.9 
 
where δcorr(SbCl5 ∙ Et3PO) is the 31P chemical shift of Et3PO in SbCl5 at infinite dilution and δcorr 
is the chemical shift of Et3PO in the solvent of interest. Thus, the error in chemical shift 
propagates as:220 
 
 
𝜎𝐴𝑁 ≈ |
𝛿𝑐𝑜𝑟𝑟
𝛿𝑆𝑏𝐶𝑙5
|√(
𝜎𝑐𝑜𝑟𝑟
𝛿𝑐𝑜𝑟𝑟
)
2
+ (
𝜎𝑆𝑏𝐶𝑙5
𝛿𝑆𝑏𝐶𝑙5
)
2
 × 100 
 
                   B.10 
 
where σAN is the standard deviation of the AN value, δcorr is the 31P chemical shift of Et3PO in a 
solvent of interest, δSbCl5 is the 31P chemical shift of Et3PO in SbCl5, σcorr is the standard 
deviation of δcorr, and σSbCl5 is the standard deviation of δSbCl5. Using an error of ±0.05 ppm, 
chemical shift values, and AN values reported by Mayer et al.156 we calculate that σAN is ~±0.12.  
In comparison, Cutmore and Hallam154 report a “precision” of ~±1.5 cm-1 for their band 
frequency measurements. To directly compare σAN and σAmI, we convert σAN to σAmI using eq.  
6.1, neglecting error in the slope of the linear fit. The error propagates as: 
 
 𝜎𝐴𝑚𝐼 = 𝜎𝐴𝑁|−0.5 𝑐𝑚
−1 𝑎𝑐𝑐#−1| 
 
                                         B.11 
 
An error of σAN~±0.12 corresponds to an error of σAmI~±0.06. Therefore, the error introduced to 
the correlation by the measurement of AN (σAmI~±0.06) is ~4% of that introduced by the 
measurement of the AmI frequency (σAmI~±1.5 cm-1), and we can neglect the error in the 
measurement of the solvent AN. 
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Error in Abscissa of Equation 6.2 (ΔHint) Negligible 
Thermodynamic data on the solvation of formamide in different solvents was collected 
by  Varfolomeev et al.153 The enthalpy of solvation (ΔHsolv) was determined for the dissolution 
of formamide in different solvents with an error of ~±0.05 kJ mol-1 (~±0.012 kcal mol-1) and this 
value was used to calculate the enthalpy of hydrogen bonding (ΔHint) between formamide and 
various solvents. We were unable to explicitly determine the error for the ΔHint values reported 
by Varfolomeev et al.153. Therefore, we use the ΔHsolv error reported by Varfolomeev et al.153 as 
an estimate of the error of the ΔHint values they report for formamide. 
To directly compare σΔH and σAmI, we convert σΔH to σAmI using eq. 6.2. Neglecting error 
in the slope of the linear fit, the error propagates as:220 
 
 𝜎𝐴𝑚𝐼 = 𝜎Δ𝐻|8.8 𝑐𝑚
−1 𝑘𝑐𝑎𝑙−1𝑚𝑜𝑙|                          B.12  
 
                      
An error of σΔH~±0.012 kcal mol-1 corresponds to an error of σAmI~±0.1 cm-1. Therefore, 
the error introduced to the correlation by the measurement of ΔH (σAmI~±0.1 cm-1) is ~7% of that 
introduced by the measurement of the AmI frequency (σAmI~±1.5 cm-1), and we can neglect the 
error in the measurement of the solvent ΔH. 
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 Fitting the AmIs Spectra of Q10 Fibrils 
Figure B.1 shows our fitting of the AmIS UVRR spectra for Q10 fibrils prepared from β-
strand and PPII monomers.  The data was originally reported by Punihaole et al.46  The spectra 
were fit using a script written in MATLAB (ver. 2015b, Natick, MA, MathWorks Inc.) .  The 
spectra, I(ν), were best-fit to the sum of four Lorentzian bands: 
 
 
𝐼(𝜐) = ∑
𝐻𝑖
4 (
𝜐 − 𝜐𝑖
𝑤𝑖
)
2
+ 1
𝑛=4
𝑖=1
 
 
                                B.13  
 
where Hi is the amplitude, νi is the center frequency, and wi is the width of the ith Lorenztian 
band.  
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Figure B.1: Fitting of the AmIS region of the UVRR spectra of Q10 fibrils prepared from (a) β-strand and (b) 
PPII monomers.  The spectra were taken from data collected by Punihaole et al.46   The spectra were fit to 
the sum of four Lorentzian bands. Reprinted with permission from Jakubek et al.  J. Phys. Chem. B., 2019, 
123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
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Appendix C  
Supporting Information for Chapter 7.0 
 UVRR Curve-Fitting 
Grams software (version 8.0, Thermo Fisher Scientific, Inc.) was used to model the Q20 
UVRR spectra as a sum of Gaussian and Lorentzian bands: 
 
𝒇(𝒙) = ∑ (𝟏 −𝑴)(𝑯𝒆−(
𝒙−𝒙𝟎
𝒘
)𝟐(𝟒𝐥𝐧 (𝟐))
𝒊 ) + (𝑴)(
𝑯
𝟒(
𝒙−𝒙𝟎
𝒘
)𝟐+𝟏
)                C.1  
 
where H is the peak height, x0 is the center peak frequency, w is the full width at half height, 
M=1 if the band is Lorentzian, and M=0 if the band is Gaussian for the ith UVRR band. The 
AmIII3
S bands where modeled as Gaussians because they are inhomogenously broadened by the 
Ψ angle distribution of the peptide.74  
 Ramachandran Ψ Angle Calculation 
Methodologies for determining the relationship between the AmIII3
S frequency and Ψ 
angle are reported by Mikhonin et al.2 The procedure used to determine the Ψ angle distribution 
from the inhomogeneous width of the AmIII3
S band was previously reported by Asher et al.1 We 
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assume that the inhomogeneous broadening of the AmIII3
S band results from only the Ψ angle 
distribution of the peptide. The Gaussian AmIII3
S bands where modeled as a sum of Lorentzian 
bands with identical homogenous linewidths: 
 
 
𝐴𝑚𝐼𝐼𝐼3
𝑆 =
1
𝜋
∑
𝑝𝑖Γ
2
Γ2 + (𝑣 − 𝑣𝑖)2
𝑀
𝑖
 
                                C.2 
                      
where pi is the probability that the i
th band occurs at center frequency νi and Γ is the homogenous 
linewidth of the AmIII3
S band. The AmIII3
S homogenous linewidth was previously estimated to 
be ~7.5 cm-1 for small crystalline peptides.74 The Ψ angle for each Lorentzian band was 
calculated using the appropriate equation derived by Mikhonin et al.64 to obtain a Ψ angle 
distribution.   
The following equation was developed by Mikhonin et al.64 to calculate Ψ from the 
AmIII3
S frequency for a peptide backbone completely solvated by water: 
 
           𝒗𝒊 = 𝟏𝟐𝟓𝟔 (𝒄𝒎
−𝟏) − 𝟓𝟒(𝒄𝒎−𝟏) 𝐬𝐢𝐧(𝚿 + 𝟐𝟔) − 𝟎. 𝟏𝟏(
𝒄𝒎−𝟏
°𝑪
)(𝑻 − 𝑻𝟎)                          C.3 
 
where νi is the frequency of the ith Lorentzian band, T is the sample temperature (°C), and T0 = 
00C. We use this equation to calculate Ψ angles for the PPII and 2.51-helix conformations of 
DQ20 and the NDQ20 supernatant, which have peptide backbones that are completely solvated 
in water. 
The following equation is used to calculate the Ψ angle distribution for a peptide 
backbone in an unknown solvation environment: 
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           𝒗𝒊 = 𝟏𝟐𝟓𝟎 (𝒄𝒎
−𝟏) − 𝟓𝟒(𝒄𝒎−𝟏) 𝐬𝐢𝐧(𝚿 + 𝟐𝟔) − 𝟎. 𝟎𝟔 (
𝒄𝒎−𝟏
°𝑪
) (𝑻 − 𝑻𝟎)                            
C.4  
 
where the variables are the same as discussed above for equation C.3. This equation was used to 
calculate the Ψ angle distribution for the turn-like structures found in DQ20 where the peptide 
backbone can engage in either peptide-peptide and/or peptide-water hydrogen bonds. 
To calculate the Ψ angle of Q20 powder and NDQ20 in water, we used the following 
equation by Mikhonin et al.64 to calculate Ψ for crystalline peptides: 
 
                               𝒗𝒊 = 𝟏𝟐𝟔𝟎 (𝒄𝒎
−𝟏) − 𝟓𝟒(𝒄𝒎−𝟏) 𝐬𝐢𝐧(𝚿 + 𝟐𝟔)                                          C.5  
 
This equation is used to calculate the Ψ angle for solid, anhydrous peptides. To calculate 
Ψ for NDQ20 fibrils, we use the equation developed by Mikhonin et al.64 for anhydrous β-sheet 
and α-helix conformations. 
 
                                   𝒗𝒊 = 𝟏𝟐𝟑𝟗 (𝒄𝒎
−𝟏) − 𝟓𝟒(𝒄𝒎−𝟏) 𝐬𝐢𝐧(𝚿 + 𝟐𝟔)                                     C.6  
 
This equation is used for anhydrous peptide backbones involved peptide-peptide 
hydrogen bonding of canonical β-sheet and/or α-helical structures. 
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 Absorbance of TFA 
 
 
 
Figure C.1: Absorbance spectrum of 1% (v/v) TFA in water. Reprinted with permission from Jakubek et al. 
J. Phys. Chem. B., 2019, 123, 8, 1749-1763. Copyright 2019 American Chemical Society. 
  
   298  
 
 
 
 
Figure C.2: Comparison of 204 nm UVRR spectra of (blue) DQ10 fibrils and (green) DQ20 fibrils. The 
AmIII3S and AmI spectral regions are similar indicating that DQ10 and DQ20 fibrils have similar secondary 
structure and hydrogen bonding interactions. The only significant difference between the two spectra is the 
presence of a strong band at ~1435 cm-1 in DQ10 fibrils that is not observed in DQ20 fibrils. This band has 
the same frequency as the C=O stretching band of TFA, which is strongly resonance enhanced at 204 nm 
excitation (see Chapter 7.0). It is possible that this band arises from TFA in the supernatant of the DQ10 
fibrils. When the DQ20 fibrils were prepared they were washed three times with nanopure H2O to remove 
any TFA in the supernatant. Reprinted with permission from Jakubek et al. J. Phys. Chem. B., 2019, 123, 8, 
1749-1763. Copyright 2019 American Chemical Society. 
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Appendix D  
Supporting Information for Chapter 8.0 
 UVRR Curve-Fitting 
We used Grams software (version 8.0, Thermo Fisher Scientific, Inc. Waltham, Mass., 
USA) to model each UVRR spectrum as a sum of Gaussian and Lorentzian bands: 
 
𝑓(𝑥) = ∑ (1 − 𝑀)(𝐻𝑒−(
𝑥−𝑥0
𝑤
)2(4ln (2))
𝑖 ) + (𝑀) (
𝐻
4(
𝑥−𝑥0
𝑤
)2+1
)                                       D.1 
 
where H is the peak height, X0 is the peak frequency, w is the full width at half height, M=1 if 
the band is Lorentzian, and M=0 if the band is Gaussian for the ith UVRR band. The AmIII3
S 
fitted bands were modeled as Gaussian bands because they are inhomogenously broadened due 
to the peptide Ψ angle distribution.74  
 Ψ Ramachandran Angle Calculation 
Details describing the methodologies for calculating Ψ angle distributions are reported by 
Mikhonin et al.64,74 We assume that the inhomogeneous broadening of the AmIII3
S band results 
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from only the Ψ angle distribution of the peptide. The Gaussian AmIII3S bands were modeled as 
a sum of Lorentzian bands with identical homogenous linewidths: 
 
                                  𝐴𝑚𝐼𝐼𝐼3
𝑆 =
1
𝜋
∑
𝑝𝑖Γ
2
Γ2+(𝑣−𝑣𝑖)2
𝑀
𝑖                                        D.2  
 
where pi is the probability that the i
th band occurs at center frequency υi, and Γ is the 
homogenous linewidth of the AmIII3
S band. The AmIII3
S homogenous linewidth was previously 
estimated from peptide crystals to be ~7.5 cm-1.74 After fitting the AmIII3
S band to Lorentzian 
bands, we calculated the Ψ angle for each Lorentzian band using the equations derived by 
Mikhonin et al.64 to obtain a Ψ angle distribution.   
We use the following equation to calculate the Ψ angle distribution for the PPII-like and 
2.51-helix-like AmIIIS
3 bands of DQ peptides: 
 
𝑣𝑖 = 1256 (𝑐𝑚
−1) − 54(𝑐𝑚−1) sin(Ψ+ 26) − 0.11(
𝑐𝑚−1
°𝐶
)(𝑇 − 𝑇0)                  D.3 
 
where υi is the frequency of the ith Lorentzian band, T=18°C is the sample temperature, and 
T0=0°C. As discussed by Mikhonin et al.,
64 this equation is used when the peptide bonds are 
fully exposed for water as expected for PPII and 2.51-helix conformations. 
We use the following equation to calculate the Ψ angle distribution for the turn-like and 
β-strand-like AmIII3S bands of DQ and NDQ peptides respectively: 
 
𝑣𝑖 = 1250 (𝑐𝑚
−1) − 54(𝑐𝑚−1) sin(Ψ+ 26) − 0.06(
𝑐𝑚−1
°𝐶
)(𝑇 − 𝑇0)                     D.4 
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where the variables are the same as those defined for equation D.3. As discussed by Mikhonin et 
al.,64 this equation is used when the hydration state of the peptide backbone is unknown. 
 
 Modeling DQ15 and DQ20 CD Spectra 
We modeled the CD spectra of DQ15 and DQ20 as a linear sum of DQ10 and NDQ15 
basis spectra. In the Chapter 8.0 we show that NDQ10-15 peptides are in a predominately β-
strand-like conformation with no noticeable differences in structure. Therefore, either the 
NDQ10 or NDQ15 CD spectrum could be used as a CD basis spectrum for the pure β-strand-like 
polyQ conformation. We use the CD spectrum of NDQ15 as our β-strand-like basis spectrum. In 
the Chapter 8.0 we also show that longer DQ peptides contain a larger sub-population of β-strand 
conformation. Therefore, we use our smallest DQ peptide (DQ10) as our basis spectrum for the 
pure DQ PPII-like structure. Spectra were modeled using the following equation: 
 
𝑀𝑜𝑑𝑒𝑙 𝑆𝑝𝑒𝑐𝑡𝑟𝑢𝑚 = (𝐷𝑄10 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚 × 𝐶𝐷𝑄10) + (𝑁𝐷𝑄15 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚 × 𝐶𝑁𝐷𝑄15)   D.5 
 
where CDQ10 and CNDQ15 are coefficients. The coefficients were adjusted to minimize the sum of 
the residual between the spectrum of interest and the model spectrum. We estimated the relative 
amount of PPII-like and β-strand-like structure in our model spectra from the coefficient values 
as follows: 
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                                  %𝛽𝑠𝑡𝑟𝑎𝑛𝑑 =
𝐶𝑁𝐷𝑄15
𝐶𝑁𝐷𝑄15+𝐶𝐷𝑄10
                                           D.6 
                                  %𝑃𝑃𝐼𝐼 =
𝐶𝐷𝑄10
𝐶𝑁𝐷𝑄15+𝐶𝐷𝑄10
                                                  D.7 
  
Our estimates assume that the DQ10 and NDQ15 CD basis spectra represent the pure 
PPII-like and β-strand-like structures of the polyQ peptide, respectively.   
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Figure D.1: CD spectral modeling of DQ15. (Blue) CD spectrum of DQ15, (Red) model spectrum from linear 
sum of DQ10 and NDQ15 spectra, (Black) residual (DQ15-Model difference spectrum. Reprinted with 
permission from Jakubek et al., J. Phys. Chem. B., 2019 123(19), 4193-4203. Copyright 2019 American 
Chemical Society. 
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Figure D.2: CD spectral modeling of DQ20. (Blue) CD spectrum of DQ20, (Red) model spectrum from linear 
sum of DQ10 and NDQ15 spectra, (Black) residual (DQ20-Model difference spectrum). Reprinted with 
permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 American 
Chemical Society.  
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 Modeling β-Strand Sub-populations in DQ Peptides 
 
 
Figure D.3: Spectra of DQ20 with 1240 cm-1 band artificially added to model (a) 0%, (b) 10%, (c) 20%, (d) 
30%, (e) 50%, and (f) 80% sub-populations of β-strand-like structure in DQ peptides. The 1250 cm-1 band 
(yellow) is that of the PPII-like conformation found in DQ peptides. The 1240 cm-1 band (green) is artificially 
added to model a β-strand sub-population. Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 
2019, 123(19), 4193-4203. Copyright 2019 American Chemical Society.  
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 Temperature Dependence of DQ15 
 
 
Figure D.4: Temperature dependence of the DQ15 CD spectrum. The DQ15 CD spectra at 20°C and 50°C are 
similar indicating only minute structural changes. In contrast, DQ20 shows a significant structural change 
upon heating from 20°C to 50°C (Figure 8.10). This difference occurs because DQ15 contains a smaller β-
strand-like sub-population compared to DQ20. As discussed in Chapter 8.0, the β-strand-like structure is 
sensitive to a temperature increase from 20°C to 50°C while the PPII-like structure shows negligible change.  
Reprinted with permission from Jakubek et al., J. Phys. Chem. B., 2019, 123(19), 4193-4203. Copyright 2019 
American Chemical Society. 
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Appendix E  
Supporting Information for Chapter 9.0 
 DOSY NMR 
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Figure E.1: 1H NMR spectra of NDQ15, DQ15, and DQ20. Peaks originating from protons on Gln and Lys 
residues are labeled.  
  
   309  
 
 
 
 
 
Figure E.2: 1H NMR spectra of DQ10 and NDQ10 previously collected by Punihaole et al.71 Peaks originating 
from protons on Gln and Lys residues are labeled.  
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1H NMR chemical shifts where assigned using the work of Bundi et al.221 The peaks 
found at ~2.00 ppm are assigned to the CβH hydrogens of Gln, and the peak at ~2.35 ppm is 
assigned to the CγH hydrogen of the Gln side chain. The peaks found at ~1.4 ppm, ~1.6 ppm, and 
~2.9 ppm are assigned to CγH, CδH, and CεH hydrogens of the Lys side chain, respectively. 
 
 
 
Figure E.3: DOSY NMR signal decays for the Glutamine and Lysine resonances of DQ10 and NDQ10.  
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 Diffusion Coefficient and Van Der Waals Volume of DQ Peptides 
 
 
 
Figure E.4: Linear correlation between the reciprocal of the diffusion coefficient and molecular volume for 
DQ peptides. Molecular volumes of DQ10, DQ15, and DQ20 were calculated by summing the volumes of Gln, 
Lys, and Asp amino acids reported by Zamyatnin.222  
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 Time Dependence of NDQ15 NMR Spectra 
 
 
 
Figure E.5: H1 NMR spectra of NDQ15 after sample preparation and 5 hours after sample preparation. 
Spectra are normalized to the Lys 1.3 ppm peak. The spectra are essentially identical indicating that the 
relative concentration of the monomer and oligomer species does not significantly change during DOSY data 
collection. 
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Appendix F  
Description of Ψ Angle Calculation Procedure 
 Determination of Ψ Angle Distributions of the AmIII3S band 
The AmIII3
S (where the superscript “S” denotes the secondary amide peptide bond) Ψ 
dihedral angle distributions were calculated using methodologies previously described in detail.62 
First, the UVRR spectrum of a polyQ peptide between 1150 cm-1 and 1750 cm-1 was assigned 
and fit to a sum of Gaussian and Lorentzian bands based on our previous, detailed UVRR 
assignments of small peptides62 and of Gln side chains.71 The UVRR spectral fit and assignments 
of disaggregated Q20 (DQ20) and non-disaggregated Q15 (NDQ15) are shown in figure 1. 
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Figure F.1: UVRR (204 nm) spectral fits and assignments of NDQ15 and DQ20. 
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The bands found in the ~1650-1700 cm-1 spectral region are assigned to the AmI bands of 
the peptide backbone and Gln side chains.62,118 The band at ~1615 cm-1 is assigned to the AmII 
band of the Gln side chains (AmIIP) based on our previous assignments of Gln.71  The band at 
~1550 cm-1 is assigned to the AmII band of the peptide backbone, which overlaps the 
atmospheric oxygen O2 stretching band (~1560 cm
-1). The intense band at ~1400 cm-1 is assigned 
to the CγH2 wagging band of the Gln side chain.
71 The intense band observed at ~1435 cm-1 in 
the spectrum of the disaggregated (but not of the non-disaggregated) peptides is assigned to the 
CO stretching band of trifluoroacetic acid (TFA) that is left over after the disaggregation 
procedure.193 The bands at ~1355, ~1320, and ~1295 cm-1 are assigned to the CαH bending, 
AmIII1, and AmIII2 bands, respectively.
82,118 The low intensity band at ~1265 cm-1 is assigned to 
the CγH2 wagging band of the Gln side chain.
71  The band observed at ~1160 cm-1 is assigned to 
the CαH rocking band of the Gln side chain.
71 
The AmIII3
S bands of peptides are found in the ~1200-1300 cm-1 spectral region. The 
AmIII3
S bandshape and frequencies depend on the peptide’s secondary structure. Thus, the 
AmIII3
S bands of the disaggregated (DQ) and non-disaggregated (NDQ) polyQ peptides differ. 
For NDQ peptides we find a single AmIII3
S band located at ~1240 cm-1. In contrast, DQ peptides 
have AmIII3
S bands located at ~1275, ~1250, and ~1215 cm-1. The AmIII3
S bands were fit to 
Gaussians because the distribution of peptide Ψ angles must inhomogenously broaden the 
AmIII3
S bands.  
We assume that the inhomogenously broadened AmIII3
S band (B(ν)) can be modeled as 
the sum of M Lorentzian bands of identical homogeneous linewidth: 
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                             F.1 
 
 
where pi is the probability for the i
th Lorentzian band to occur at center frequency νi, while Γ is 
the homogeneous linewidth of the AmIII3
S
 vibration. We previously determined from peptide 
crystals that Γ is ∼7.5 cm−1 for the AmIII3S bands.71,74 The AmIII3S bands were fit to the sum of 
the fewest number of Lorentzian bands (M) needed to accurately model the AmIII3
S band shape. 
We utilized Γ =7.5 cm−1 and a 5 cm-1 separation between Lorentzians. 
After fitting the inhomogeneously broadened AmIII3
S bands to a sum of Lorentzians, we 
calculated the individual contributing Ψ dihedral angles from the center frequency of each 
Lorentzian band as described in section F.2.  
 Correlating the AmIII3S Frequencies to their Ψ Angle Distribution 
We calculated the Ψ angle distributions from the set of AmIII3S Lorentzian band 
frequencies using the equations of Mikhonin et al. who proposed different AmIII3
S νi-Ψ angle 
correlations for peptide bonds with different peptide bond solvation states.64   
We calculated Ψ angle distributions for the AmIII3S bands indicative of PPII and 2.51-
helix structures using eq. F.2: 
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𝜐𝑖 = 1256 cm
−1 − 54cm−1 sin(Ψ + 26) − 0.11 cm−1/°𝐶(𝑇 − 𝑇0)     F.2   
where T = 18°C is the sample temperature and T0 = 0°C. Rearrangement of this equation to solve 
for Ψ yields the equation: 
 
Ψ = arcsin (
𝜐𝐴𝑚𝐼𝐼𝐼 − 1256 + 0.11(𝑇 − 𝑇0)
−54
) − 26 
                    F.3 
 
 
As discussed in detail by Mikhonin et al.,64 eq. F.3 is used for situations when the peptide 
bonds are fully exposed to water, such as in the case of PPII-like and 2.51-helices. 
Eq. F.4 was utilized to calculate the Ψ Ramachandran angles from the AmIIIS3 band 
frequencies of structures with complex or poorly defined solvation such as for turn-like 
conformations: 
 
 𝜐𝑖 = 1250 cm
−1 − 54cm−1 sin(Ψ + 26) − 0.06 cm−1/°𝐶(𝑇 − 𝑇0)                   F.4 
 
where parameters T and T0 are defined as in eq. F.2. Rearrangement of eq F.4 to solve for Ψ 
yields: 
 
Ψ = arcsin (
𝜐𝐴𝑚𝐼𝐼𝐼 − 1250 + 0.06(𝑇 − 𝑇0)
−54
) − 26 
    F.5 
 
Eq. F.5 is recommended by Mikhonin et al.64 for situations when the hydrogen bonding states of 
the peptide bond N–H groups are complex. This situation occurs, for example, in the case of 
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turn-like structures, where the peptide bonds can engage in both inter-amide and amide-water 
hydrogen bonding. 
 Valid Range of Lorenzian Frequencies 
It is important to note that some Lorentzian band frequencies lie outside the valid range 
of our AmIII3
S
 νi -Ψ angle correlations. For example, Ψ < ~1200 and Ψ >~1310 values are 
invalid because they are just outside the valid sin Ψ domain frequency range, (Figure F.2).  
To determine the valid limits of the AmIII3
S
 νi -Ψ correlation frequency range, we 
calculated the valid lower and upper limits of the AmIII3
S νi frequency in equations F.2 and F.4. 
In these equations, the maxima and minima of νi depend on the maximum and minimum values 
of the term -54 cm-1 sin(Ψ+26°), while all other terms are constant. We calculated νi for 
equations F.2 and F.4 to determine the maximum and minimum values of the quantity -54(cm-1) 
sin(Ψ+26°). 
For example, we determined the lower limit of the AmIII3
S νi frequency correlation by 
minimizing the term -54 cm-1sin (Ψ+26) of eq F.2 (T=18o) 
𝜐𝑖 = 1254 cm
−1 − 54 cm−1 
and eq F.4 (T=18o) 
𝜐𝑖 = 1249 cm
−1 − 54 cm−1 
We calculated the lower limits of equations F.2 and F.4 to be 1200 cm-1 and 1195 cm-1, 
respectively. We find that the νi minimum allowed Ψ values occur at Ψ=64°. Because of the 
resulting decrease in the AmIII3
S νi frequencies, additional regions of the Ψ angle distribution 
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become invalid solutions. Figure F.3 illustrates this point; the data for Ψ>40° are invalid, and are, 
thus, ignored.    
By calculating νi for maximum values of the term -54cm-1 sin(Ψ+26), we determined that 
the upper limits of eqns F.2 and F.4 are νi=1308 cm-1 and νi=1303 cm-1, respectively. The νi 
frequency maximum occurs at Ψ=-116°. Thus, νi frequency values >~1310 cm-1 are undefined. 
An example of a Ψ angle outside the AmIII3S -Ψ correlation range can be shown for an 
AmIII3
S frequency of 1190 cm-1 for a peptide with complicated hydrogen bonding (eq F.4): 
𝜐𝑖 = 1250 cm
−1 − 54cm−1 sin(Ψ + 26) − 0.06 cm−1/°𝐶(𝑇 − 𝑇0) 
1190 cm−1 = 1250 cm−1 − 54cm−1 sin(Ψ + 26) − 0.06 cm−1/°𝐶(𝑇 − 𝑇0) 
Because T-T0=18°: 
1190 cm−1 = 1250 cm−1 − 54cm−1 sin(Ψ + 26) − 1.08 cm−1 
1190 cm−1 = 1249 cm−1 − 54cm−1 sin(Ψ + 26) 
−59 cm−1 = −54cm−1 sin(Ψ + 26) 
1.09 = sin(Ψ + 26) 
sin−1(1.09) = Ψ + 26° 
sin−1(1.09)is mathematically undefined! 
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Figure F.2: Range of the AmIII3S  νi frequency-Ψ angle correlation.  The red boxes highlight AmIII3S 
frequencies that are outside of the valid correlation range.  
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Figure F.3: Ψ angle distribution of the DQ10 peptide. The blue arrow indicates the exclusion of particular Ψ 
angles from the distribution. As discussed above, these excluded Ψ angles occur because the frequencies of the 
Lorentzian bands that model the Ψ angle distribution lie outside of the valid range of Ψ angles.  
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Our Ψ angle distributions will show gaps between data points as our Ψ angle distributions 
approach Ψ =64° (Figure F.4). To calculate the Ψ angle distributions, we use Mikhonin’s 
equations to convert the center frequencies of our AmIII3
S
 frequency Lorentzian bands into Ψ 
angles.64 Our Ψ angle distribution histograms consist of an array of discrete data points each 
represented by a histogram bar chosen to have a width of ~7°.  
For adjacent Ψ angle distances of ≤ 7° the bars overlap. Because there is a sinusoidal 
AmIII3
S νi-Ψ correlation, the spacing between Ψ angle data points depends on the AmIII3S 
frequency. At ~1230 cm-1 (Ψ = ~0°) δΨ/δν = ~1°/cm-1 resulting in a spacing between bars of ~5° 
and the bars overlap (Figure F.5).  At ~1210 cm-1 (Ψ = ~30°) δΨ/δν = ~2°/cm-1 resulting in a 
spacing of ~10° and gaps appear between histogram data points as shown in Figure F.5.  
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Figure F.4: Gaps between Ψ angle data points in the Ψ angle distribution of DQ10. These gaps are indicated 
by the blue arrow. 
 
 
Figure F.5: Overlapped histogram bars of the Ψ angle distribution of DQ10. The blue arrows indicate regions 
where the spacing between data points show both overlapping and non-overlapping Ψ angle bars (see text for 
details).  
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